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 Nerve Growth Factor (NGF) has long been recognized as a critical factor 
in the survival and maintenance of sympathetic neurons.  Recent findings have 
shown that NGF is also required for the sympathetic neuron’s axonal growth and 
appropriate target organ innervation during development.  However, the 
molecular mechanisms by which NGF elicits these effects are largely unknown.  
The ubiquitously expressed adapter protein SH2B1 binds to active NGF receptor 
TrkA and has been implicated in NGF-mediated differentiation and survival of 
sympathetic neurons.  This work provides evidence that SH2B1β facilitates the 
NGF-dependent nuclear export of FoxO1, a pro-apoptotic transcription factor.  
While SH2B1 was originally thought to localize and function only at the cell 
membrane, more recent studies indicated that SH2B1β undergoes 
nucleocytoplasmic shuttling.  The work described in this thesis identifies a 
functional nuclear localization sequence and provides evidence that nuclear 
cycling of SH2B1β is critical to promote NGF-mediated differentiation of the 
preneuronal PC12 cell line.  SH2B1β was found to specifically enhance the NGF-
induced transcription of a primary response gene required for neuronal 
differentiation, urokinase plasminogen activator receptor (uPAR).  Preventing 
xi 
translocation either into or out of the nucleus abolished the ability of SH2B1β to 
enhance the transcription of uPAR in response to NGF.  Similarly, NGF-
dependent neurite outgrowth was inhibited in PC12 cells stably expressing a 
nuclear import defective SH2B1β.  Knocking down endogenous levels of SH2B1 
inhibited the NGF-induced transcription of uPAR as well as NGF-dependent 
neurite outgrowth, suggesting that endogenous SH2B1 is required for both NGF-
dependent gene expression and neurite outgrowth.  TAP tagged-SH2B1β was 
used to identify nuclear binding partners of SH2B1, including a putative 
transcription factor that inhibits NGF-dependent neurite outgrowth.  Taken 
together, these results suggest a nuclear role for SH2B1β during NGF-dependent 
differentiation and survival.  The ability of SH2B1β to influence the subcellular 
localization of FoxO1 and bind to and counteract the function of a novel 
transcription factor raises the possibility SH2B1β cycling between the nucleus 






 The central challenge in understanding the development of the nervous 
system is to determine the molecular mechanisms that enable neurons to extend 
their axons and dendrites, precisely navigate great distances in order to find their 
correct targets, and selectively synapse with them.  The central nervous system 
contains over 100 billion neurons intricately connected together, each one 
forming, on average, over 1000 associations with other neurons (1).  
Understanding such a complex network is a formidable feat.  However, it is of 
utmost importance in order to improve the treatment of neural developmental 
defects, neurodegenerative diseases, and spinal cord injury.  Adding to the 
difficulty of studying neurons within the central nervous system (CNS) is the fact 
that the viability of the organism hinges upon its proper function.  Consequently, 
genetic and or physical manipulations to the CNS often result in lethality.  As a 
result, the postganglionic sympathetic neuron has become a preferred model for 
studying the mechanisms involved in the formation of the nervous system.   
2 
The Sympathetic Nervous System 
 
 The sympathetic nervous system is part of the autonomic nervous system 
(ANS), which is critical in maintaining homeostasis in the body.  The majority of 
the functions performed by the ANS are carried out without conscious control.  
Postganglionic sympathetic neurons innervate almost every organ system in the 
body and thus regulate many physiological processes, including blood pressure, 
blood glucose levels, respiration, heart rate, pupil dilation, and gastrointestinal 
paristalsis.  During an organism’s resting state, the sympathetic nervous system 
is basally active, although, it becomes more active during times of stress.  Upon 
activation by a stressor, the sympathetic nervous system simultaneously affects 
the multiple organ systems which it innervates, triggering an increase in heart 
rate, mobilization of glucose from the liver, dilation of pupils and bronchi, and 
increased sphincter tone (2).  Despite these dramatic physiological effects, 
animals are able to survive without a sympathetic nervous system.  Examples of 
complete surgical extirpation of the sympathetic chain (sympathectomy) have 
demonstrated postoperative viability, although these animals require constant 
temperature control and stress free environments (3). 
Development of the Sympathetic Nervous System 
 Postganglionic sympathetic neurons develop from neural crest cells, which 
migrate ventrolaterally within the mesoderm around each side of the neural tube, 
and form the sympathetic ganglion primordia (2).  At this point the cells undergo 
specification and acquire noradrenergic properties (2).  A portion of these 
noradrenergic neuroblasts give rise to the sympathetic ganglia which forms a 
chainlike column that traverses the length of either side of the spinal cord.  It is 
from this position that the postganglionic sympathetic neurons are faced with the 
challenge of projecting axons to the developing organs which they innervate.  
The axons must find their way through the rapidly changing environment of the 
embryo and often must extend great distances across a range of tissues.  While 
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the molecular mechanisms of axon initiation are not well understood, there have 
been several critical discoveries which address the mechanisms mediating 
extension and guidance of the axon.  
Proximal Axon Extension 
 It has long since been recognized that axonal projections from 
sympathetic ganglia follow the pathways of arterial vasculature in order to reach 
their targets (4).  Although, until recently it was unclear what was directing the 
axons to seek out and follow the arterial tissue.  Two factors, artemin (ARTN) and 
neurotrophin-3 (NT-3), appear to share a role in such proximal axon guidance in 
vivo (5, 6).  ARTN is a member of the glial-derived neurotrophic factor (GDNF) 
family and signals through the receptor tyrosine kinase RET and co-receptor 
GFRα3 (7).  Characterization of ARTN and GFRα3 deficient mice by Honma et 
al. (5) revealed similar defects in the sympathetic innervation of the gut.  
Furthermore, ARTN transcript was detected within proximity to sympathetic 
neuroblasts as well as along the arterial wall (5).  The arterial produced ARTN 
was found to be a potent chemoattractant for the sympathetic neuroblast, 
suggesting that ARTN guides the early axonal projections to and along the 
arteries.   
 However, the ARTN-/- mice did not exhibit a complete loss of sympathetic 
innervation, suggesting that ARTN alone cannot account for proper proximal 
axonal guidance and elongation.  As mentioned, NT-3 provides a similar role as 
ARTN in proximal axon extension.  Interestingly, NT-3 was originally thought to 
mediate the survival of sympathetic neurons because mice lacking NT-3 
demonstrated a 50% reduction of cells within the superior cervical ganglion (8).  
In a follow-up study, Kuruvilla et al. (6) confirmed the impaired sympathetic 
development of NT-3-/- mice, although they concluded that NT-3 was important 
for proximal axonal extension and not sympathetic neuron survival.  During the 
early stages of sympathetic axonal growth, the NT-3-/- mice displayed reduced 
axonal projections along the vasculature as well as reduced target innervation, 
but did not demonstrate an increase in sympathetic neuron death compared to 
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WT mice (6).  Only later in development, after failure to properly innervate target 
organs, did the sympathetic neurons in NT-3-/- mice undergo apoptosis (6).  
Similar to ARTN, NT-3 seems to signal for the proximal axon extension of 
sympathetic neurons, however distal axonal extension, final target innervation, 
and survival are dependent upon other signals.   
 Paradoxically, after an initial burst of proliferation, successful development 
of an organism’s sympathetic nervous system hinges upon the orchestrated 
demise of half of all neurons generated during development (9).  In development 
as well as in maintenance, the fate of sympathetic neurons is dependent upon 
limiting quantities of neurotrophic factors located at a neuron’s target destination.  
While seemingly inefficient, this is a highly selective process which dictates that 
the number of neuronal innervations allowed to persist will be proportional to that 
of the amount of trophic factor produced.  Neurons receiving less than sufficient 
amounts of neurotrophins undergo apoptosis (9, 10).  Nerve growth factor (NGF), 
another member of the neurotrophin family of growth factors, is critical for the 
survival of sympathetic neurons and elicits effects through binding to the receptor 
tyrosine kinase TrkA.  Strikingly, mice with a targeted deletion of the NGF gene 
display almost a complete loss of sensory and sympathetic neurons (11).   
Nerve Growth Factor and Survival of Sympathetic Neurons 
 Due to the absolute NGF dependence of sympathetic neurons for survival, 
it was difficult to assess whether NGF was required for other aspects of 
sympathetic neuron development.  In order to circumvent this requirement for 
NGF, a double knockout was generated lacking NGF as well as the pro-apoptotic 
Bax gene (12).  Sensory neurons that previously died in the NGF-/- mice were 
unable to undergo apoptosis and therefore persisted in NGF-/-/ Bax-/- mice (12).  
Although sympathetic neurons were not investigated in this study (12).  Soon 
after, this elegant mechanism was employed to assess NGF’s role during 
sympathetic neuron development.  In stark contrast to the NGF-/- mice, the NGF-/-/ 
Bax-/- double knockout mice did not exhibit excess death of sympathetic chain 
neurons (13).  However, several of their organs displayed either impaired or 
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complete loss of sympathetic innervation (13).  This study concluded that in 
addition to survival, NGF is also required for the sympathetic innervation of target 
organs (13).   
 Taken together, these results indicate that ARTN and NT-3 function in 
concert to mediate axon extension of sympathetic neurons to and along 
proximate vasculature.  Separately, NGF signaling is required for target 
innervation, and perhaps distal extension of the axon, in addition to its 
established role in sympathetic neuron survival.   
Molecular Mechanisms of Neutrophin-mediated Differentiation and Survival 
 Several of the aforementioned in vivo studies have demonstrated distinct 
developmental consequences of deletion of critical ligands and/or receptors.  
However, at the molecular level, it is largely unclear as to how the cell derives 
such specific biological responses from these signals.  For example, NT-3 was 
previously thought to function through the interaction with its high affinity receptor 
TrkC, yet deletion of TrkC within mice did not mirror the defects observed in the 
sympathetic neurons of NT-3-/- mice (14).  Instead, further genetic studies 
demonstrated that NT-3 binds to and activates the same receptor as NGF, 
tyrosine kinase receptor TrkA (14, 15).  Moreover, in sympathetic nerve cultures, 
both NT-3 and NGF treatment elicit identical responses, including the 
autophosphorylation of TrkA as well as the activation of the Ras/Raf/MEK/ERK 
and PI3K/Akt pathways (6).  How the cell achieves the physiological specificity of 
NT-3 versus NGF from the activation of the same receptor and signal 
transduction pathways is unknown. 
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Cell Culture Model of Sympathetic Neuritogenesis  
 
 Much of our current understanding regarding the molecular mechanisms 
of neuronal differentiation and survival has come from cell culture work.  
Specifically, the PC12 cell line has been the prevailing model system for 
elucidating the mechanisms of NGF-mediated differentiation of sympathetic 
neurons.  Indeed, during the 28 years between the time NGF was first discovered 
and the first published appearance of the PC12 cell line (16), relatively little 
advancement had been made towards understanding the NGF response (17).  
As discussed previously, the sympathetic neuron’s dependence upon NGF for 
frank survival limits the types of experiments that can be performed, and 
confounds the interpretation of experimental controls which do not receive NGF.  
Importantly, while the PC12 cell line is responsive to NGF, it can be cultured in its 
absence.  Derived from a solid rat pheochromocytoma tumor, PC12 cells cease 
proliferation in response to NGF, exhibit somatic hypertrophy, and acquire 
neurites (16).  The NGF-dependent neurite outgrowth of PC12 cells reflect 
morphological and biochemical changes similar to that of differentiating 
sympathetic neurons in vivo.  In response to NGF, PC12 cells express several 
neuronal specific markers (16) and are capable of forming synapses with primary 
neurons (18). 
 The NGF-dependent transformation of the rounded nondescript PC12 cell 
into a fully differentiated neuron, represents an exquisite amount of molecular 
control.  In order for the cell to undergo such dramatic morphological and 
biochemical changes, a cell must specifically activate transcription of genes that 
facilitate differentiation, as well as repress transcription of genes that oppose the 
change.  Utilizing the PC12 model system, many of the molecular pathways 
responsible for these changes have been elucidated.  Early work characterizing 
the pathways elicited by NGF’s association and activation of TrkA came to a 
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troubling conclusion; the pathways were identical to those elicited in response to 
epidermal growth factor (EGF) activation of EGF receptor (EGFR).  In response 
to both NGF and EGF stimulation, the PC12 cell activates phospholipase Cγ, 
PI3K/Akt, Ras/Raf/MEK extracellular regulated kinases (ERKs) 1 and 2, Jun N-
terminal kinase (JNK), p38, and atypical protein kinase C (19-21).  Intriguingly, 
these ligands facilitate very different biological responses.  While EGF induces a 
mitogenic response in PC12 cells (22), NGF causes cessation of cell division and 
promotes morphological differentiation (16, 23).  In the years since the 
identification of this phenomenon, there have been several published 
observations that NGF elicits a more prolonged activation of ERK than EGF.  
This led to the hypothesis that activation of different pathways are not required, 
instead, sustained verses short-lived activation of ERKs mediate either mitogenic 
or neurogenic effects, respectively (24-27).  Indeed, the activation of ERK is 
required for NGF-mediated differentiation in PC12 cells (28-30).  However, the 
identification of adapter and/or scaffolding proteins recruited specifically to 
activated TrkA have been identified.  The scaffolding protein FRS2 recruits a 
complex of proteins, including Crk, C3G, Rap1 and B-Raf to active TrkA, but not 
active EGFR (31), resulting in the prolonged activation of ERKs 1 and 2 (32).  
While the duration of ERK activity does appear to be required for the differential 
effects of NGF and EGF, the current belief is that separate pathways are induced 
through receptor specific adapter/scaffold proteins, which result in different 
durations of ERK activity. 
 From this work emerged the importance of adapter proteins in the cell’s 
ability to translate extracellular signals into specific and appropriate biological 
responses.  Indeed, the earlier discussed issue concerning the specificity that 
arises from NT-3 and NGF is most likely explained by a difference in each 
ligand’s capacity to form specific receptor/adapter signaling complexes.  
Potentially, this difference could be due to NT-3 and NGF causing unique 
conformational changes in TrkA, which form unique binding sites for specific 
adapter proteins.  Given that NT-3 is thought to function earlier than NGF in the 
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developing sympathetic neuron (2), it is also possible that temporally regulated 
expression of specialized TrkA adapter proteins mediate the specific responses 
of NT-3 and NGF.  In order to uncover the molecular mechanisms by which this 
specificity arises, the continued identification and characterization of the adapter 
proteins that interact with TrkA is required.  To this end, the Carter-Su lab has 
identified the adapter protein, SH2B1β, which associates with active TrkA and 
enhances NGF-dependent differentiation of PC12 cells (33).  The mechanism by 
which SH2B1β facilitates this effect is of great interest, because SH2B1β is able 
to associate with both active Trks (NT-3 and NGF) (33, 34) as well as RET 
(receptor for ARTN and GDNF) (35).   
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The Adapter Protein SH2B1 
 
 Cells have evolved processes by which external environmental stimuli are 
converted into biological responses.  The process of conducting the information 
held by biological messengers, such as hormones and growth factors, across the 
cell membrane frequently involves receptors that recognize the initial signal, and 
molecules within the cell that transduce that signal into a cellular response.  To 
achieve the specific and appropriate cellular responses from the signal, the cell 
often employs a class of proteins termed adapter proteins.  Adapter proteins are 
important signaling molecules that usually lack intrinsic enzymatic activity, but 
instead serve to connect proteins together.  In the case of receptor tyrosine 
kinases or receptor–associated tyrosine kinases [e.g. Janus kinases (JAKs)], 
ligand binding to the receptor initiates changes within the receptor, which 
activates the receptor or the receptor-associated tyrosine kinase, respectively, 
leading to the tyrosyl phosphorylation of the kinase and the receptor.  The 
phosphorylation of receptors and receptor-associated kinases provides binding 
sites for adapter proteins that contain phosphotyrosine-binding motifs such as 
Src homology 2 (SH2) or phosphotyrosine binding (PTB) domains.  Adapter 
proteins are typically composed of several modular protein-protein interaction 
domains, allowing these proteins to link together multiple regulator and effector 
proteins.  The many domains within adapter proteins and the specificity 
possessed by these domains provide these adapter molecules with the ability to 
elicit diverse, individual responses to a particular signal.   
One group of adapters that plays a role in a variety of signaling pathways is the 
SH2B family of adapter proteins (FIG 1.1).  Indeed, SH2B family members have 
been implicated in signal transduction processes for a number of receptor 
tyrosine kinases, including the receptors for nerve growth factor (NGF) (33, 34), 
insulin (36, 37), insulin-like growth factor I (IGF-I) (38), brain derived neurotrophic 
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factor (BDNF) (34), glial-cell-line-derived neurotrophic factor (GDNF) (35), 
platelet-derived growth factor (PDGF) (39), and fibroblast growth factor (FGF) 
(40) as well as for the JAK family of tyrosine kinases (41) (42).  SH2B family 
members include SH2B1 (originally named SH2-B, also known as PSM), SH2B2 
(originally named APS) and SH2B3 (originally named Lnk) (FIG 1.1).  These 
proteins all share a common domain structure that includes a SH2 domain, a PH 
domain, several proline rich regions, and a dimerization domain.  The three 
members of the SH2B family were first identified as signaling molecules involved 
in immune cell activation (43-45).  After its initial identification, SH2B1 transcript 




FIG. 1.1.  Schematic of SH2B family members.   
Schematics are shown for rat SH2B1 (isoforms α, β, γ, and δ), SH2B2, and SH2B3, with the 
numbers representing amino acids.  The abbreviations used are DD for dimerization domain, P 
for proline-rich region, PH for pleckstrin homology domain, SH2 for Src homology 2 domain, and 
Y for tyrosine.  Alternative splicing of SH2B1 results in 4 isoforms.  Unique sequences for each 
isoform have been denoted in the schematic by the C-terminal shaded boxes labeled with the 
respective isoform letter, the orange boxes present in isoforms SH2B1γ and SH2B1δ indicate a 
shared sequence within the splicing region. 
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splicing at the 3’ end, giving rise to four protein products, SH2B1α, β, γ, and δ 
(43) (41) (37) (46) (FIG 1.1).  All four SH2B1 isoforms are identical with respect 
to their N-termini, including their PH and SH2 domains, and differ only at their C-
termini shortly after the SH2 domain.  
SH2B1 Associates with a Variety of Receptor and non-Receptor Tyrosine 
Kinases 
 As SH2B1 lacks intrinsic catalytic activity, a good deal of effort in the last 
decade has gone into establishing an adapter function for SH2B1 by identifying 
binding partners of SH2B1.  TrkA, a variety of other receptor tyrosine kinases, 
and JAK2 a receptor-associated tyrosine kinase, were among the first 
characterized binding partners of SH2B1; many of these initial interactions were 
identified in yeast two-hybrid screens (34, 36-38, 40, 41).  In order to fully 
understand SH2B1’s function, it is important to understand the similarities and/or 
differences by which SH2B1 operates within the context of different tyrosine 
kinases.   
 Initial studies aimed at characterizing the interaction of SH2B1 with its 
upstream binding partners, were carried out in the context of GH activated JAK2.  
GH binds to the GH receptor a member of the cytokine family of receptors, and 
activates the GH receptor associated JAK2.  Studies using 3T3-F442A 
preadipocyte cells demonstrated that SH2B1 selectively associates with 
endogenous GH-activated JAK2 (41).  Glutathione-S-transferase pulldown, co-
immunoprecipitation, and/or yeast two-hybrid assays using SH2B1α, β, and/or γ 
confirmed that maximal interaction of SH2B1 with JAK2 requires kinase-active, 
tyrosyl phosphorylated JAK2 and the SH2 domain of SH2B1 (41, 47).  The 
primary JAK2 binding site for the SH2 domain of SH2B1 has been identified as 
phosphoTyr813 (48), which resides in a YXXL motif in the pseudokinase domain 
(JH2) of JAK2 adjacent to the region linking JH2 to the JH1 kinase domain.  The 
JH2 domain has been hypothesized to be an autoinhibitory domain that gets 
displaced upon ligand binding to the associated cytokine receptor (49).  This 
same phosphotyrosine (pTyr813) in JAK2 has been shown to bind the SH2 
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domain of another member of the SH2B family of proteins, SH2B2 (50), and an 
analogous tyrosine in JAK3 has been implicated as the binding site in JAK3 for 
the SH2 domain of SH2B1 (48).  Although SH2B1 also binds to JAK1(42), JAK1 
does not possess a tyrosine corresponding to phosphoTyr813 in JAK2 and its 
site of interaction with SH2B1 remains unknown.   
 Interestingly, in contrast to its binding site in JAK2 and JAK3, the binding 
site of the SH2 domain of SH2B1 is thought to reside within the kinase domain 
for TrkA and TrkB (34, 51, 52), insulin receptor (37, 53-56), and GDNF receptor 
RET (57), and in the kinase insert domain of PDGF receptor (58).  
Crystallographic studies with the SH2 domains of SH2B1 and SH2B2 and their 
binding sites in JAK2 and the insulin receptor indicate that this difference in 
binding site location influences which family member binds preferentially.  Thus, 
the SH2 domain of SH2B2, which dimerizes, shows a preference for the insulin 
receptor, whereas the SH2 domain of SH2B1, which does not dimerize, shows a 
preference for JAK2 (59).  It seems reasonable to speculate that these 
differences in binding site location might also influence which tyrosines in SH2B1 
(and SH2B2) are phosphorylated by the associated kinase, what proteins SH2B1 
(and SH2B2) could recruit to the different receptor complexes, and/or the ability 
of any recruited proteins to interact with additional binding partners.  
 In addition to the SH2-dependent interaction of SH2B1 with 
phosphoTyr813 in JAK2, there appears to be one or more lower-affinity 
interactions involving amino acids in SH2B1 that reside outside of the SH2 
domain that allow it to bind to inactive JAK2 (60).  The suggestion was made that 
the interaction via this site(s) in SH2B1 with inactive JAK2 might serve to 
increase the local concentration of SH2B1 around JAK2, thereby facilitating 
binding of the SH2 domain to ligand-activated JAK2.  This would result in a more 
rapid and robust cellular response to hormones and cytokines that activate JAK2.  
Alternatively or additionally, this interaction, which appears to be inhibitory in 
nature, might also help prevent abnormal activation of JAK2.  Interestingly, 
Miquet et al. (61) reported finding, in a mouse model of GH excess in which JAK2 
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was not phosphorylated, increased levels of SH2B1, particularly in membranes.  
Based upon this correlative study, the authors suggested that in this model, 
SH2B1 could be a negative regulator of JAK2.  However, an SH2 domain-
independent association has not been reported for SH2B1 and TrkA.  
Phosphorylation of SH2B1 
 Activation of TrkA by NGF not only promotes SH2B1 binding to TrkA but 
also promotes the tyrosyl phosphorylation of SH2B1 (and SH2B2) (34, 39).  The 
tyrosyl phosphorylation of SH2B1 is also observed upon activation of the insulin 
receptor, PDGF receptor, and FGF receptor (33, 40, 46, 62).  These sites of 
phosphorylation have not yet been determined, however, insulin receptor has 
been reported to phosphorylate the SH2B family member SH2B2 on a tyrosine in 
its C-terminus (Tyr618) (63).  This phosphotyrosine has been reported to bind the 
E2-dependent ubiquitin ligase c-Cbl and facilitate ligand-stimulated tyrosyl 
phosphorylation of c-Cbl, association of Cbl with the adapter protein Crk, and 
translocation of the GLUT4 glucose transporter to the plasma membrane (63).  
SH2B2 recruitment of c-Cbl has also been implicated in the ubiquitylation of the 
insulin receptor (64).  Tyr618 in SH2B2 has been indirectly implicated as a target 
of erythropoietin-activated JAK2, important for the recruitment of c-Cbl and 
subsequent inhibition of EPO-dependent activation of the signal transducer and 
activator of transcription (Stat) 5 (65).  The α isoform of SH2B1 has a similar 
tyrosine in its C-terminus, raising the possibility that it too can recruit c-Cbl.  This 
phosphotyrosine is present only in the α isoform of SH2B1, while a different 
tyrosine is unique to the β isoform.  Thus, although expected to recruit many of 
the same proteins, the α and β isoforms may be able to recruit a subset of unique 
binding proteins.  Phosphorylation of a different subset of the tyrosines in SH2B1 
by different receptor tyrosine kinases could also increase the diversity of SH2B1-
mediated responses by allowing for the recruitment of receptor-specific 
phosphotyrosine binding partners.  Support for the latter idea is provided by the 
finding that PDGF stimulates binding of p85 to SH2B1 whereas insulin and IGF-1 
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do not (66).  As an SH2 domain-containing subunit of phosphatidyl inositol 3 
(PI3) kinase, p85 would be expected to bind to phosphorylated tyrosines. 
While it is unknown which sites within SH2B1 are phosphorylated by the 
aforementioned receptor tyrosine kinases, the activation of JAK2 by GH has 
been shown to phosphorylate SH2B1β tyrosines 439 and 494 (67).  Both of these 
sites were identified by two-dimensional phosphopeptide mapping as the major 
JAK2 phosphorylation sites in SH2B1β.  A search for other JAKs that 
phosphorylate SH2B1 revealed that JAK1, but not JAK3, also phosphorylates 
SH2B1β when expressed in 293T or COS7 cells, with mutation of Tyr439 
substantially diminishing the degree of phosphorylation.  In contrast to wild-type 
SH2B1β, SH2B1β lacking these two tyrosines fails to enhance GH-induced 
membrane ruffling, suggesting that when phosphorylated by JAK2 in response to 
GH, Tyr439 and/or Tyr494 in SH2B1β recruits a protein(s) that links SH2B1β to 
the actin cytoskeleton.  It remains to be seen whether NGF-activated TrkA 
phosphorylates these same tyrosines or different tyrosines within SH2B1.  This is 
a particularly interesting matter since it is possible that these phosphorylated 
tyrosines in SH2B1 function as docking sites for other signaling molecules.  
 In addition to the tyrosyl phosphorylation of SH2B1, NGF stimulation of 
TrkA results in the phosphorylation of SH2B1 on multiple serines and/or 
threonines (68).  One potential site of serine phosphorylation has been identified, 
serine 96, which has been shown to be phosphorylated by a kinase that lies 
downstream of MEK, e.g. ERK (68).  Whether or not this phosphoserine, or other 
phosphoserines and/or threonines, are capable of recruiting proteins to SH2B1-
TrkA complexes has not been studied.  A level of SH2B1 Ser/Thr 
phosphorylation similar to that seen with NGFhas been observed upon activation 
of JAK2 by GH (41) and of PDGF receptor (60). 
SH2B1 Binding Partners 
 Several other binding partners have been identified that appear to bind to 
domains in SH2B1 other than the SH2 domain or phosphorylated tyrosines.  One 
of these is Rac, a major actin-regulating protein involved in cell ruffling, 
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lamellipodia formation, and cell motility (69-71).  GH both activates Rac and 
promotes membrane ruffling in a variety of cell types (72-74).  Consistent with 
SH2B1 participating in GH-stimulated actin reorganization and cell motility, both 
ectopically expressed and endogenous SH2B1 localize to membrane ruffles and 
lamellipodia.  Further, overexpression of SH2B1 enhances GH-induced 
membrane ruffling, pinocytosis and lamellipodia formation in 3T3-F442A 
preadipocytes whereas SH2B1β lacking a functional SH2 domain 
[SH2B1β(R555E)] inhibits GH-stimulation of these functions.  Finally, the same 
region of SH2B1β (amino acids 85-106 containing a proline-rich domain) found to 
be required for GH-induced cell motility is also required for SH2B1β to co-
immunoprecipitate with Rac (73).  These data suggest that SH2B1β enhances 
GH induced cell motility at least in part by recruiting Rac to GH-activated 
JAK2/GH receptor/SH2B1 complexes at the plasma membrane.  It seems likely 
that SH2B1 will be found to bind additional proteins that interact with or regulate 
the actin cytoskeleton, particularly since one or both of the JAK2 phosphorylation 
sites in SH2B1β is required for the stimulatory effect of SH2B1 on membrane 
ruffling (FIG. 1.2, A). 
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FIG. 1.2.  The multiple roles for SH2B1.   
(A), GH binding to the GH receptor leads to activation and autophosphorylation of JAK2.  JAK2 
tyrosyl phosphorylation (green stars) at amino acid 813 recruits the SH2 domain of SH2B1.  JAK2 
phosphorylates SH2B1β on tyrosines 439 and 494.  These phosphotyrosines form potential 
binding sites for other signaling proteins.  GH also promotes serine/threonine phosphorylation of 
SH2B1β (yellow stars).  These phosphorylated amino acids as well as other protein-protein 
interaction domains in SH2-Bβ may serve to recruit proteins to GHR/JAK2/SH2B1β complexes, 
such as Rac (proteins with “?” represent potential SH2B1 interacting proteins). (B), Model of 
SH2B1 action in leptin signaling.  SH2B1 binds to and potentiates activation of JAK2 in response 
to leptin, globally enhancing the activation of pathways downstream of JAK2 (box 1).  SH2B1 
binds simultaneously to both JAK2 and IRS1 or IRS2, mediating formation of a complex of JAK2, 
SH2B1, and IRS1 or IRS2.  Consequently, SH2B1 mediates tyrosine phosphorylation of IRS1 and 
IRS2, resulting in activation of the PI3-kinase pathway (box 2). 
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A role for SH2B family members in the regulation of the actin cytoskeleton is 
further supported by the finding that SH2B2 also binds proteins involved in actin 
regulation.  SH2B2 was reported to bind to Vav3, a guanine nucleotide exchange 
factor for Rac and other Rho family GTPases (75).  Insulin was  found to promote 
the binding of the N-terminal 182 amino acids of SH2B2 to Enigma and the co-
localization of SH2B2 and Enigma in large F-actin containing ruffles (76).  
Enigma is a PDZ and LIM domain-containing protein that was previously shown 
to be associated with the actin cytoskeleton.   
 Interestingly, the overexpression of SH2B1 was found to enhance NGF-
dependent neurite outgrowth of PC12 cells (33, 34).  While the small GTPases 
Rac, Rho, and Cdc42 have each been implicated in regulating the growth cone 
activity of an elongating neurite (77, 78), the Rac binding site is surprisingly not 
required for SH2B1 to enhance NGF-mediated neurite outgrowth (79).  This topic 
will be covered in greater detail in Chapter 4, however, these results suggest that 
GH and NGF-mediated changes to the actin cytoskeleton may employ very 
separate functions of SH2B1.   
 Additionally, SH2B1 has also been reported to recruit other adapter 
proteins.  Qian et al. (34) found SH2B1 to co-immunoprecipitate with the small 
adapter protein Grb2, implicated in the regulation of ERKs 1 and 2.  Ren et al. 
(80) found SH2B1 to recruit the much larger adapter insulin receptor substrate 
(IRS) adapter proteins to activated JAK2 in response to leptin.  Leptin is a 
hormone secreted by adipose tissue that regulates energy homeostasis through 
activation of its long isoform receptor (LRb) in hypothalamic neurons (81). Leptin 
binding to LRb activates the LRb-associated JAK2, which in turn phosphorylates 
and activates downstream signaling proteins, including the IRS proteins (82-84) 
and the transcription factor Stat3 (85-88).  Loss of either leptin or LRb in mice 
results in morbid obesity (89-92).  In HEK cells stably expressing LRb, SH2B1β 
has been shown to recruit IRS1 and IRS2 to JAK2, and promote both the 
formation of a ternary complex containing JAK2, SH2B1 and either IRS1 or IRS2 
(93) and the subsequent tyrosyl phosphorylation of IRS1 and IRS2 (93) (FIG. 1.2, 
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B).  The phosphorylated tyrosines in IRS proteins bind the SH2 domain of the PI3 
kinase regulatory subunit p85, the initial and rate limiting step in the activation of 
the PI3-kinase pathway (94).  The PH domain of SH2B1 is required for the 
interaction of SH2B1 with IRS proteins (93).  Interestingly, in addition to enabling 
leptin-dependent activation of PI3-kinase by recruiting IRS proteins, SH2B1 also 
has the potential to influence leptin-dependent activation of both PI3-kinase and 
Stat3 by a completely different mechanism, one that involves SH2B1 binding only 
to JAK2. 
SH2B1 Enhancement of Tyrosine Kinase Activity 
 Although SH2B1 plays an adapter role in the recruitment of Rac, Grb2, 
IRS1, IRS2, and presumably other proteins to JAK2, its influence on JAK 
signaling pathways appears to extend beyond that of a classic adapter protein.  
In vitro kinase assays and anti-phosphotyrosine immunoblots of JAK2 suggested 
that SH2B1 can directly stimulate JAK2 kinase activity and autophosphorylation 
(95) (47).  SH2B1α and β were found to enhance GH-dependent tyrosyl 
phosphorylation of JAK2 and Stat5b by a mechanism requiring the SH2 domain 
of SH2B1 (95) (47) (FIG. 1.3).  Enhancement by SH2B1 of JAK2 activity appears 
to be unique within the JAK family because overexpression of SH2B1β does not 
similarly enhance the autophosphorylation of JAK1 or JAK3 (42).  The latter was 
somewhat surprising because SH2B1 binds to JAK3 at a site analogous to its 
binding site in JAK2 (48). 
 Two mechanisms have been proposed for how SH2B1 enhances JAK2 
activity.  The first is that dimerization of SH2B1 leads to dimerization of its 




FIG. 1.3.  SH2B1 enhances JAK2 kinase activity. 
SH2B1 directly enhances JAK2’s kinase activity (box 1) resulting in an increase in 
phosphorylated STAT5b (box 2) and presumably other substrates of JAK2. 
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In support of this, an N-terminal dimerization domain (amino acids 24-85 of rat 
SH2B1) was identified and found to be required for SH2B1 to induce dimerization 
of JAK2 in a yeast two-hybrid assay.  Furthermore, SH2B1 lacking that domain 
acts as a dominant negative for GH-induced activation of JAK2.  An alternative 
model suggested by Kurzer et al. (50) is that SH2B1 increases the number of 
active JAK2 molecules by stabilizing a conformational change in JAK2 that 
maintains JAK2 in an active state.  This model is based in part upon two main 
findings.  The first was that, in an overexpression system, the SH2 domain of 
SH2B1, which binds only to the phosphorylated form of Tyr813, is sufficient to 
activate JAK2.  The second is that the SH2B1-mediated increase in JAK2 
dimerization occurs even if only one SH2B1 can bind to the dimer.  This model is 
based on the idea that JAK2 must first be active (and autophosphorylated) to 
bind SH2B1 at phosphoTyr813 and that the binding of SH2B1 causes a 
conformational change that maintains JAK2 in an active state.  Dimerization of 
SH2B1 is hypothesized to enhance the binding of SH2B1 to an already existing 
JAK2 dimer.  Importantly, both models agree that the ability of SH2B1 to enhance 
JAK2 activity is a direct function of SH2B1, and not a result of competition with a 
JAK2 inhibitor or recruitment of an activator of JAK2.  
 The ability of SH2B1 to enhance tyrosine kinase activity appears not to be 
unique to JAK2.  In addition to JAK2, SH2B1 has been reported to positively 
regulate the kinase activity of TrkA (96), FGF receptor (40), and insulin receptor 
(62, 93, 97).  The ability of SH2B1 to enhance the kinase activity of TrkA will be 
discussed more thoroughly later in this Chapter. 
Phenotype of SH2B1-/- Mice 
 The generation of SH2B1-/- mice has revealed a number of physiological 
roles for SH2B1 consistent with its role as an adapter and/or enhancer protein for 
JAK2.  However, there is only limited published work from these SH2B1-/- mice 
regarding the role of SH2B1 in TrkA function.  One of the most notable 
phenotypes consistent with SH2B1 acting in JAK2 signaling pathways is the 
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severe hyperphagia and obesity observed by Ren et al. (80) in SH2B1-/- mice.  
SH2B1-/- mice grew to twice the body weight of wild-type littermates within 21 
weeks from birth.  In accordance with the ability of SH2B1 to enhance leptin 
action, the obesity in the SH2B1-/- mice was accompanied by severe leptin 
resistance as characterized by substantially elevated plasma leptin levels.  
Plasma leptin levels were found to be dramatically elevated in these mice prior to 
the onset of their obesity, consistent with hyperleptinemia being a cause rather 
than a corollary of obesity in these mice.  A second group of investigators 
reported that after 6 to 10 weeks, the size and weight of their SH2B1-/- mice were 
similar to that of wild-type mice (98).  The discrepancy between the two sets of 
findings has been hypothesized to potentially result from differences in diet and 
level of environmental stress (80).  Both groups did, however, report an initial 
postnatal growth retardation and proportionate dwarfism, consistent with a 
stimulatory effect of SH2B1 on GH action.  However, Ohtsuka et al. (98) did not 
find evidence for the enhancer effect of SH2B1, i.e. enhanced activation of JAK2.  
They did not observe a reduced stimulatory effect of the JAK2 activator, 
interleukin 3, on responses of MAST cells from SH2B1-/- mice.  They also 
reported finding no difference in the ability of GH to stimulate Stat5 activation in 
the liver.  Whether this lack of an expected decreased response in MAST cells 
and liver from SH2B1-/- mice is because the enhancer effect of SH2B1 seen in 
cell culture and in vitro does not manifest itself in the context of the whole animal, 
the experiments were not done in such a way to observe the enhancer effect of 
SH2B1, or whether the absence of SH2B1 was compensated for during 
development is not known. 
 The SH2B1-/- mice exhibited additional phenotypes that are consistent with 
SH2B1 acting as a positive regular for IGF-1 and insulin.  Both groups reported 
that SH2B1-/- mice had impaired fertility with Ohtsuka et al. (98) noting that the 
developmental defects in gonadal organs were similar to those seen in mice with 
IGF-I or follicle-stimulating hormone (FSH) receptor deficiencies.  These results 
are consistent with SH21β playing a positive role in the IGF-I pathway that up-
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regulates levels of FSH receptor.  Although Ohtsuka et al. (98) mentioned seeing 
no differences in blood glucose levels, Duan et al. (99) observed age-dependent 
hyperinsulinemia, hyperglycemia and glucose intolerance in the SH2B1-/- mice.  
Consistent with SH2B1-/- mice exhibiting insulin insensitivity, Duan et al. also 
observed impaired insulin receptor activation and signaling in the liver, skeletal 
muscle and fat, including impaired tyrosine phosphorylation of IRS1 and 2 and 
activation of PI3 kinase kinase/Akt and Erk1/2 pathways.  Examination of 
pancreatic islets in SH2B1-/- mice revealed enlarged islet size in mice, but no 
abnormalities of the insulin-producing β cells, suggesting that SH2B1 is not 
required for β cell growth and function.  These findings complement the data 
obtained from immortalized cell lines, and suggest a role for SH2B1 in 
maintaining insulin/glucose balance.  Whether SH2B1-/- mice exhibit other 
phenotypes predicted from the role of SH2B1 as a signaling protein for TrkA has 
not been rigorously examined.  Ohtsuka et al. (98) reported that sensory neurons 
from SH2B1-/- mice were able to undergo neurite outgrowth in response to NGF, 
although they did not provide the data concerning this particular observation.  
Unfortunately, neither study has provided characterization of the sympathetic 
nervous system of the SH2B1-/- mice.    
 Interestingly, by using a neuronal specific enolase promoter to drive 
transgenic expression of SH2B1β in the systemic SH2B1 knockout mice 
(SH2B1TgKO), Ren et al. (100) were recently able to rescue the obesity and 
hyperlipidemia observed in the SH2B1KO mice.  The characteristic leptin and 
insulin insensitivity of the SH2B1KO mice was similarly rescued in the SH2B1TgKO 
mice, suggesting that restoring the levels of neuronal SH2B1β alone is sufficient 
to restore leptin and insulin action (100).  As mentioned earlier, the systemic 
deletion of SH2B1 significantly reduced leptin signaling, resulting in impaired 
leptin-induced activation of hypothalamic JAK2 (80).  The study supports a 
conclusion in which both the enhancer and adapter functions of SH2B1β are 
required for proper leptin signaling.  As an enhancer of JAK2, SH2B1β amplifies 
JAK2 phosphorylation and activation of Stat3 (80) (100).  As an adapter, SH2B1β 
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also facilitates the second arm of the leptin signaling cascade in which SH2B1β 
recruits IRS2 to JAK2 resulting in the activation of the PI3K pathway, required for 
the regulation of energy metabolism (101).  While the possibility remains that 
restoration of neuronal SH2B1β regulates obesity by additional leptin-




Evidence for the Role of SH2B1β  in Neuronal Differentiation and 
Survival 
 
 As mentioned previously, SH2B1 was implicated in neuronal function 
several years ago (33, 34).  Qian et al. (34) identified both SH2B1 (recently 
identified as the γ isoform, Doche, M., Maures, T., J., and Carter-Su, C., 
unpublished observation) and SH2B2 as TrkA, B, and C binding proteins, using a 
yeast two-hybrid assay employing a cDNA library isolated from rat spinal cord 
and dorsal root ganglion.  Attempts to determine exactly which tyrosine residue 
within TrkA mediated the interaction with SH2B1 were hampered because three 
of the tyrosines (Y679, Y683, and Y684) within the kinase activation loop TrkA, 
are required for catalytic activity (34).  Using a yeast two-hybrid assay, Qian et al. 
(34) demonstrated that SH2B1γ bound to a mutant TrkA in which all but the three 
tyrosines within the activation loop were mutated to phenylalanines.  Rui et al. 
(33) confirmed the phosphotyrosine-dependent interaction between SH2B1β and 
TrkA by demonstrating that GST-SH2B1β pulled down TrkA only from lysates of 
NGF-treated PC12 cells.  Additionally, the GST-SH2B1β(R555E) mutant, which 
contains a functionally inactivating point mutation within its SH2 domain, was 
unable to pull down TrkA from cells with or without prior NGF treatment, 
indicating that SH2B1 requires a functional SH2 domain for its interaction with 
TrkA 
 The rapid NGF-dependent association of SH2B1 to TrkA mirrored in timing 
the NGF-dependent association of well known TrkA effector molecules Shc and 
PLC-γ.  Upon NGF stimulation, Shc and PLC-γ are recruited to phospho-tyrosine 
residues 499 and 785, respectively, where they are then tyrosyl phosphorylated 
by active TrkA (102) (103, 104).  Similarly, the NGF-dependent association 
between SH2B1 and TrkA resulted in the rapid tyrosyl phosphorylation of SH2B1 
in neonatal sympathetic neurons (34) as well as in PC12 cells (33).  While TrkA-
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dependent phosphorylation of PLC-γ triggers its activation (105), SH2B1 contains 
no intrinsic enzymatic activity.  Therefore, the SH2B1 association with TrkA more 
closely resembles that of the adapter protein Shc, which links TrkA receptors to 
Grb2, SOS, and the Ras-ERK signaling cascade (28, 104).  Upon NGF activation 
of TrkA, Grb2 is recruited to the receptor complex through the association 
between its SH2 domain and a phosphotyrosine docking site on Shc (106).  Myc-
tagged SH2B1γ was also shown to immunoprecipitate Grb2 in 293 cells (34).  
However, the SH2B1γ/Grb2 interaction seen in 293 cells co-expressing TrkA and 
SH2B1 was dependent upon a proline rich region in SH2B1 and was observed 
whether or not cells had been treated with NGF (34).   
 The TrkA/SH2B1 interaction was hypothesized to play a central role in the 
specific activation of Ras-dependent or Ras-independent signaling cascades 
(34).  Indeed, dissociated neonatal sympathetic neurons cultured in the presence 
of NGF exhibit potently reduced the survival ratse when α-SH2B1 antibodies 
were introduced by trituration (34).  In addition to promoting the survival of 
neurons, SH2B1γ demonstrated an ability to regulate the maintenance of axonal 
processes of neurons within explants of sympathetic ganglia.  Sympathetic 
neurons were transfected with cDNA encoding either SH2B1γ or a truncation 
mutant of SH2B1γ containing only the C-terminal portion (including the full SH2 
domain).  In the presence of NGF, neurons overexpressing SH2B1γ displayed 
long and branched axonal processes, while neurons overexpressing the 
truncation mutant of SH2B1γ exhibited significant axonal degeneration after 2 
days (34).  Similarly, overexpression of SH2B1γ (34) and SH2B1β (33) enhanced 
NGF-dependent neurite outgrowth of PC12 cells.  Taken together, these results 
implicated SH2B1 as an important mediator of Trk receptor signaling, that 
contributes to both neuronal differentiation and survival. 
 However, the precise mechanism by which SH2B1 mediates these effects 
has yet to be determined.  Studies performed by the Ginty laboratory (34, 96) 
favor a mechanism whereby SH2B1 performs an adapter/enhancer function for 
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Trk receptors, much like the mechanism described above for leptin signaling.  
Specifically, when co-expressed with ERK1 and TrkA in 293 cells, SH2B1γ 
enhanced the NGF stimulation of ERK1.  The association of SH2B1γ with both 
Grb2 and active TrkA was required for enhancement of ERK1 phosphorylation 
(34).  Additionally, overexpression of SH2B1γ was found to potentiate the activity 
of TrkA (96).  PC12 cells stably overexpressing full-length SH2B1γ enhanced 
both the magnitude and duration of NGF-induced TrkA phosphorylation at 
tyrosine 490 (Shc binding site in rat) as well as the phosphorylation of ERKs 1 
and 2 (96).  This was assessed by stimulating the cells with a pulse of NGF (100 
ng/ml) for 10 minutes before replacing with new medium containing a function 
blocking NGF antibody.  However, PC12 cells stably overexpressing an N-
terminal truncation mutant of SH2B1γ(ΔN237) were unable to potentiate NGF-
induced activity of TrkA and also displayed reduced phosphorylation of ERKs 1 
and 2 compared to control cells (96).  The importance of the N-terminal portion of 
SH2B1γ was thought to arise from a multimerization domain located between 
amino acids 100-237 (96).  This multimerization domain was proposed to 
facilitate the formation of homo or heteropentamers of SH2B1 and SH2B2, 
according to the results of size exclusion chromatography from 293 cells 
overexpressing SH2B1 eluted as part of a ~440 kDa complex (96).  While 
multimerization of SH2B1 was found to be independent of NGF stimulation, Qian 
et al. (96) concluded that multimerization was required to enhance NGF-
dependent TrkA activity.   
 The Ginty group also examined whether multimerzation of SH2B1 is 
required for the enhancement of NGF-dependent neurite outgrowth (96).  Using a 
PC12 cell line that expresses little to no TrkA (PC12nnr5) and is unresponsive to 
NGF, Qian et al. (96) transiently expressed mutant TrkA lacking all conserved 
tyrosines except for those within the activation loop, as well as wild-type SH2B1γ, 
SH2B1γ(ΔN237), or vector control.  Only cells expressing full-length SH2B1γ 
were able to facilitate NGF-dependent neurite formation (96).  These results 
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suggest that the N-terminal 237 amino acids are required for SH2B1’s role in 
NGF-dependent neurite outgrowth (96).   
 Collectively, these results suggested to Qian and Ginty (96) that the 
formation of pentameric complexes of SH2B1γ potentiate the NGF-induced 
activity of TrkA.  SH2B1γ also functions to couple Grb2 to active TrkA, thereby 
transducing the signal through a Ras-dependent mechanism (34).  Enhancement 
of NGF-mediated TrkA autophosphorylation by SH2B1γ thus leads to an 
enhanced and prolonged activation of ERKs 1 and 2, which drives neuronal 
differentiation (96).  
 The mechanism put forth by Qian and Ginty, however, contains several 
points of contention within the field.  Rui et al. (33, 68) similarly demonstrated that 
NGF promotes a rapid association of SH2B1 with TrkA and subsequent tyrosyl 
phosphorylation of SH2B1 on tyrosines as well as serines/threonines.  
Furthermore, the overexpression of SH2B1β within PC12 cells significantly 
enhanced NGF-dependent neurite outgrowth while overexpression of 
SH2B1β(R555E), which cannot bind to TrkA, inhibited NGF-dependent 
differentiation in a dominant negative manner (33).  While the aforementioned 
results are all consistent with the mechanisms proposed by Qian et al. (34, 96), a 
critical incongruity between the groups is whether SH2B1 actually enhances the 
activity of TrkA in response to NGF.  Even though overexpression of SH2B1β 
and SH2B1β(R555E) demonstrate opposing effects with regard to NGF-
dependent neurite outgrowth, neither augmented the NGF-induced 
autophosphorylation of TrkA compared to GFP-control, assessed using a general 
anti-phosphotyrosine antibody (33).  Moreover, NGF-induced phosphorylation of 
Shc, PLC-γ, or ERKs 1 and 2 was also not substantially affected by 
overexpression of SH2B1β or SH2B1β(R555E) (33).  These findings indicated 
that while overexpression of SH2B1β may cause indirect enhancement of TrkA or 
ERKs 1 and 2, the dominant negative effect of overexpressed SH2B1β(R555E) 
on NGF-dependent neurite outgrowth is unlikely to be a result of reduced TrkA 
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activation or a diminished ability of TrkA to phosphorylate the substrates 
responsible for the Shc/Ras/MEK/ERK cascade or PLCγ pathways (33).  These 
results suggest that SH2B1β might facilitate NGF-dependent differentiation 
through a novel pathway at a point downstream of or parallel to ERKs 1 and 2.  
Although both SH2B1γ and SH2B1β facilitate a similar level of enhancement of 
NGF-dependent neurite outgrowth (33, 34), it is possible that the use of different 
isoforms of SH2B1 could explain the observed discrepancy.  A direct comparison 
of each isoform’s ability to modulate NGF-induced TrkA activity has yet to be 
made.  In any case, there remains an unexplained mechanism by which the β 
isoform of SH2B1 enhances NGF-dependent neurite outgrowth.   
 The second discrepancy concerning the findings of Qian et al. (96) 
pertains to the multimerization domain.  As mentioned previously, a ~440 kDa 
complex containing SH2B1 was obtained using a size exclusion chromatography 
column (34).  Because SH2B1γ is approximately 87 kDa, the conclusion was that 
SH2B1α assumes a pentameric conformation in cells, mediated by a 
multimerization domain (a.a. 100-237).  Qian et al. (96) unambiguously 
demonstrated that SH2B1 is at least capable of forming dimers by co-
immunoprecipitating differentially tagged forms of SH2B1.  However, the study 
failed to provide sufficient evidence that the 440 kDa complex contained SH2B1 
only and not endogenous interacting partners of SH2B1.  Adding to the 
uncertainty of this finding, Nishi et al. (47) identified a dimerization domain within 
SH2B1 (amino acids 26-84) and SH2B2 (23-81) that is both necessary and 
sufficient to mediate dimerization of SH2B1.  Based upon X-ray crystallography 
of SH2B2, a molecular model of SH2B1 revealed a novel dimerization motif in 
which a stretch of phenylalanines of the two monomers interdigitate, analogous 
to the previously identified leucine zipper (47).  In contrast to the multimerization 
domain reported by Qian et al.(96), the phenylalanine zipper is only capable of 
facilitating the formation of SH2B1 homo- or heterodimers with SH2B2.  These 
results do not support the existence of SH2B1 pentamers, but support the finding 
that the N-terminal portion of SH2B1 is responsible for dimerization and 
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potentially, the activation of (receptor) tyrosine kinases (34, 47).  Unfortunately, 
an SH2B1γ N-terminal truncation mutant lacking only the first 100 amino acids 
and thus the phenylalanine zipper (47), was tested only for its ability to 
multimerize.  The NΔ100 truncation mutant was not tested for its ability to 
activate TrkA or its ability to enhance NGF-induced neurite outgrowth.  Therefore, 
the conclusion that SH2B1γ requires the N-terminus for enhancing the activity of 
TrkA cannot be substantiated.  The only N-terminal truncation mutant thoroughly 
tested was SH2B1α(NΔ237) (96).  As mentioned previously, overexpression of 
this mutant failed to enhance, but did not inhibit, TrkA activation or NGF-
dependent differentiation of PC12 cells (96).  However, the NΔ237 truncation 
removed several critical domains from SH2B1γ, including a functional nuclear 
export sequence (NES), as described in (79).  Because the NΔ237 truncation 
both disrupts the subcellular localization of SH2B1 and likely compromises its 
nuclear function, it is difficult to distinguish the reason SH2B1α(NΔ237) failed to 
enhance NGF-dependent differentiation. 
A Nuclear Role for SH2B1 
 A common assumption in all of the aforementioned studies of SH2B1 is 
that SH2B1 localizes and functions at the plasma membrane.  Its presence at the 
plasma membrane and its interactions with numerous activated JAK and receptor 
tyrosine kinases normally found at the plasma membrane indicate that SH2B1 
does indeed carry out functions at the plasma membrane.  However, while 
investigating the ability of SH2B1β to enhance NGF-induced neuronal 
differentiation of cultured PC12 cells, Chen et al. (79) made the unexpected 
finding that SH2B1β undergoes constitutive nucleocytoplasmic shuttling, even 
though at steady state, it appears to resides primarily at the plasma membrane 
and in the cytoplasm.  Inhibition of Crm1-mediated nuclear export with leptomycin 
B caused both endogenous and ectopically expressed SH2B1β to accumulate in 
the nucleus.  Nuclear accumulation of SH2B1β was also seen after deleting or 
mutating a previously unrecognized nuclear-export sequence (NES).  Importantly, 
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deletion or mutation of the NES (79) within SH2B1β destroys the ability of 
overexpressed SH2B1β to enhance NGF-dependent differentiation of PC12 cells 
but not the ability of SH2B1β to bind TrkA.  The presence of the NES in all 
isoforms of SH2B1 suggests that all isoforms of SH2B1 will be found to undergo 
nucleocytoplasmic shuttling. Together, these findings suggest that SH2B1 must 
undergo nucleocytoplasmic shuttling for it to enhance NGF-induced neuronal 






 Clearly, SH2B1 plays an important role in the signal transduction for 
several receptor and cytoplasmic tyrosine kinases.  As suggested by the 
evidence presented thus far, SH2B1 is a unique molecule capable of functioning 
as both an adapter as well (or simultaneously) as an enhancer of tyrosine kinase 
activity.  However, the mechanism by which SH2B1 enhances neuronal 
differentiation and survival in response to NGF is not clear.  In contrast to findings 
from the Ginty laboratory (34), Rui et al. (33) concluded that SH2B1β mediated 
NGF’s effects in a manner independent of the Ras/MEK/ERK or PLCγ pathways, 
possibly through a novel pathway.  Therefore, the aim of this thesis project was 
to elucidate the mechanism by which SH2B1β enhances NGF-dependent 
differentiation and survival of neurons. 
 In Chapter 2, we first sought to determine the mechanism by which 
SH2B1β enhances NGF-dependent survival of neurons.  In both primary 
sympathetic neurons and terminally differentiated PC12 cells, the removal of 
neurotrophic factors results in the retraction and degeneration of neurite 
outgrowths and eventual apoptosis (107, 108).  NGF is a potent survival factor, 
and protects PC12 cells from apoptosis induced by neurotrophic factor 
withdrawal (108, 109), cytotoxic drugs (110-112), and oxidative stress (113-115).  
The anti-apoptotic properties of NGF are elicited through the activation of the 
PI3K/Akt pathway (116).  Thus, we hypothesized that SH2B1β may enhance the 
NGF-induced activation of Akt.   
 Indeed, as reported in Chapter 2, overexpression of GFP-SH2B1β in PC12 
cells was found to enhance NGF-dependent activation of Akt kinase activity as 
well as the phosphorylation of downstream Akt targets GSK-3α/β, FKHRL1 
(FoxO3a), and FKHR (FoxO1).  However, the NGF-dependent activation of Akt 
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and the phosphorylation of the downstream effectors were found not to be 
inhibited by overexpression of SH2B1β(R555E), which functions as a dominant 
negative.  Normal NGF-induction of the Akt pathway in cells overexpressing 
SH2B1β(R555E) was especially surprising in light of our unpublished 
observations that SH2B1β(R555E) promotes PC12 cell death and the finding 
from Qian et al. (34) that expression of the N-terminal truncation of SH2B1 leads 
to the degeneration of sympathetic neurons.  Interestingly, we found that 
overexpression of SH2B1β(R555E) inhibits the redistribution of FoxO1 from the 
nucleus to the cytoplasm.  FoxO1 functions as a pro-apoptotic transcription factor 
(117-119) as well as a negative regulator of differentiation (120).  Direct 
phosphorylation of FoxO1 by Akt is known to be required for the formation of a 
14-3-3/FoxO1 complex, which is then exported from the nucleus and tethered 
within the cytoplasm (118).  As mentioned, NGF-induced FoxO1 phosphorylation 
was normal in SH2B1β(R555E) expressing cells, although FoxO1 remained 
nuclear.  These results suggested that SH2B1β might directly participate in the 
regulation of the nuclear export of FoxO1 in addition to enhancing the Akt 
pathway.   
 Concurrent with the aforementioned finding, Dr. Linyi Chen in the Carter-
Su laboratory discovered that SH2B1β contains a nuclear export sequence and 
undergoes nucleocytoplasmic shuttling.  The nuclear presence of SH2B1β was 
especially surprising since SH2B1β was thought to localize and function only at 
the plasma membrane (39).  Interestingly, blocking the nuclear export of SH2B1β 
also blocked SH2B1β enhancement of NGF-dependent differentiation in PC12 
cells.  Together, Dr. Linyi Chen and I hypothesized that SH2B1β’s newfound 
nuclear localization may account for the ability of SH2B1β to enhance NGF-
dependent neuronal differentiation and survival.  
 In Chapter 3, collaborative work between Dr. Chen and I demonstrated 
that SH2B1β enhances expression of a subset of NGF-sensitive genes important 
for differentiation.  Using microarray analysis of PC12 cells, we established that 
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the overexpression of SH2B1β leads to altered transcription of only a specific 
subset of NGF-responsive genes.  If SH2B1β enhances NGF-induced neuronal 
differentiation of PC12 cells primarily by enhancing NGF-activation of TrkA as 
has been hypothesized (96), we would expect a corresponding general 
enhancement of NGF induction or inhibition of NGF-responsive gene expression.  
Instead, of the 511 genes whose expression at least doubled after NGF 
treatment in control cells, only 34 demonstrated a further NGF-dependent 
doubling in SH2B1β overexpressing PC12 cells.  Among the subset of NGF-
responsive genes that were enhanced by the presence of SH2B1β, we identified 
Plaur (uPAR), Mmp3, and Mmp10 whose gene products encode urokinase 
plasminogen activator receptor (uPAR), matrix metalloproteinase 3 (MMP3), and 
matrix metalloproteinase 10 (MMP10).  These proteins were of particular interest 
because uPAR has been shown to be required for NGF-mediated neuronal 
differentiation (121, 122) and MMP3, present in growth cones of NGF-treated 
PC12 cells, has been implicated in neurite penetration through the extracellular 
matrix (123).  Moreover, uPAR, MMP 3, and MMP 10 are all situated in the same 
proteolytic cascade responsible for extracellular matrix degradation required for 
neurite penetration through the extracellular matrix.  Interestingly, the PC12 cells 
expressing the dominant negative SH2B1β(R555E) are not only unable to 
undergo NGF-dependent neurite outgrowth, but they also demonstrate a 
coincident inability to promote NGF-induced transcription of Plaur, Mmp3, and 
Mmp10 (124).  These results suggest that SH2B1β may mediate NGF-induced 
neuronal differentiation and neurite outgrowth at least in part by enhancing NGF-
dependent expression of uPAR, MMP3, and MMP10.  Accordingly, depletion of 
endogenous SH2B1 using RNA interference blocked the ability of NGF to induce 
transcription of these genes.  In light of these findings, we hypothesized that the 
nucleocytoplasmic shuttling by SH2B1β is required for SH2B1β enhancement of 
NGF-induced neuronal differentiation and is of consequence to the ability of 
SH2B1β to facilitate transcription of the genes encoding uPAR, MMP3, and 
MMP10.  In Chapter 4, I wanted to directly address this hypothesis by identifying 
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a nuclear localization sequence (NLS) within SH2B1β.  I found that disrupting 
SH2B1β translocation into the nucleus abolished the ability of SH2B1β to 
enhance NGF-induced neuronal differentiation of PC12 cells.  Surprisingly, both 
the SH2B1β nuclear import mutant [SH2B1β(mNLS)] as well as the nuclear 
export mutant [SH2B1β(ΔNES)] blocked the ability of SH2B1β to enhance NGF-
induced transcription of Plaur, Mmp3, and Mmp10.  The inability of the nuclear 
localization defective SH2B1β(mNLS) to enhance NGF-induced differentiation or 
gene expression appears not to be a consequence of SH2B1β(mNLS) 
compromising the NGF signaling cascade because the extent and duration of 
phosphorylation of NGF effector molecules were unaffected in the 
SH2B1β(mNLS) expressing cells compared to SH2B1β expressing cells.  
Together these findings suggest that SH2B1β plays a critical role in NGF-
mediated neuronal differentiation by facilitating enhancement of NGF-mediated 
gene expression through a novel nuclear mechanism.   
 In order to shed light on SH2B1β’s role in the nucleus I wanted to establish 
nuclear binding partners for SH2B1β with the expectation that they may provide a 
functional context for SH2B1β.  Therefore, I performed a tandem affinity 
purification (TAP) of SH2B1β using cytoplasmic/nuclear lysates from NGF-
treated PC12 cells.  The purification and subsequent MS/MS yielded several 
potential binding proteins.  In Chapter 5, I identfied cell division cycle associated-
7 (CDCA7) as a novel nuclear binding partner for SH2B1β.  Described as a 
putative transcription factor, overexpression of CDCA7 in Rat1a cells induced 
anchorage-independent growth (125).  In my hands, GFP-tagged CDCA7 
dramatically blocks NGF-dependent differentiation, however, preliminary data 
suggest that the inhibition can be rescued by co-expression with SH2B1β.  The 
association between CDCA7 and SH2B1 was confirmed by an NGF-dependent 
co-immunoprecipitation of overexpressed CDCA7 with endogenous SH2B1.  
However, the co-immunoprecipitated SH2B1 has a molecular weight of 110 kDa, 
and thus co-migrates with a specific highly phosphorylated form of SH2B1β or 
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possibly the δ SH2B1 isoform.  We therefore tested the ability of SH2B1δ to bind.  
Upon expression of SH2B1δ, we observed surprising steady state localization at 
the plasma membrane, nucleoplasm, and nucleolus.  Overexpressed CDCA7 
was able to co-immunoprecipitate overexpressed SH2B1δ in an NGF-dependent 
manner.  Collectively, these findings suggest that SH2B1β may relieve the 
actions of a pro-mitogenic transcription factor, allowing the cells to undergo 
neurogenic changes in response to NGF (FIG 1.4).   
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FIG. 1.4.  A nuclear role for SH2B1.   
Binding of NGF to TrkA causes activation and autophosphorylation of TrkA.  SH2B1β is tyrosyl 
phosphorylated (green stars) by TrkA and serine/threonine phosphorylated (yellow stars) by 
downstream kinases.  Hypothetical roles for nuclear SH2B1β include shuttling activators (box 1) 
or repressors (box 2) of NGF dependent transcription in or out of the nucleus, respectively.  
SH2B1β may also directly enhance transcription of NGF-responsive genes, perhaps as serving 




Portions of Chapter 1 are found in my review of SH2B1 published in TRENDS in 
Endocrinology and Metabolism (2007).  Vol 18, 1, under the title “SH2B1 and 
JAK2 a multifunctional adapter protein and kinase made for each other” by Travis 
J. Maures, Jason H. Kurzer, and Christin Carter-Su. 
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Chapter 2  
SH2B1 Is a Positive Regulator of Nerve Growth Factor-mediated 
Activation of the Akt/Forkhead Pathway in PC12 Cells 
Abstract 
 
To gain insight into the mechanism by which the adapter protein SH2-B promotes 
nerve growth factor (NGF) mediated neuronal differentiation and survival, the 
effect of SH2-B on the serine/threonine kinase Akt/PKB and downstream effector 
proteins was examined.  PC12 cells stably overexpressing SH2-Bβ, which exhibit 
enhanced NGF-induced neuronal differentiation compared to control cells, 
showed enhanced and prolonged NGF-induced phosphorylation of Akt on 
Ser473 and Akt enzymatic activity.  Surprisingly, NGF-induced phosphorylation of 
Akt on Ser473 and Akt activity were not altered in cells overexpressing SH2-
Bβ(R555E) with a defective SH2 domain, despite the ability of the overexpressed 
SH2-Bβ(R555E) to block NGF-induced differentiation.  Consistent with SH2-Bβ 
enhancing the activity of Akt, cells overexpressing SH2-Bβ but not SH2-
Bβ(R555E) exhibited increased and/or prolonged phosphorylation of the pro-
apoptotic Akt effector proteins, glycogen synthase kinase-3 (GSK-3), and 
Forkhead transcription factors, FKHRL1/FOXO3 and FKHR/FOXO1.  
Immunolocalization studies indicated that while ectopically expressed FKHR was 
primarily concentrated in the cytoplasm of control cells and cells transiently 
overexpressing SH2-Bβ, it was concentrated in the nucleus of cells transiently 
overexpressing SH2-Bβ(R555E).  Similarly, SH2-Bβ stimulated the accumulation 
of FKHR in the cytoplasm of 293T and Cos-7 cells, whereas SH2-Bβ(R555E) 
enhanced its accumulation in the nucleus.  In PC12 cells stably expressing forms 
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of SH2-Bβ, SH2-Bβ mimicked the ability of NGF to promote redistribution of 
FKHR to the cytoplasm whereas SH2-Bβ(R555E) blocked this effect of NGF.  
Taken together, these data indicate that SH2-B is a positive regulator of NGF-





 Nerve growth factor (NGF) is a trophic factor essential for the development 
and survival of sympathetic and sensory neurons.  PC12 cells, a well-established 
cell culture model of sympathetic neurons, differentiate into a neuronal-like 
phenotype in the presence of NGF1.  In both sympathetic neurons and PC12 
cells, removal of trophic support triggers retraction of neurite outgrowths and 
eventual apoptosis (107, 108).  NGF protects PC12 cells from apoptosis induced 
by trophic factor withdrawal (108, 109), cytotoxic drugs (110-112), and oxidative 
stressors (113-115).   The mechanism(s) by which NGF elicits its effects on 
neuronal differentiation and survival are only beginning to be understood.  
 A majority of the neurotrophic effects of NGF are believed to be initiated 
by binding of NGF to the membrane receptor tyrosine kinase TrkA.  NGF binding 
activates TrkA which phosphorylates itself on multiple tyrosines (126).  Binding of 
different signaling proteins to these phosphorylated tyrosines initiates multiple 
signaling pathways.  Several of these TrkA binding proteins and/or their 
downstream effector proteins have been implicated in the regulation of neuronal 
differentiation and/or survival.  One of the first pathways shown to be required for 
NGF-induced neuronal differentiation of PC12 cells is the Ras/Raf/MEK/ERK 
pathway.  The TrkA binding protein Shc, as well as Ras, Raf, MEK and ERK 
have been implicated in neuronal differentiation of PC12 cells (28, 29, 127, 128).  
Another TrkA binding protein implicated in NGF-induced differentiation of PC12 
cells is phospholipase Cγ, a protein that mediates the production of diacylglycerol 
and inositol trisphosphate, leading to release of intracellular Ca2+ stores and 
activation of protein kinase C (129-131). 
A third pathway, involving the TrkA binding protein phosphatidylinositol 3’ (PI3) 
kinase and the serine/threonine kinase Akt/PKB, has been implicated in axon 
caliber and branching (132).  However, it is primarily emerging as a transducer of 
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survival signals.  Akt activity has been linked to cell survival in several cell types 
(133, 134) and is both necessary and sufficient for NGF-dependent survival of 
sympathetic neurons (135).  Inhibition of PI3 kinase by wortmannnin or 
LY294002 blocks the ability of NGF to prevent apoptosis in both PC12 cells and 
primary sympathetic neurons (135, 136).  Activated forms of PI3 kinase and AKT 
promote neuronal survival in the absence of external survival factors (134, 135, 
137-142).  Lipid products of PI3 kinase have been shown to recruit Akt to the 
plasma membrane via the PH domain of Akt, leading to phosphorylation of Akt at 
Ser473 and Thr308 by phosphoinositide-dependent kinases (143-145).  
Phosphorylation of both sites is required for full activation of Akt (146).  Akt can 
phosphorylate and modulate the activity of several proteins involved in cellular 
survival, including members of the FOXO family of forkhead transcription factors 
(147, 148), glycogen synthase kinase-3 (GSK-3) (149), the Bcl2 family members 
BAD and Bax (150-152), nuclear factor-κB (153, 154) and caspase 9 (155). 
Phosphorylation of GSK-3 by Akt at Ser 21 (α isoform) or Ser 9 (β isoform) 
inactivates GSK-3 and is believed to be the primary mechanism responsible for 
growth factor inhibition of this protein kinase(156, 157).  Inactivation of GSK-3 is 
thought to contribute to the survival effects of Akt activation and to reduce 
neurotrophin factor withdrawal-induced neurite retraction.  Inhibition of GSK-3 by 
LiCl reduces NGF withdrawal-induced apoptosis in PC12 cells (158) and the 
degree of neurite retraction observed in wortmannnin-treated SH-SY5Y 
neuroblastoma cells (159). 
 Multiple Forkhead family members are targets of Akt (148, 160).  Three 
mammalian members of this family, namely FKHR/FOXO1 (161), 
FKHRL1/FOXO3 (162) and AFX/FOXO4 (163), belong to the FOXO subfamily.  
Proteins in this subfamily have sequence similarity to the nematode homologue 
Daf-16, which is a downstream target of two Akt homologues in an insulin-related 
signaling pathway, and have been implicated in apoptosis of neuronal cells (164-
166).  Daf-16 as well as AFX, FKHR, and FKHRL1 contain multiple consensus 
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Akt phosphorylation sites (161, 163) and Akt can directly phosphorylate the three 
mammalian forkhead proteins in vitro (148, 160). 
 Akt is thought to inhibit the activity of forkhead transcription factors 
primarily by regulating their subcellular localization (117, 167).  In this paradigm, 
FKHR in the nucleus induces the expression of genes critical for cell death, such 
as the Fas ligand gene.  When activated, Akt phosphorylates FKHR proteins in 
the nucleus, resulting in binding of FKHR proteins to 14-3-3 and subsequent 
export from the nucleus.  This relocation of FKHR proteins to the cytoplasm 
functionally represses their transcriptional activity (117, 118, 167, 168).  Binding 
to 14-3-3 is also thought to help retain FKHR in the cytoplasm by masking a site 
necessary for nuclear reimport (118).   
 SH2-B was identified as a binding protein of the receptor for NGF (TrkA) 
(33, 34), as well as of the receptors for insulin (36), platelet-derived growth factor 
(39), fibroblast growth factor (58), insulin like growth factor-1 (38), hepatocyte 
growth factor (58); the cytokine receptor-associated tyrosine kinase JAK2 (41), 
and the R1 Fc epsilon R1 receptor (43).  Four SH2-B isoforms (α, β, γ, δ) have 
now been identified; they differ in their C-termini downstream of the SH2 domain 
(37, 41, 43, 46) (FIG. 1.1).  SH2-B belongs to a family of adapter proteins that 
include APS and Lnk (44, 45).  
 We and others have shown that SH2-B (α or β isoform) is vital for NGF-
induced neurite outgrowth in cultured PC12 cells and maintenance of the 
neuronal phenotype of primary cultured rat sympathetic neurons (33, 34).  NGF 
stimulates the association of SH2-Bβ with TrkA via the SH2 domain of SH2-Bβ 
and the tyrosyl phosphorylation of SH2-Bβ.  Mutating the critical Arg to Glu 
(R555E) within the SH2 domain of SH2-Bβ abolishes both the NGF-induced 
association of SH2-Bβ with TrkA and the tyrosyl phosphorylation of SH2-Bβ (33).  
Stable overexpression of SH2-Bβ enhances NGF-induced neuronal differentiation 
of PC12 cells, whereas stable expression of SH2-Bβ(R555E) blocks NGF-
induced differentiation of PC12 cells (33).  Interestingly, cells stably expressing 
44 
SH2-Bβ(R555E) do not show impaired NGF-induced tyrosyl phosphorylation of 
TrkA, Shc, phospholipase C-γ, ERK1 or ERK2 (41), suggesting that impaired 
activation of these signaling proteins is not responsible for the dramatic overall 
impairment of neuronal differentiation.  SH2-B has also been implicated in 
neuronal survival.  Neuronal sympathetic neurons triturated with anti-SH2-B 
antibodies exhibit a reduced rate of survival when grown in NGF-containing 
medium.  Similarly, transient expression of an N-terminally truncated form of 
SH2-B promotes degeneration of axons of sympathetic neurons in explants of 
superior cervical ganglia grown in the presence of NGF (34). In the current work, 
we extend these earlier studies designed to determine the role of SH2-Bβ in 
neuronal differentiation and survival by examining the hypothesis that SH2-Bβ 




Materials and Methods 
 
 Cells and Reagents.  Parental  PC12 cells were obtained from Dr. Ben 
Margolis (University of Michigan) or ATCC.  Pools of PC12 cells stably 
expressing GFP, GFP-SH2-Bβ and GFP-SH2-Bβ(R555E) were made as 
described previously (41) and used for FIGS. 2.2-2.5.  FIG. 2.8 used cells made 
in a similar fashion with the exception that all GFP positive cells were pooled 
instead of only those with the top 2% expression level.  The stock of 293T cells 
was obtained from Dr. O. A MacDougald (University of Michigan, Ann Arbor, MI).  
Murine NGF was from BD Bioscience.  Triton X-100, aprotinin, and leupeptin 
were purchased from Roche Molecular Biochemicals.  The nitrocellulose 
membranes and enhanced chemiluminescence (ECL) detection system were 
from Amersham Corp.  X-ray film came from DuPont or Kodak (FIG. 2.8B), horse 
serum from ICN Biomedicals, fetal bovine serum from Invitrogen and poly-L-
lysine from Sigma. 
 Plasmids, Antibodies and Fluorescent Probes.  pcDNA-Flag-FKHR 
was a gift of Drs. E. Tang and K. Guan (148).  cDNAs encoding GFP-tagged wild-
type SH2-Bβ and SH2-Bβ(R555E) have been described previously (33).  Anti-
SH2-Bβ antibody (αSH2-Bβ) was prepared as described previously (41) and 
used at a dilution of 1:15,000 for western blotting.  Antibodies that recognize the 
following proteins were used for western blotting at a dilution of 1:1000: phospho-
Akt (Ser473) (αpAkt-Ser473) (Cell Signaling, #9276), Akt (αAkt) (Cell Signaling, 
#9272), FKHRL1 (αFKHRL1) (Upstate Biotechnology, #06-951), phospho-GSK-
3(Ser 21/9) (αpGSK-3) (Cell Signaling, #9331S) and phospho-GSK-
3(Y279/Y216) (used to detect total GSK-3) (αGSK-3) (Upstate Biotechnology, 
#05-413).  Anti-Flag M2 monoclonal antibody (αFlag) was obtained from Sigma 
and used at a dilution of 1:1000 for immunocytochemistry.  Texas Red dye-
conjugated AffiniPure Goat Anti-mouse IgG (H+L) was from Jackson 
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ImmunoResearch and was used at a dilution of 1:400.  Anti-rabbit IgG 
conjugated to horseradish peroxidase was from Santa Cruz.  Antibody to FKHR 
(αFKHR)(Cell Signaling, 9462) which recognizes only unphosphorylated FKHR 
(T Maures and C Carter-Su, unpublished observation and personal 
communication with Cell Signaling technical support) 
Cell Culture.  PC12 cells were grown at 37°C in 5% CO2 in Dulbecco’s 
modified Eagle’s medium (DMEM) supplemented with 1 mM L-glutamine, and 1 
mM antibiotic-antimycotic (Invitrogen) (supplemented DMEM), 10% heat-
inactivated horse serum, and 5% fetal bovine serum.  Cells used for experiments 
were plated on poly-L-lysine coated coverslips (for analysis by confocal 
microscopy), Lab-TekII Chamber Slide System 154941 (Nalge Nunc International 
Corp) (FIG. 2.8A) or on collagen-coated dishes.  The latter were prepared by 
incubating with 0.1mg/ml collagen (type I rat tail, Collaborative Biomedical 
Products, #354236) in 0.02N acetic acid for 1 h.  The confluent cells were 
deprived of serum overnight using supplemented DMEM containing 1% bovine 
serum albumin and treated as indicated with NGF.  293T and Cos-7 cells were 
grown in supplemented DMEM and 8% calf serum.   
RT-PCR.  Total RNA was prepared from PC12 cells using TRIZOL reagent 
as per the manufacturer’s protocol (Life Technologies).  Oligonucleotide primers 
that recognize all four known isoforms of murine SH2-B were used to amplify 1 
µg of total RNA (sense primer 5’- TCTCCCCTAGTTCTGCCTCCATTG-3’, 
corresponding to nucleotides 1638-1661 of murine SH2-Bα, β, γ, δ; antisense 
primer 5’-CGCCCCCGACGCCTCTTCT-3’ corresponding to nucleotides 2428-
2410 in murine SH2-Bγ, Genebank accession# AF421139 (46).  Expression of 
SH2-Bγ was determined using the sense primer 5’-
TTCAACTTCCAGGGCAAGGCTAA-3’ (corresponding to the rat equivalent of 
nucleotides 1991-2013 in murine SH2-Bα, β, γ, δ in which nucleotide 2011 is a T 
rather than an A) and an antisense primer specific for SH2-Bγ (5’-
CCGGCCTCACTTCTTGGGTGCA-3’, corresponding to nucleotides 2220-2241 in 
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murine SH2-Bγ).  Reaction products were resolved by agarose gel 
electrophoresis and detected by ethidium bromide staining.  PCR products were 
extracted (Qiagen Qiaex II Gel Extraction Kit) and sequenced to verify which 
isoform they represented. 
 Immunoblotting.  Cells were solubilized in lysis buffer (50mM Tris [pH 
7.5], 0.1% Triton X-100, 150 mM NaCl, 2mM EGTA).  The lysates were 
centrifuged and the supernatants boiled for 5 min in a mixture (80:20) of lysis 
buffer:sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) 
sample buffer.  Solubilized proteins were separated by SDS-PAGE.  Proteins in 
the gel were transferred to a nitrocellulose membrane and detected by 
immunoblotting with desired antibodies and enhanced chemiluminescence (41).  
For quantification, immunoblots with signals in the linear range were scanned 
and the resulting images were analyzed using multi-analyst image software from 
Bio-Rad (FIG. 2.3, 2.4C).  In FIG. 2.5B quantification used the NIH Image 1.62 f 
software.   
 Immunolocalization.  PC12 cells were plated onto poly-L-lysine treated 
glass coverslips or Lab-TekII Chamber Slide System and transfected with various 
cDNA using Lipofectamine Plus (Invitrogen).  Both 293T and Cos-7 cells were 
plated on coverslips and transfected using calcium phosphate precipitation.  
Twenty-four h after transfection, cells were incubated in serum-free medium 
overnight.  As indicated, NGF was added following serum deprivation at a 
concentration of 100ng/ml. Cells were then fixed in 4% formaldehyde and 
permeabilized with 0.1% Triton X-100.  Cells were incubated with αFlag for 1 h, 
then for 45 min with anti-mouse IgG conjugated to Texas Red.  Coverslips were 
mounted using mounting medium (90% glycerol and 10% phosphate buffered 
saline) (FIGS. 2.6B, 2.7B, 2.7C) or Prolong Anti-fade P-7481 (Molecular Probes) 
(FIGS. 2.7A, 2.8A) and examined using epifluorescence microscopy (Nikon 
Eclipse TE 200) with a 60x objective.  In other experiments, coverslips under a 
Noran OZ laser scanning confocal microscope equipped with a 100x Nikon 
objective.  In some experiments, fluorescently labeled antibodies and GFP-
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tagged proteins were imaged Where indicated, the mean intensities of 
neighboring cytosolic and nuclear regions (approximately 5 µm2 each) were 
calculated using Adobe PhotoshopTM, corrected for background, and presented 
as nuclear-to-cytosol fluorescence ratios.   
 In Vitro Akt Kinase Assays.  Immunocomplex Akt kinase assays were 
performed using the Akt1/PKB alpha IP-kinase assay kit from Upstate 
Biotechnology.  After 4-5 h serum deprivation, NGF was added to PC12 cells 
stably expressing GFP, GFP-SH2-Bβ or GFP-SH2-Bβ(R555E) for various lengths 
of time.  PC12 cells were placed on ice and proteins were extracted according to 
the manufacturer’s instructions.  Akt was immunoprecipitated from cell lysates 
using anti-Akt/PKB antibody.  After washing, the immunoprecipitates were 
resuspended in 40 µl of kinase assay buffer containing 10 µCi of [γ-32P]ATP and 
10µl of a specific substrate peptide (RPRAATF) and incubated at room 
temperature for 20 min with constant shaking.  The reaction was stopped by 
addition of 20 µl of 40% trichloroacetic acid.  The phosphorylated substrate was 
spotted onto P81 phosphocellulose paper (Whatman).  Residual [γ-32P]ATP was 
removed by extensive washing.  Radioactivity bound to the filter was quantified 





 Isoforms of SH2-B Expressed in PC12 Cells.  We first examined which 
isoforms of SH2-B are predominantly expressed in PC12 cells.  RNA prepared 
from PC12 cells was PCR amplified using primers that would amplify all four 
known isoforms (α, β, γ, δ) (predicted products:  ~637, 737, 790, 690 bp 
respectively) (FIG. 2.1A).   The PCR products migrated with a size most closely 
resembling that predicted for the β isoform (FIG. 2.1B, lane 1) and co-migrated 
with the PCR product using SH2-Bβ cDNA as template (data not shown).  The 
PCR products were cleaved by the restriction enzyme BsiEI which cleaves only 
the 100 bp insert present in the β and γ isoforms (FIG. 2.1A).   The BsiEI 
products (FIG. 2.1B, lane 3) co-migrated with the BsiEI cleaved forms of the PCR 
product obtained using rat SH2-Bβ cDNA as the template (FIG. 2.1B, lane 4).  To 
confirm the identity of the PCR product as SH2-Bβ, the PCR product was gel 
purified and sequenced.  The sequence corresponded to that predicted for the β 
isoform, suggesting that SH2-Bβ is the primary isoform of SH2-B expressed in 
PC12 cells.  Because the RT-PCR products for the β and γ isoforms are only 53 
bp different in size and therefore might be difficult to separate on the gel and 





FIG. 2.1.  PCR reveals the expression of the β  isoform of SH2-B in PC12 
cells.   
A) Schematic of the 4 isoforms of SH2-B.  Exons are denoted by the boxes and are numbered.  
B) Total RNA was prepared from cells.  Oligonucleotide primers that recognize all four known 
isoforms of murine SH2-B (lane 1) or the γ isoform (lane 2) were used to amplify 1 µg of total RNA 
using PCR.  The PCR product from a duplicate of lane 2 (lane 3) or the PCR product from cDNA 
encoding SH2-Bβ (lane 4) was digested with BsiE1 and digestion products separated in an 
agarose gel.  For lanes 3 and 4, β denotes the predicted migration of the PCR product using the β 
isoform as template and β’ denotes the predicted migration of the BsiE1 digestion products of the 
β isoform. 
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specific for the γ isoform of SH2-B were designed to test further whether SH2-Bγ 
is expressed in PC12 cells.  Figure 1B (lane 2) shows that the γ isoform is also 
expressed in PC12 cells.  Since it was possible that some δ isoform was also 
amplified by the primers used even though the primer sequence was not an exact 
match, the PCR amplified cDNA using γ specific primers was gel purified and 
sequenced.  The sequence obtained from two different PCR products 
corresponded to the γ isoform.  Taken together, the results of FIG. 2.1 are 
consistent with SH2-Bβ being the primary isoform of SH2-B expressed in PC12 
cells.  Other isoforms (e.g. γ isoform) appear to be expressed, but to a 
significantly lesser extent than the β isoform.  These results are consistent with 
the previous finding that after dephosphorylation by alkaline phosphatase, SH-2B 
in PC12 cells comigrates with the dephosphorylated SH2-Bβ expressed 
ectopically in COS cells (33).  Based upon these findings, all subsequent 
experiments focused on the β isoform of SH2-B. 
 SH2-Bβ  Enhances NGF Stimulated Activation of Akt.  To determine 
whether SH2-Bβ is involved in the regulation of Akt by NGF, we first examined 
whether stable overexpression of SH2-Bβ or a mutated form of SH2-Bβ that lacks 
a functional SH2 domain, SH2-Bβ(R555E), affects the ability of NGF to stimulate 
the phosphorylation of Serine 473 in Akt.  Maximal activation of Akt requires 
phosphorylation of Ser473 (146).  PC12 cells stably expressing GFP, GFP-SH2-
Bβ, or GFP-SH2-Bβ(R555E) were treated with 100 ng/ml NGF for various times 
and cell lysates were collected.  Solubilized proteins were separated by SDS-
PAGE and immunoblotted with antibody that specifically recognizes 
phosphorylated Ser473 (pSer473) within Akt.  In control cells overexpressing 
GFP, NGF induced the appearance of pSer473 within Akt within 15 min (FIG. 
2.2A, top panel, lane 2).  Phosphorylation was maximal at the 15 min timepoint 
and returned to nondetectable levels by 2 h.  A similar NGF-induced increase in 
the amount of pSer 473, both in terms of magnitude and time course, was 
observed in cells overexpressing GFP-SH2-Bβ (R555E) (FIG. 2.2A, bottom 
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panel).  In contrast, overexpression of GFP-SH2-Bβ both enhanced and 
prolonged NGF-induced phosphorylation of Ser473 (FIG. 2A, middle panel).  The 
observed changes in the amount of pSer473 were not due to changes in the 
amount of Akt.  No significant change in total Akt was observed after NGF 
treatment and the levels of Akt in the three cell lines were indistinguishable (FIG. 
2.2B).  These observations demonstrate that overexpression of SH2-Bβ 
enhances NGF induced Akt activation while overexpression of SH2-Bβ (R555E) 
has no effect.  To verify levels of expression of GFP-SH2-Bβ in the stably 
expressing cell lines, cell lysates were immunoblotted with antibody to SH2-B 
(αSH2-B).  FIG. 2.2C shows a very high level of expression (>10 fold) of both 
GFP-SH2-Bβ and GFP- SH2-Bβ(R555E) compared to endogenous SH2-Bβ.  
These levels of expression of SH2-Bβ are sufficiently high to enhance (GFP-SH2-
Bβ) or block (GFP-SH2-Bβ(R555E), NGF-induced neuronal differentiation of 




FIG. 2.2.  SH2-Bβ  enhances and prolongs NGF-induced phosphorylation of 
Ser473 in Akt.   
PC12 cells stably overexpressing GFP alone (GFP), GFP-SH2-Bβ or GFP-SH2-Bβ (R555E) as 
indicated were stimulated with 100 ng/ml NGF for the indicated times.  In parallel experiments, an 
equal amount of protein in the lysates was immunoblotted with αpAkt(Ser473) (Panel A), αAkt 
(Panel B), or αSH2-B (Panel C).  SH2-Bβ(R555E) compared to endogenous SH2-Bβ.  These 
levels of expression of SH2-Bβ are sufficiently high to enhance (GFP-SH2-Bβ) or block (GFP-
SH2-Bβ(R555E), NGF-induced neuronal differentiation of PC12 cells ((33); data not shown). 
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To verify more directly the effect of SH2-Bβ on NGF-induced activation of Akt, we 
measured the enzymatic activity of Akt following exposure of the different cell 
lines to NGF.  Cells were treated with NGF and solubilized.  Akt was 
immunoprecipitated using anti-Akt/PKB antibody (αAkt) and incubated at room 
temperature for 20 min with [γ-32P]ATP and a specific substrate peptide 
(RPRAATF).  The reaction was stopped by addition of trichloroacetic acid and the 
phosphorylated substrate was spotted onto P81 phosphocellulose paper.  
Radioactivity bound to the filter was quantified by scintillation counting.  The time 
course of Akt activation in response to 100 ng/ml NGF generally paralleled that of 
phosphorylation of Akt on Ser473.  In control PC12 cells stably expressing GFP 
alone, stimulation with NGF resulted in a dramatic increase in Akt activity after 3 
min.  Akt activity returned to near baseline levels by 2 h (FIG. 2.3A).  Similar 
results were obtained in PC12 cells stably expressing SH2-Bβ(R555E) (data not 
shown).   In contrast, but consistent with the pSer473 results, Akt activity in PC12 
cells stably expressing GFP-SH2-Bβ was enhanced at 15 and 60 min compared 
to control cells expressing GFP and remained elevated for 2 h.  Overexpression 
of GFP-SH2-Bβ did not enhance the activity of Akt at the three min time point.  
However, overexpression of GFP-SH2-Bβ was found in preliminary studies to 
enhance NGF-induced Akt activity at the 3 min time-point when NGF was tested 
at a concentration of 10 or 50 ng/ml, rather than at 100 ng/ml (data not shown), 
suggesting that SH2-Bβ not only prolonged NGF-activation of Akt but also shifted 






FIG. 2.3.  SH2-Bβ  enhances and prolongs NGF-induced activity of Akt. 
PC12 cells stably overexpressing GFP alone and GFP-SH2-Bβ were stimulated with 100 ng/ml 
NGF for the indicated times.  Akt was immunoprecipitated and kinase activity was determined.  
The results show the mean and range of two separate experiments. 
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 SH2-Bβ  Enhances Phosphorylation of GSK-3.  To investigate whether 
SH2-Bβ affects downstream targets of Akt, we first examined whether 
overexpression of SH2-Bβ alters NGF-induced phosphorylation of GSK-3 on Ser-
21 (α isoform) or Ser-9 (β isoform).  Akt phosphorylation of the GSK-3α isoform 
on Ser-21 or of GSK-3β on Ser-9 results in partial inactivation of GSK-3 (157).  
Phosphorylation of both GSK-3α and GSK-3β in response to NGF was rapid, 
substantial and transient, with maximal stimulation being observed at 15 min or 1 
h  (FIGS. 2.4A and C).  As with Akt, phosphorylation of GSK-3 was prolonged in 
PC12 cells stably expressing SH2-Bβ compared to cells expressing GFP alone or 
SH2-Bβ(R555E).  The observed changes in the amount of pSer21/9 were not due 
to changes in the amount of GSK-3.  No significant change in total GSK-3α/β was 
observed after NGF treatment and the levels of GSK-3 in the three cell lines were 
indistinguishable (FIG. 2.4B). 
 SH2-Bβ  Enhances NGF-induced Phosphorylation of FKHRL1.  To 
investigate further whether SH2-Bβ affects downstream targets of Akt, we 
examined whether SH2-Bβ affects NGF induced phosphorylation of forkhead 
(FKHR/FOXO) family members.  As shown in the anti-FKHRL1 (αFKHRL1) 
immunoblots in FIG. 2.5A (upper panel), in control cells overexpressing GFP 
alone, NGF induces a transient upward shift in the migration of FKHRL1, 
consistent with an increase in phosphorylation.  The ratio of phosphorylated 
(upper band) to unphosphorylated (lower band) FKHRL1 was maximal at 15 or 
30 min and declined thereafter (Fig 5A, 5B).  Phosphorylation was significantly 
prolonged in PC12 cells stably expressing SH2-Bβ (FIG. 2.5A, middle panel) 
compared to control cells expressing GFP alone (FIG. 2.5A, upper panel) or cells 
expressing SH2-Bβ(R555E) (FIG. 2.5A, lower panel). 
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FIG. 2.4.  SH2-Bβ  enhances and prolongs NGF-induced phosphorylation of 
GSK-3α /β  on Ser21/Ser9.   
PC12 cells stably overexpressing GFP alone, GFP-SH2-Bβ, and GFP-SH2-Bβ (R555E) were 
stimulated with 100 ng/ml NGF for the indicated times.  An equal amount of protein in the lysates 
was immunoblotted with αpGSK-3(Ser 21/9) (Panel A) or αGSK-3 (Panel B). The resulting films 
from three separate experiments using αpGSK-3 were scanned and the relative amounts of 
bound pGSK-3 were calculated (Panel C).  The results show the mean and standard error of the 
mean for three separate experiments, normalized to the 15 min control (GFP).  An asterisk (*) 
denotes a p value <0.05 (two-tailed, paired Student t-Test) between experimental [GFP-SH2-Bβ 
and GFP-SH2-Bβ (R555E)] and control (GFP) values. 
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 SH2-Bβ(R555E) Redistributes FKHR to the Nucleus.  FKHR 
transcription factors are inactivated by Akt-mediated phosphorylation which 
stimulates the redistribution of FKHR from the nucleus to the cytoplasm (117, 
167, 168).  Because SH2-Bβ stimulated the NGF-induced phosphorylation of 
FKHRL1, we examined whether overexpression of SH2-Bβ would alter the 
subcellular distribution of FKHR proteins.  PC12 cells were transiently co-
transfected with cDNAs encoding Flag-tagged FKHR and either GFP alone, GFP-
SH2-Bβ, or GFP-SH2-Bβ(R555E).  After 24 h, the cells were incubated in serum-
free medium, fixed in 4% formaldehyde, permeabilized with 0.1% Triton X-100, 
and then incubated with αFlag followed by anti-mouse IgG conjugated to Texas 
Red.  In some experiments, the location of Flag-FKHR was determined in cells 
that co-expressed GFP, GFP-SH2-Bβ, or GFP-SH2-Bβ (R555E) using a Noran 
OZ laser scanning confocal microscope equipped with a 100× Nikon objective 
(FIG. 2.6A, upper panel).  In other experiments, GFP and fluorophore conjugated 
antibodies were imaged by epifluorescence microscopy (Nikon Eclipse TE 200) 
with a 60x objective (FIG. 2.6A, lower panel).  The mean intensities of 
neighboring cytosolic and nuclear regions (approximately 5 µm2 each) in the 
epifluorescent images were calculated using Adobe PhotoshopTM, corrected for 
background, and expressed as nuclear-to-cytosol fluorescence ratios (FIG. 2.6B).  
FIGS 2.6A and B show that in control PC12 cells co-expressing GFP and FKHR 
under quiescent conditions, FKHR was mainly localized in the cytoplasm and 
excluded from the nucleus.  Co-expression of GFP-SH2-Bβ did not generally alter 
the subcellular localization of FKHR in these cells.  In contrast, overexpression of 
SH2-Bβ (R555E) caused a dramatic redistribution of FKHR to the nucleus. 
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FIG. 2.5.  SH2-Bβ  enhances and prolongs NGF-induced phosphorylation of 
FKHRL1.   
PC12 cells stably overexpressing GFP alone, GFP-SH2-Bβ, and GFP-SH2-Bβ (R555E) were 
stimulated with 100 ng/ml NGF for the indicated times.  An equal amount of protein in the lysates 
was immunoblotted with αFKHRL1 (Panel A).  The films in Panel A were scanned and the relative 
amounts of FKHRL1 were calculated (Panel B).  The results show the mean intensity of the 




 To determine whether this ability of SH2-Bβ (R555E) to redistribute FKHR 
was specific to PC12 cells, we examined the effect of expressing GFP, GFP-
SH2-Bβ, and GFP-SH2-Bβ (R555E) on the subcellular distribution of Flag-FKHR 
in cultured Cos-7 and 293T cells.  In transiently transfected Cos-7 cells (FIG. 
2.7A), Flag-FKHR was predominantly localized in the cytoplasm and excluded 
from the nucleus of about 75% of Cos-7 cells expressing GFP.  Much like what 
was observed in the PC12 cells, co-expression of GFP-SH2-Bβ with Flag-FKHR 
did not alter the subcellular localization of FKHR.  However, overexpression of 
SH2- Bβ (R555E) resulted in increased retention (from ~25% to ~40% of cells) of 
FKHR within the nucleus of Cos-7 cells (40%).  293T cells ectopically expressing 
Flag-FKHR and GFP displayed a lower basal level of cytoplasmic FKHR (~50%) 
and a higher basal level of nuclear FKHR than seen in Cos-7 cells (Fig 7B, C).  In 
these cells, overexpression of SH2-Bβ caused an increase in the percentage of 
the cells (~65%) that retained FKHR in the cytoplasm and excluded it from the 
nucleus.  As observed with PC12 and Cos-7 cells, ectopic expression of SH2-Bβ 
(R555E) caused a substantial decrease in the percentage of 293T cells 
containing FKHR in the cytoplasm (from ~50% to ~30%) and corresponding 
increase in the percentage of cells containing FKHR in the nucleus (from ~50% to 
~70%). 
 Thus, a substantial percentage of all three cell types exhibited a 
subcellular redistribution of FKHR from the cytoplasm to the nucleus when 
expressing SH2-Bβ (R555E).  To determine whether this nuclear localization 
could be reversed with NGF stimulation, PC12 cells stably expressing GFP, 
GFP-SH2-Bβ, or GFP-SH2-Bβ (R555E) were transiently transfected with cDNA 
encoding Flag-FKHR.  After transfection the cells were deprived of serum 
overnight and treated with 100 ng/ml NGF for 1 h before fixing and staining.  
Figure 8 demonstrates FKHR's characteristic subcellular shift after NGF 
treatment in the GFP expressing control cells.  The addition of NGF led to an 
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FIG. 2.6.  SH2-Bβ  (R555E) promotes FKHR retention in the nucleus of PC12 
cells.   
PC12 cells (Panels A and B) were transiently cotransfected with cDNA encoding Flag-FKHR and 
either GFP alone, GFP-SH2-Bβ or GFP-SH2-Bβ (R555E).  Ectopically expressed proteins were 
imaged using either confocal (Panel A, upper) or epifluorescence (Panel A, lower) microscopy.  
For Panel B, relative levels of FKHR in the cytoplasm and nucleus were determined by comparing 
the intensity of the signal in identically sized regions placed in the cytoplasm and nucleus of the 
same cell (Panel B).  The results show the mean and standard error for a total of 16-18 cells from 




FIG. 2.7.  SH2-Bβ(R555E) redistributes FKHR to the nucleus in 293T and 
Cos-7 cells.  
A)  Cos-7 cells  were transiently cotransfected with cDNA encoding Flag-FKHR and either GFP 
alone, GFP-SH2-Bβ, or GFP-SH2-Bβ (R555E).  The number of COS-7 cells in which FKHR was 
excluded from the nucleus (designated “C for “cytoplasmic”) and in which FKHR was present or 
concentrated in the nucleus (designated “N”) were graphed as a percentage of the total number 
of GFP-positive cells counted.  116, 69, and 103 cells expressing GFP alone, GFP-SH2-Bβ, and 
GFP-SH2-Bβ (R555E) respectively were assessed from two trials.  B and C)  293T cells were 
transiently cotransfected with cDNA encoding Flag-FKHR and either GFP alone, GFP-SH2-Bβ, or 
GFP-SH2-Bβ (R555E). Ectopically expressed proteins were imaged using epifluorescence 
microscopy (Panel B).  The number of 293T cells in which FKHR was excluded from the nucleus 
(designated “C for “cytoplasmic”) and in which FKHR was present or concentrated in the nucleus 
(designated “N”) were graphed as a percentage of the total number of GFP-positive cells counted.  




increased number of cells with Flag-FKHR excluded from the nucleus (from 
~40% to ~60%).  Consistent with the studies using 293T cells which displayed a 
similar percentage of cells in which FKHR was excluded from the nucleus, stable 
expression of GFP-SH2-Bβ in PC12 cells increased the number of cells with 
cytoplasmic Flag-FKHR, to a level above that seen in the control cells even in the 
presence of NGF.  Treatment with NGF did not result in a further increase in the 
number of cells with FKHR in the cytoplasm.  In contrast, PC12 cells stably 
expressing GFP-SH2-Bβ (R555E) were unable to shift FKHR from the nucleus to 
the cytoplasm even after NGF treatment.  These results suggest that 
overexpression of SH2-Bβ can mimic the action of NGF on the subcellular 
distribution of FKHR whereas overexpression of SH2-Bβ(R555E) blocks the 
ability of NGF to redistribute FKHR to the cytoplasm. 
 Because cytoplasmic localization of FKHR is thought to be dependent on 
its phosphorylation, we examined whether overexpression of SH2-Bβ or SH2-Bβ 
(R555E) affects the serine/threonine phosphorylation of FKHR measured under 
the exact experimental conditions used to study the subcellular localization of 
FKHR in FIG. 2.8A. Cells were deprived and stimulated with NGF in the same 
manner as above, before collecting total cell lysates.  Proteins were separated by 
SDS-PAGE and immunoblotted with anti-FKHR, an antibody that recognizes 
unphosphorylated but not phosphorylated FKHR.  Thus, the degree of 
phosphorylation is indicated by a decrease in the signal.  As shown in Fig 8B, 
phosphorylation of ectopically expressed Flag-FKHR was identical in cells 
expressing GFP and SH2-Bβ (R555E).  Phosphorylated Flag-FKHR peaked 
between 15-30 minutes in both lines and began to return to its unphosphorylated 




FIG. 2.8.  SH2-Bβ  mimics and SH2-Bβ(R555E) blocks NGF-induced 
redistribution of FKHR from the nucleus to the cytoplasm.   
PC12 cells stably expressing GFP, GFP-SH2-Bβ, or GFP-SH2-Bβ (R555E) were transiently 
transfected with cDNA encoding Flag-FKHR.  A)  Cells were incubated in serum free medium for 
24 h and fixed (white bars) or treated with 100ng/ml NGF for 1 h and fixed (gray bars).  Units are 
defined as the percentage of cells with Flag-FKHR excluded from the nucleus (defined “C” for 
“cytoplasmic”) divided by the total number of cells counted of which expressed Flag-FKHR 
(defined “N+C”).  103, 100, 114, 192, 126, and 107 cells expressing GFP alone (minus and plus 
NGF), GFP-SH2-Bβ (minus and plus NGF), and GFP-SH2-Bβ (R555E) (minus and plus NGF) 
respectively were assessed in two trials. B)  Cells were deprived for 24 h and then treated with 
100ng/ml NGF for 0, 0.25, 0.5, 2, and 3 h.  An equal amount of protein in the lysates was 
immunoblotted with αFKHR.  It is important to note that this antibody recognizes only 
unphosphorylated FKHR. 
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expressing GFP-SH2-Bβ showed an increase in the duration of FKHR 
phosphorylation.  Similar results were obtained looking at the phosphorylation of 
endogenous FKHR both in cells that did and cells that did not co-express Flag-
FKHR (data not shown).  Thus, FKHR appears to be phosphorylated normally in 
the GFP-SH2-Bβ (R555E) cell line in response to NGF treatment, yet still 
displays an inability to shift FKHR from the nucleus to the cytoplasm in response 
to NGF suggesting that SH2-Bβ acts at least in part, downstream of Akt 
phosphorylation. 
 Consistent with FKHR being redistributed to the nucleus where it is 
thought to be proapoptotic by virtue of stimulating the transcription of 
proapoptotic proteins, co-expression of FKHR and SH2-Bβ(R555E) appeared to 
be deleterious to the cells.  In contrast to GFP and GFP-SH2-Bβ for which most 
of the cells co-expressed FKHR and either GFP or GFP-SH2-Bβ, significantly 
fewer cells could be found co-expressing FKHR and SH2-Bβ (R555E) in either 
PC12 cells or 293T cells.  For example, in 293T cells deprived of serum 
overnight, 86% of cells expressing SH2-Bβ also expressed FKHR whereas only 
16% of cells expressing SH2-Bβ (R555E) also expressed FKHR.  Also consistent 
with nuclear FKHR being deleterious to the cell, when PC12 cells were 
transfected with cDNA encoding FKHR lacking its three AKT consensus 
phosphorylation sites, essentially no PC12 cells were found to express this FKHR 





 The results presented in this study provide strong evidence that at least 
one mechanism by which the putative adapter protein SH2-Bβ contributes to the 
ability of NGF to promote survival of sympathetic neurons is to enhance the 
ability of NGF to activate Akt.  Using the well-studied PC12 cell as a model 
system, we showed that NGF-induced activation of Akt is both enhanced and/or 
prolonged in cells overexpressing wild-type SH2-Bβ.  This is most likely a 
consequence of the increased NGF-induced phosphorylation of Akt, since it 
correlates in magnitude and time course with the increased NGF-induced 
phosphorylation of Ser 473.  Phosphorylation of Ser 473 and Thr 308 have both 
been shown to be obligatory for maximal activation of Akt (146).  This increased 
activity of Akt is most likely responsible for the similarly enhanced and prolonged 
NGF-induced  phosphorylation of the Akt effector proteins, GSK-3, FKHRL1 and 
FKHR.  The simplest explanation for this activation of Akt is that it is a 
consequence of the reported ability of SH2-Bβ to enhance and prolong NGF-
induced tyrosyl phosphorylation of TrkA (96).  Based upon what is known about 
how Akt is activated by receptor tyrosine kinases  (102, 143-146), we would 
predict that the more highly phosphorylated TrkA would recruit more PI3 kinase, 
which in turn would stimulate the recruitment of more Akt to the plasma 
membrane, which would result in more molecules of Akt being phosphorylated on 
Ser473 and Thr 308 by phosphoinositide-dependent kinases.  The NGF-induced 
activation of Akt (and phosphorylation of its downstream effectors GSK-3, 
FKHRL1, and FKHR) reported here, like the previously reported activation of 
TrkA, is enhanced by overexpression of SH2-B, but is not affected by ectopic 
expression of a form of SH2-B expected to act as a dominant negative, such as 
SH2-Bβ(R555E) (33) (in the case of Akt) or an N-terminally truncated form of 
SH2-B (in the case of TrkA) (96).  It is also possible that SH2-Bβ enhances and 
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prolongs NGF activation of Akt by acting at a point downstream of TrkA, for 
instance by blocking the dephosphorylation of Akt. 
 Enhanced NGF-induced phosphorylation of Akt substrates presumably 
contributes to the ability of SH2-B to protect against axonal degeneration and/or 
neuron cell death.  GSK-3, which exhibits increased NGF-induced 
phosphorylation in PC12 cells stably expressing SH2-Bβ, is inhibited upon 
phosphorylation by Akt (117) and inhibition of GSK-3 has been reported to 
reduce neuronal death caused by inhibition of Akt (169).  One mechanism 
proposed by which inhibition of GSK-3 contributes to neuronal survival is by 
stabilization of β-catenin (170).  Downregulation of GSK-3 as a consequence of 
SH2-Bβ enhanced phosphorylation would also be expected to prevent neurite 
retraction.  It seems likely that SH2-Bβ enhancement of NGF-induced 
phosphorylation and consequent inactivation of other pro-apoptotic, Akt 
substrates, such as the Bcl2 family member BAD, will also be found to contribute 
to the survival effects of SH2-Bβ.    
 The lack of a negative effect of SH2-Bβ(R555E) on Akt activity was 
somewhat surprising to us, given the ability of this mutant to completely block 
NGF-induced neuronal differentiation of PC12 cells (33) and our anecdotal 
observation that this mutant SH2-Bβ promotes cell death.  This suggested to us 
that the ability of SH2-Bβ to enhance and prolong NGF-induced activation of Akt 
may not be the only mechanism by which SH2-Bβ contributes to NGF-induced 
differentiation and/or survival of PC12 cells and/or sympathetic neurons.  The 
finding that SH2-Bβ(R555E) profoundly affects the subcellular distribution of 
FKHR, even in the absence of NGF, provides support for the hypothesis that 
SH2-Bβ affects more than just Akt-mediated phosphorylation of FKHR.  Based 
upon the current dogma (118), activated Akt moves to the nucleus where it can 
phosphorylate members of the FKHR family on multiple Ser/Thr.  The 
phosphorylated FKHR binds to 14-3-3 which facilitates its export from the 
nucleus and may facilitate retention in the cytoplasm.  Recently, the 
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phosphorylation of two novel casein kinase 1 sites within FKHR, Ser 322 and 
Ser325, were shown to be required for FKHR to interact with the export 
machinery (171).  Because FKHR members have been implicated in the 
regulation of a variety of apoptotic genes, including Fas ligand and cyclin 
dependent kinase inhibitor p27KIP1 (172), inhibition of FKHR activity by keeping it 
out of the nucleus would promote cell survival.  The current results suggest that 
SH2-B may participate in regulating the subcellular distribution of FKHR.  One 
scenario is that SH2-B acts as a scaffolding protein that promotes the interaction 
of FKHR with 14-3-3.  Another possibility is that SH2-B facilitates the transport of 
FKHR out of the nucleus.  One can envision SH2-Bβ(R555E) acting as a 
dominant negative by binding to some but not all of the proteins necessary for 
FKHR interaction with 14-3-3 or for nuclear export of FKHR.  The likelihood of 
this possibility is suggested by our recent finding (Chen and Carter-Su, submitted 
for publication) that SH2-Bβ itself cycles between the cytoplasm and the nucleus.  
Alternatively, SH2-Bβ might take one or more of the proteins required for these 
events to the wrong subcellular location or affect the ability of FKHR to be 
phosphorylated on the casein kinase I phosphorylation sites Ser322 and Ser325.  
Any of these scenarios could occur as a consequence of SH2-Bβ(R555E) not 
binding to TrkA (or other neurotrophic receptor tyrosine kinases) and/or not being 
phosphorylated on tyrosines, serines, or threonines as a consequence of not 
binding to activated TrkA (33, 68).  However, the fact that overexpression of SH2-
Bβ causes FKHR to shift to the cytoplasm in the absence of NGF suggests that 
modification of SH2-Bβ by TrkA is not necessary for SH2-Bβ to affect the 
subcellular distribution of FKHR.   
In summary, using PC12 cells as a model system, we have provided substantial 
evidence that SH2-Bβ enhances and prolongs NGF activation of Akt and 
phosphorylation of its downstream effectors, including GSK-3α and β, FKHRL1, 
and FKHR.  This action would be expected to contribute to the observed ability of 
overexpressed SH2-Bβ to enhance NGF-induced neuronal differentiation of 
69 
PC12 cells and survival of sympathetic neurons (33, 34).  SH2-Bβ appears to 
have an additional effect on FKHR and potentially other members of the FKHR 
family, namely promoting or retaining FKHR in the cytoplasm, thereby preventing 
it from acting as a transcription factor.  We are actively involved in determining 
the mechanisms by which SH2-Bβ and its mutants affect the subcellular 
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Chapter 3 
SH2B1β  (SH2-Bβ ) Enhances Expression of a Subset of Nerve 
Growth Factor-Regulated Genes Important for Neuronal 
Differentiation Including Genes Encoding UPAR and MMP3/10 
Abstract 
 
 Previous work showed that the adapter protein SH2B1 (SH2-B) binds to 
the activated form of the nerve growth factor (NGF) receptor TrkA and is critical 
for both NGF-dependent neurite outgrowth and maintenance.  To identify 
SH2B1β regulated genes critical for neurite outgrowth, we performed microarray 
analysis of control PC12 cells and PC12 cells stably overexpressing SH2B1β 
(PC12-SH2B1β) or the dominant negative SH2B1β(R555E) (PC12-
SH2B1β[R555E]).  NGF-induced microarray expression of Plaur and Mmp10 
genes was greatly enhanced in PC12-SH2B1β cells while NGF-induced Plaur 
and Mmp3 expression was substantially depressed in PC12-SH2B1β(R555E) 
cells.  Plaur, Mmp3 and Mmp10 are among the 12 genes most highly 
upregulated after 6 h of NGF.  Their protein products (uPAR, MMP3, MMP10) lie 
in the same pathway of extracellular matrix degradation; uPAR has been shown 
previously to be critical for NGF-induced neurite outgrowth.  QT-PCR analysis 
revealed SH2B1β-enhancement of NGF-induction of all three genes and the 
suppression of NGF-induction of all three when endogenous SH2B1 was reduced 
using shRNA against SH2B1 and in PC12-SH2B1β(R555E) cells.  NGF-induced 
levels of uPAR and MMP3/10 and neurite outgrowth through Matrigel (MMP3-
dependent) were also increased in PC12-SH2B1β cells.  These results suggest 
that SH2B1β stimulates NGF-induced neuronal differentiation at least in part by 
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enhancing expression of a specific subset of NGF-sensitive genes, including 




 Nerve growth factor (NGF) plays a critical role in the development of the 
peripheral nervous system.  This is especially true for sympathetic neurons, 
which are over-produced during development and are believed to compete for the 
limited quantities of target-derived NGF for their survival; only the select neurons 
that successfully innervate NGF-producing target organs persist (9, 173, 174).  
Sympathetic neuron requirement for NGF for survival has been well documented 
both in vitro and in vivo [reviewed in (175, 176)].  However, due to the absolute 
NGF dependence of sympathetic neurons for survival, it has been difficult to 
assess the necessity for NGF on other aspects of sympathetic neuron 
development and function, such as axonal growth and target innervation.  The 
use of Bax knockout mice circumvented this problem.  Deletion of Bax, a pro-
apoptotic transcription factor, dramatically reduces trophic-factor deprivation-
induced apoptosis of both sensory and sympathetic neurons (177).  The sensory 
and sympathetic neurons that die off in mice lacking NGF (NGF-/-) and the NGF 
receptor TrkA (TrkA-/-) (11, 178) are able to persist when those mice are crossed 
with the Bax-/- mice (12).  In the double knockout mice, axons from both 
sympathetic and sensory neurons appear unable to reach their targets, resulting 
in impaired target innervation (6, 12, 13).  Although experiments using these mice 
implicate NGF as an essential signal required for normal axonal growth of and 
peripheral target innervation by sympathetic and sensory neurons in vivo, the 
actual mechanisms by which NGF elicits these effects are only beginning to be 
understood.  Most of what we know about NGF-induced neuronal differentiation 
and NGF signal transduction events has come from the PC12 cell model.  PC12 
cells, derived from a rat pheochromocytoma, can be induced to differentiate into 
sympathetic neuron-like cells by NGF (16, 179).  Upon exposure to NGF, these 
cells first cease to proliferate.  They then exhibit somatic hypertrophy, acquire 
neurites and express neuronal specific genes. The neurite outgrowths are 
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capable of forming typical looking synapses with primary neurons from rat cortex 
(18).  As has been documented for sympathetic and sensory neurons, once 
PC12 cells differentiate into a neuronal phenotype, they depend on NGF for 
survival [for review, see (180)].  
 NGF initiation of neuronal differentiation starts with NGF binding to its 
receptor tyrosine kinase TrkA and activating TrkA.  The activated TrkA 
autophosphorylates and the phosphorylated tyrosines in the TrkA cytoplasmic 
domain bind a number of different signaling molecules and initiate a variety of 
downstream signaling pathways implicated in neuronal differentiation (181, 182).  
Binding proteins include Shc, phospholipase C-γ (PLC-γ), fibroblast growth 
receptor substrate 2 (Frs2, SNT), and CHK, a homolog of the cytoplasmic 
tyrosine kinase CSK (control of Src kinase).  Binding of these and presumably 
other TrkA binding proteins lead to the activation of PLC-γ/Ca2+; NFκB; 
phosphatidylinositol-3-kinase (PI3K)/Akt; Ras/Raf/MEK/ extracellular regulated 
kinases (ERKs) 1 and 2; JNK; p38; and atypical protein kinase C pathways 
[reviewed in (19), (20)].  
 We and others identified the putative adapter/scaffold protein SH2B1 as 
one of the signaling proteins that bind to the NGF-activated form of TrkA (33, 34).  
NGF promotes the rapid association of SH2B1 with TrkA and subsequent 
phosphorylation of SH2B1 on tyrosines as well as serines/threonines (33, 34, 
68).  SH2B1 belongs to a family of adapter proteins that also includes APS 
(SH2B2) and Lnk (SH2B3) (43-45).  SH2B1 family members contain a pleckstrin 
homology (PH) domain, at least one dimerization domain and a C-terminal Src 
homology (SH2) domain [reviewed in (183)]; it is the SH2 domain that binds to 
TrkA.  The four known SH2B1 splice variants, α, β, γ, and δ, differ only in their C-
termini starting just past the SH2 domain (33, 37, 46), suggesting that all 
isoforms would be recruited to TrkA and would share many but perhaps not all, 
responses.  SH2B1 has been implicated in NGF-induced neurite outgrowth of 
PC12 cells (33, 34).  Thus, overexpression of SH2B1α or SH2B1β enhances 
NGF-induced neurite outgrowth in PC12 cells.  In contrast, mutating a critical 
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arginine (SH2B1β[R555E]) within the SH2 domain of SH2B1β that prevents 
SH2B1β from binding to and being phosphorylated by TrkA, blocks NGF-induced 
neurite outgrowth of PC12 cells (33, 68). SH2B1 has also been implicated in the 
NGF-dependent maintenance of explants of sympathetic cervical ganglia (34).  
Dissociated primary sympathetic neurons growing in NGF-containing medium 
exhibit a reduced rate of survival when anti-SH2B1 antibodies are introduced by 
trituration.  Similarly, axonal processes are nearly eliminated when an SH2B1 
mutant that blocks SH2B1-mediated signaling is introduced within explants of 
sympathetic ganglia grown in the presence of NGF.  In contrast, NGF-treated 
neurons into which wild-type SH2B1 is introduced thrive and have elaborate, 
long-branching axonal processes. 
 The mechanism by which SH2B1 enhances neurite outgrowth is unknown.  
Qian and Ginty (96) suggest that SH2B1 potentiates NGF-induction of 
autophosphorylation of TrkA, assessed using antibody to phosphotyrosine 490 in 
TrkA, the binding site for Shc.  Such a generalized stimulation of TrkA activity by 
SH2B1 might be expected to enhance the expression of all NGF-sensitive genes.  
However, SH2B1 potentiation of NGF-induction of TrkA activity cannot explain 
the ability of the dominant negative SH2B1β(R555E) to block NGF-induced 
neurite outgrowth, since PC12-SH2B1β(R555E) cells did not exhibit decreased 
TrkA autophosphorylation in general (33) or on tyrosine 490 (Maures T and 
Carter-Su, C, unpublished observation) in response to NGF.  The inability of 
SH2B1β(R555E) to inhibit NGF-induced tyrosyl phosphorylation of TrkA, 
phospholipase Cγ or Shc or activation of ERKs 1 and 2 led us to hypothesize that 
SH2B1β may initiate a previously unknown NGF signaling pathway (33).  
SH2B1β contains both a nuclear export (79) and nuclear localization signal 
(Maures, T, Chen, L and Carter-Su, C, manuscript in preparation).  Experiments 
using truncated and mutated forms of SH2B1β, as well as the inhibitor of nuclear 
export leptomycin B, revealed that both ectopically expressed and endogenous 
SH2B1β shuttle between the cytoplasm/plasma membrane and the nucleus (79).  
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Unlike wild-type SH2B1β, SH2B1β mutants with a defective nuclear export (79) 
or import (Maures, T, Chen, L and Carter-Su, C, manuscript in preparation) signal 
are unable to enhance NGF-induced neurite outgrowth.  Together, these findings 
led us to hypothesize that while SH2B1β might have a modest stimulatory effect 
on multiple NGF-sensitive genes, there would exist a specific subset of genes 
important for neurite outgrowth that were particularly sensitive to SH2B1β.   
 To determine whether SH2B1β regulates all or a subset of NGF-
responsive genes early in the NGF-induced neuronal differentiation program, and 
at the same time identify SH2B1-regulated genes important for neurite outgrowth, 
we performed microarray analysis on cRNA prepared from NGF-treated PC12 
cells stably expressing SH2B1β, SH2B1β(R555E), or SH2B1β vector.  We 
identified both a subset of NGF-responsive genes whose NGF-regulated 
expression is enhanced substantially further by SH2B1β and/or substantially 
dampened by SH2B1β(R555E), as well as a subset of genes whose expression 
is not altered by SH2B1β or SH2B1β(R555E).  We confirmed the NGF and 
SH2B1β regulation of a subset of these SH2B1β regulated genes using QT-PCR.  
We further characterized SH2B1β regulation of the proteins encoded by three of 
the genes most highly up-regulated by NGF and whose NGF up-regulation 
appeared to depend upon SH2B1β: Plaur, Mmp3 and Mmp10, encoding 
urokinase plasminogen activator receptor (uPAR), matrix metalloproteinase 
(MMP) 3 (stromelysin-1; transin-1) and MMP10 (stromelysin-2; transin-2), 
respectively.  These proteins were of particular interest because uPAR has been 
shown previously to be required for NGF-induced neuronal differentiation and 
MMP3 and MMP10  lie in the same extracellular matrix degradation pathway as 
uPAR.  Consistent with MMP3 being important for neurite outgrowth and 
penetration through an extracellular matrix, we showed that SH2B1β enhances 
neurite extension through Matrigel.  Finally, we confirmed a critical role for 
endogenous SH2B1 in the expression of these proteins using shRNA to SH2B1, 
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which was found to suppress NGF-induced expression of Plaur, Mmp3 and 
Mmp10. 
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Materials and Methods 
 
 Antibodies and reagents.  Polyclonal antibody to rat SH2B1 (αSH2B1), 
kind gift of Dr. Liangyou Rui (University of Michigan), was raised against an 
SH2B1β glutathione S-transferase fusion protein (93) and used at a dilution of 
1:1000 for western blotting.  Monoclonal antibody to neuronal β-tubulin (TUJ1) 
was from Covance (MMS-435P) and used at a dilution of 1:1000 for 
immunostaining of neurites. Antibody to α-tubulin (Cell Signaling) was used at a 
dilution of 1:1000 for western blotting.  Polyclonal anti-MMP3 antibody (αMMP3) 
was from Chemicon (Cat#AB19150) and used at 1:1000 for western blotting.  A 
polyclonal antibody against the ligand-binding NH(2)-terminal domain of rat uPAR 
was used for western blots at a dilution 1:500 as previously described (184).  
Anti-mouse uPAR monoclonal antibody used for immunostaining (at a dilution of 
1:1000) was from R&D System (Cat#AF534). Alexa Fluor 555-conjugated anti-
mouse IgG used for immunocytochemistry and Alexa Fluor 680-conjugated anti-
rabbit IgG used for western blotting came from Invitrogen.  NGF, rat-tail collagen 
I and growth factor-reduced Matrigel were purchased from BD Bioscience.  
Purified human MMP3 was from Triple Points Biologicals (Cat#H-MMP-3, 
0.1ug/ul), fluorescein was from BioRad and Syber green I was from Sigma. 
TaqMan RT-PCR kit was purchased from Applied Biosystem (Roche) 
(Cat#N808-0234).   
  Stable cell lines and cell culture.  The stock of PC12 cells was 
purchased from American Type Culture Collection.  PC12 cells were plated on 
collagen-coated plates (0.1 mg/ml rat tail collagen in 0.02 N acetic acid) and 
grown at 37°C in 10% CO2 in Dulbecco’s Modified Eagles Medium (DMEM) 
(Invitrogen) supplemented with 10% heat-inactivated horse serum (ICN), 5% fetal 
bovine serum (Invitrogen), 1 mM L-glutamine and 1 mM antibiotic-antimycotic 
(Invitrogen).  PC12 cells stably overexpressing GFP (control PC12 cells), GFP-
SH2B1β (PC12-SH2B1β cells), or GFP-SH2B1β(R555E) (PC12-SH2B1β[R555E] 
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cells) were described previously (79).  Experimental plates were incubated in 
serum-free medium overnight and then treated with vehicle or 100 ng/ml NGF for 
the indicated times. 
 RNA preparation and microarray analysis.  Total RNA was isolated 
from control and NGF-treated cells using Stat60 (Tel-Test, Inc.) and Rneasy spin 
columns (Qiagen) according to the manufacturers’ instructions.  RNA from five 
experiments, each performed in duplicate, was prepared and the quality of RNA 
checked by optical density and agarose gels.  To assess further the quality of the 
RNA and confirm that the cells responded to NGF, QT-PCR was used to monitor 
the expression level of some known NGF-responsive genes.  Based on these 
results, RNA from duplicates of two independent experiments was combined in 
equal proportions for microarray analysis.  Increasingly, data sets in the Gene 
Expression Omnibus Database use pooled RNA samples for microarray 
analyses; the advantage of pooled RNA samples has been documented (185, 
186).  Preparation of cRNA from equal amounts of pooled RNA per cell line and 
its hybridization to rat genome RAE233A oligonucleotide arrays (Affymetrix) was 
performed by the Cell and Molecular Biology Core of the Michigan Diabetes 
Research and Training Center.  The averaged NGF responsiveness (+NGF/-
NGF) was used in Tables 1,2 and 4 for genes represented by more than one 
probe set.  Probe sets with raw data less than 100 in all six samples were not 
included in Tables 1-4 to minimize false positive results.  For calculating NGF 
responsiveness, values of raw data that are smaller than 50 are regarded as 50. 
 QT-PCR.  Gene expression of Plaur, Mmp3, Mmp10, Stc1, Ca2 and Glrx1 
was determined by QT-PCR using SYBR green I and the iCycler system with 
iCycler iQ Real Time Detection System software (BioRad Laboratories). Primer 
sequences were designed using PrimerExpress software and are listed in Table 
5.  Amplicons generated from each primer pair were 50-52bp. Loading of each 
sample was normalized with fluorescein. All readings were normalized to the 
gene expression of glyceraldehyde-3-phosphate dehydrogenase (GAPDH). 
Levels of GAPDH expression were not different in control PC12, PC12-SH2B1β 
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and PC12-SH2B1β[R555E] cells (FIGs. 3.3 and 3.4) nor in shControl versus 
PC12-shSH2B cells (FIG. 3.9B). 
 Cell lysis and immunoblotting.  Cells were washed three times with 
chilled PBS (10 mM sodium phosphate, 137 mM NaCl, pH 7.4) containing 1 mM 
Na3VO4, solubilized in sample buffer (62.5 mM Tris-HCl, pH 6.8, 25% glycerol, 
4% SDS, 0.01% bromophenol blue), and boiled for 10 min before centrifugation 
at 13,200 rpm for 1 min.  Equal amounts of the solubilized proteins were 
separated on SDS-PAGE gels, transferred to PVDF (FIG. 3.6A) or nitrocellulose 
(FIG. 3.9A) membranes, immunoblotted with the indicated antibody, and detected 
using Alexa Fluor 680-conjugated anti-rabbit IgG and an Odyssey Infrared 
Imaging System (LI-COR Biosciences).   
 Analysis of uPAR distribution.  PC12 cells were plated onto Matrigel 
coated coverslips, deprived of serum and incubated for the indicated time with 
100 ng/ml NGF.  Cells were fixed with 4% paraformaldehyde, incubated with 
uPAR monoclonal antibody, followed by Alexa Fluor 555-conjugated secondary 
antibody.  Analysis of uPAR distribution was performed with an Olympus 
FluoView 500 laser scanning confocal microscope utilizing a 60X oil-immersion 
objective and FluoView version 5.0 software.  Alexa Fluor 555 fluorescence was 
excited with a Green Helium Neon (HeNe) laser at 543 nm and emission was 
measured through a 560 nm long pass filter (560 and above).  GFP fluorescence 
was excited with an Argon (Ar) laser at 488 nm and emission was measured 
through a 505-525 nm filter.  
 Zymogram gel analysis.  PC12 cells were incubated overnight in DMEM 
containing 0.1% chicken ovalbumin and then treated with 100 ng/ml NGF as 
indicated.  Proteins in conditioned medium were concentrated 3-4 fold using 
Centricon 30 concentrator (Millipore) and separated on a 0.1% casein-containing, 
pre-stained, Tris glycine gel (Invitrogen, Inc.) under non-reducing conditions.  The 
gel was washed three times with renaturation buffer (2.5% Triton X-100) to 
remove SDS and renature the MMPs and then developed overnight at 37°C in 
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developing buffer (50 mM Tris-HCl, pH 7.5, 200 mM NaCl, 5 mM CaCl2, 0.02% 
Brij-35) to visualize regions in the gel which contain active MMP.  
 Neurite outgrowth through Matrigel.  Neurite outgrowth through 
Matrigel was assessed using a modified method of Nordstrom et al. (123).  
Briefly, 50 µl of 1:3 diluted Growth Factor Reduced, phenol red-free Matrigel (BD 
Biosciences) was added to the cis plane of a 24-well transwell membrane (6.5 
mm2, 5 µm pore size) and allowed to solidify at 37°C for 30 min.  The trans plane 
of the transwell membrane was coated with 1:10 diluted Growth Factor Reduced 
Matrigel overnight at room temperature.  Cells were plated onto the cis plane of 
the transwell membrane at a density of 50,000 cells/well in phenol red-free 
DMEM containing 0.1% chicken ovalbumin.  NGF (100 ng/ml) was added to the 
outer chamber.  After 4 days, cells were fixed and immunostained for neuronal β-
tubulin (TUJ1) followed by Alexa Fluor 555-conjugated secondary antibody.  
Neurites on the trans plane of the membrane were visualized by fluorescence 
microscopy (Nikon Eclipse TE2000) and counted. 
 Silencing of SH2B1 gene.  SH2B1 siRNA vector was constructed by 
inserting an oligonucleotide containing the SH2B1 sequence (5’-
CATCTGTGGTTCCAGTCCA-3’) corresponding to nucleotides 1771-1789 of rat 
SH2B1 (GenBankTM accession number AF047577) into the pSuper retro vector 
containing the puromycin resistance gene (pSuper retro puro) (OligoEngine).  A 
pSuper vector containing a non-targeting siRNA with a low sequence similarity to 
known genes was used as a control.  The SH2B1 and control siRNA vectors 
were transfected into subconfluent PC12 cells using a BioRad Gene Pulser Xcell 
electroporator (400V, 500µF, 0.4 cm cuvette).  After 14h, cells were washed with 
PBS and fresh growth medium was added.  Twenty-four hours later, the medium 
was changed to a selection medium containing 5 µg/ml puromycin and selected 
for pSuper positive PC12 cells for 30 days.  The efficacy of the SH2B1 RNAi was 





 Identification of a subset of NGF-responsive genes that are 
regulated by SH2B1β .  To determine whether SH2B1β regulates the expression 
of all or a subset of NGF-sensitive genes in cells and at the same time identify 
SH2B1-regulated genes important for neurite outgrowth, we performed a global 
analysis of gene expression in pooled PC12 cells stably expressing GFP (control 
cells), GFP tagged wild-type SH2B1β (PC12-SH2B1β cells) or GFP tagged 
dominant negative SH2B1β(R555E) (PC12- SH2B1β[R555E] cells) treated with 
or without 100 ng/ml NGF for 6 h.  Microarray analysis of control PC12 cells 
using the rat Affymetrix gene chip RAE223A that detects ~15,900 known genes 
and ESTs identified 511 genes and ESTs whose expression at least doubled in 
response to NGF (FIG. 3.1, Supplemental Table S1).  Expression of 79 known 
genes more than tripled (Table 1).  Microarray analysis of control PC12 cells 
identified a similar number (513) of genes whose expression was decreased by 
more than 50% following NGF treatment (FIG. 3.1, Supplemental Table S2).  
Together, these microarray studies indicate that NGF rapidly regulates (both 
positively and negatively) the expression of ~1000 genes/ESTs, many more than 
previously recognized.  Among the 511 genes/ESTs whose expression was at 
least doubled by NGF in control cells, 34 of them  showed a further doubling in 





FIG. 3.1.  SH2B1β  enhances a subset of NGF-responsive genes.  
(A) The expression of 511 genes and ESTs (588 probe sets) was at least doubled by treatment of 
control PC12 cells with NGF (6h, 100 ng/ml) (C+/C- ≥ 2).  Among the 511 genes and ESTs, the 
NGF-induced expression of 34 genes and ESTs was enhanced by at least 100% by 
overexpression of SH2B1β, represented by the white circle (C+/C- ≥ 2 and ΔS /ΔC ≥ 2 where ΔS 
= S+/S- and ΔC = C+/C-).  Among the 511 genes and ESTs, the NGF-induced expression of 153 
genes was reduced by 50% or more in cells overexpressing SH2B1β (R555E), represented by 
the dark grey circle (C+/C- ≥ 2 and ΔR/ΔC ≤ 0.5 where ΔR = R+/R- and ΔC = C+/C-).  There were 
only 2 genes and 4 ESTs that matched both criteria, represented by the overlapping area 
between the white and dark grey circles (C+/C- ≥ 2, ΔS/Δ C ≥ 2, ΔR/ΔC ≤ 0.5).  (B) The 
expression of 513 genes and ESTs (507 probe sets) was reduced by at least 50% by treatment 
with NGF (6h, 100 ng/ml) (C+/C- ≤ 0.5).  Among the 513 genes and ESTs, the expression of 49 
genes and ESTs was further reduced by over-expression of SH2B1β, represented by the white 
circle (C+/C- ≤ 0.5 and ΔS/ΔC ≤ 0.5).  The NGF-induced inhibition of 105 genes and ESTs was, in 
addition, dampened by overexpression of SH2B1β(R555E), represented by the dark grey circle 
(C+/C- ≤ 0.5 and ΔR/ΔC ≥ 2).  There was only 1 EST that matched both criteria, represented by 
the overlapping area between the white and dark grey circles (C+/C- ≤ 0.5, ΔS/ΔC ≤ 0.5, ΔR/ΔC ≥ 
2). C-, S- and R-: gene expression levels in control PC12, PC12-SH2B1β, and PC12-
SH2B1β(R555E) cells, respectively, in the absence of NGF.  C+, S+ and R+: gene expression 
levels in NGF-treated control PC12, PC12-SH2B1β, and PC12-SH2B1β(R555E) cells, 




Table 3.1.  NGF induces increases in gene expression in PC12 cells.   
Control PC12 cells were incubated for 0 or 6 h with 100 ng/ml NGF and gene expression profiles 
were assessed as described in MATERIALS AND METHODS.  Gene symbols, gene titles and 
unigene numbers are listed for the 77 known genes exhibiting NGF-induced gene expression of 
at least 3 times basal (no NGF) in control PC12 cells (C+/C- ≥ 3), arranged in descending order 
based on the magnitude of the NGF induction of expression.  The 74 ESTs that met this criterion 
are included in Supplement Table S1. C-, C+: gene expression levels in untreated and NGF-
treated control PC12 cells, respectively. “a”: Genes represented by more than one probe set; 
values listed are the average of the replicates. 
 
Gene symb Gene Title Unigene C+/C- 
Mmp3 matrix metalloproteinase 3 Rn.32086 114.81 
Crh corticotropin releasing hormone Rn.10349 56.80 
Pai1 serine (or cysteine) proteinase inhibitor, member 1 Rn.29367 46.58 
Mmp10 matrix metalloproteinase 10 Rn.9946 38.02 
Mmp13 matrix metalloproteinase 13 Rn.10997 22.90 
Egr1 Early growth response 1 Rn.9096 21.60 
Ca2(a) carbonic anhydrase 2 Rn.26083 14.81 
Scn6a sodium channel, voltage-gated, type 6, alpha poly p. Rn.54541 12.32 
Fosl1 Fos-like antigen 1 Rn.11306 10.22 
Plaur Plasminogen activator, urokinase receptor Rn.82711 9.78 
Vrl1 vanilloid receptor-like protein 1 Rn.44866 7.73 
Vgf VGF nerve growth factor inducible Rn.9704 7.15 
Krt1-18 keratin complex 1, acidic, gene 18 Rn.11104 6.78 
Ret(a) Ret proto-oncogene  Rn.44178 6.66 
Dusp6 dual specificity phosphatase 6 Rn.4313 6.61 
Ania4 activity and neurotransmitter-induced early gene 4 Rn.40517 6.41 
Klf5 Kruppel-like factor 5 (intestinal) Rn.17478 5.50 
Bmp1 
bone morphogenetic protein 1 (procollagen C-
proetinase) 
Rn.87080 5.43 
Giot2 gonadotropin inducible ovarian transcription factor 2 Rn.77686 5.19 
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Nid67 putative small membrane protein NID67 Rn.8865 5.18 
Glrx1(a) glutaredoxin 1 (thioltransferase) Rn.1484 4.94 
Ifrd1 interferon-related developmental regulator 1 Rn.3723 4.90 
LOC286921 aldose reductase-like protein Rn.23676 4.83 
Tage4 tumor-associated glycoprotein pE4 Rn.10677 4.83 
Tjp2 tight junction protein 2 Rn.10965 4.70 
Gpr37 
G protein-coupled receptor 37(endothelin receptor 
type B-like) 
Rn.28035 4.69 
Tub Tubby (mouse) homolog Rn.30017 4.66 
Tfpi tissue factor pathway inhibitor Rn.15795 4.56 
Prkaa2 AMP-activated protein kinase Rn.64583 4.48 
Pcscl peroxisomal Ca-dependent solute carrier-like protein Rn.17644 4.47 
Cga glycoprotein hormones, alpha subunit Rn.10589 4.22 
Ctsk cathepsin K Rn.5598 4.20 
Ager advanced glycosylation end product-specific receptor Rn.9829 4.10 
Scya2 small inducible cytokine A2 Rn.4772 4.10 
Fgf15 fibroblast growth factor 15 Rn.81230 4.04 
Arc activity regulated cytoskeletal-associated protein Rn.10086 3.98 
Lnk linker of T-cell receptor pathways Rn.11228 3.98 
Bat3(a) HLA-B-associated transcript 3 Rn.22304 3.97 
Itga1 integrin, alpha 1 Rn.91044 3.87 
Hes1 hairy and enhancer of split 1 (Drosophila) Rn.19727 3.87 
Ptafr platelet-activating factor receptor Rn.10137 3.80 
Lgals3 lectin, galactose binding, soluble 3 Rn.764 3.79 
Rgs5 regulator of G-protein signaling 5 Rn.1150 3.78 
Glrx1 glutaredoxin 1 (thioltransferase) Rn.1484 3.77 
Synd1 Syndecan Rn.11176 3.74 
S100a10 S-100 related protein, clone 42C Rn.4083 3.69 
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Ak4 adenylate kinase 4 Rn.44288 3.68 
Scamp5 secretory carrier membrane protein 5 Rn.24420 3.66 
Rdc1 chemokine orphan receptor 1 Rn.12959 3.65 
Bdnf(a) Brain derived neurothrophic factor Rn.11266 3.59 
Filip filamin-interacting protein L-Filip Rn.44931 3.59 
Cdkn1a cyclin-dependent kinase inhibitor 1A Rn.10089 3.57 
Ptgs1 prostaglandin-endoperoxide synthase 1 Rn.44404 3.51 
Hpx hemopexin Rn.2380 3.50 
Ecel1 endothelin converting enzyme-like 1 Rn.45803 3.47 
Hk2 Hexokinase 2 Rn.91375 3.44 
Clcn2 chloride channel 2 Rn.11073 3.39 
Upb1 ureidopropionase, beta Rn.11110 3.38 
Snk serum-inducible kinase Rn.12100 3.38 
Nr2f6 nuclear receptor subfamily 2, group F, member 6 Rn.25840 3.35 
Junb jun B proto-oncogene Rn.15806 3.32 
Prss11 protease, serine, 11 Rn.2782 3.32 
Adcyap1r1 adenylate cyclase activating polypeptide 1 receptor 1 Rn.88408 3.32 
Lasp1 LIM and SH3 protein 1 Rn.69815 3.30 
Ehd4 pincher Rn.7379 3.29 
Msg1 melanocyte-specific gene 1 protein Rn.8163 3.26 
Gls glutaminase Rn.5762 3.23 
Axcam axonal-associated cell adhesion molecule Rn.10117 3.17 
Dcamkl1 
double cortin and calcium/calmodulin-dependent  
protein kinase-like 1 
Rn.80575 3.16 
Stc1 stanniocalcin 1 Rn.10647 3.12 
Cyp4a12 cytochrome P450, 4a12 Rn.10034 3.08 
S100a4 S100 calcium-binding protein A4 Rn.504 3.06 
LOC59314 CaM-KII inhibitory protein Rn.42880 3.06 
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Slc6a2 
solute carrier family 6(neurotransmitter transporter, 
noradrenalin),member 2 
Rn.14577 3.05 
Thrsp Thyroid hormone responsive protein (spot14) Rn.81140 3.04 
Tceb3 
transcription elongation factor B (SIII), polypeptide 3 
(110kD) 
Rn.37427 3.04 
Anxa2 calpactin I heavy chain Rn.28 3.04 
Crmp4 Collapsin response mediator protein 4 Rn.8499 3.01 
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displayed a 50% or greater reduction in NGF-dependent expression in PC12-
SH2B1β(R555E) cells (FIG. 3.1).  Only two known genes (Plaur and Glrx1) and 4 
ESTs fit both criteria (ie exhibit NGF-induction that was both enhanced by at least 
100% in PC12-SH2B1β cells and  reduced by 50% or more in PC12-
SH2B1β(R555E) cells) (FIG. 3.1, Table 2). 
 Similarly, among the 513 genes/ESTs whose expression was down-
regulated by NGF by at least 50%, 49 showed a susbstantially greater (at least a 
doubling of the NGF-inhibition seen in control cells) NGF-dependent reduction in 
expression in PC12-SH2B1β cells (FIG. 3.1, Table 4) while 105 exhibited a 
substantially diminished (by ≥ 50%) NGF-dependent decrease in expression in 
PC12-SH2B1β(R555E) cells (Supplemental Table S4). None of the known genes 
and only one EST fulfilled both of these criteria. The finding that some, but not all, 
of the NGF-responsive genes show enhanced responsiveness to NGF in 
SH2B1β-overexpressing cells and/or reduced responsiveness to NGF in 
SH2B1β(R555E)-expressing cells is consistent with SH2B1β enhancing the NGF-
induced regulation of expression of a subset of NGF-responsive genes during 
neuronal differentiation.   
 Functional classification of NGF-responsive genes that are also 
regulated by SH2B1β .  To obtain insight into the cellular processes that are 
regulated by SH2B1β, genes whose expression level was induced or inhibited by 
greater than a factor of two following treatment with NGF were grouped into Gene 
Ontology (GO) categories using DAVID (Data for Annotation, Visualization and 
Integrated Discovery) (187).  For each of the three different cell lines, an average 
of 76% of input genes were categorized.  As predicted given NGF’s ability to 
promote neuronal differentiation, following stimulation of control PC12 cells with 
NGF for 6 h, the expression of genes associated with cell differentiation, 
intracellular signaling cascade, cell death, organogenesis, and morphogenesis 
was enhanced (FIG. 3.2A).  Compared to control cells, PC12-SH2B1β cells had 
an increased number of NGF-induced genes overrepresented in all of the above-
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mentioned categories whereas PC12-SH2B1β(R555E) cells had a decreased 
number.  Also as predicted from NGF’s ability to promote neuronal differentiation, 
genes whose expression in control PC12 cells was decreased by NGF by more 
than 50% were associated with cell cycle, cell proliferation, and cell migration 
(FIG. 3.2B).  Overexpressing SH2B1β increased the number of NGF-induced 
genes overrepresented in all of the above-mentioned categories while 
overexpressing SH2B1β(R555E) reduced  NGF-induced overrepresentation of 
genes in all 3 categories. In addition, genes in the category of cell differentiation 
were overrepresented in cells overexpressing SH2B1β and to a lesser extent in 
cells overexpressing SH2B1β(R555E).  These findings are consistent with 
SH2B1β increasing NGF-induced neuronal differentiation at least in part by 
enhancing NGF-induced expression of a subset of genes whose products are 
implicated in morphogenesis, organogenesis, cell survival and intracellular 
signaling, and by increasing the degree of NGF-inhibition of expression of a 
subset of genes whose products are implicated in cell cycle progression, cell 
proliferation and cell migration.  SH2B1β(R555E) appears to play a dominant 
negative role with regards to a subset of NGF regulated genes that affect 
morphogenesis, organogenesis, cell survival, intracellular signaling and cell 
differentiation, consistent with the substantially decreased ability of PC12-




FIG. 3.2.  Functional classification of NGF-responsive genes in control 
PC12, PC12-SH2B1β, and PC12-SH2B1β(R555E) cells.   
Genes that were either up-regulated to at least twice the basal value by NGF (A) or down-
regulated more than 50% by NGF (B) in control PC12, PC12-SH2B1β, and PC12-
SH2B1β(R555E) cells were grouped into Gene Ontology categories. Overrepresented categories 




 Novel SH2B1β-regulated genes likely to be involved in neuronal 
differentiation.  Because PC12-SH2B1β and PC12-SH2B1β(R555E) cells 
display substantially enhanced and impaired neurite outgrowth, respectively, we 
reasoned that genes whose expression pattern is substantially enhanced 
following NGF treatment and whose NGF-enhancement is greatly increased in 
PC12-SH2B1β cells and/or substantially decreased in PC12-SH2B1β(R555E) 
cells would be prime candidates for further investigation.  Seventeen known 
genes exhibited at least a doubling of expression in response to NGF in control 
cells and at least a further doubling in NGF-induced expression in PC12-SH2B1β 
cells (Table 2).  Of these 17 genes, Mmp10 exhibited both the greatest NGF-
induction of gene expression in control PC12 cells (+NGF/-NGF ~ 38) and the  
greatest further enhancement (~7 x) upon overexpression of SH2B1β.  Mmp10 
encodes matrix metalloproteinase 10 (MMP10), a proteinase involved in the 
degradation of the extracellular matrix [reviewed in (188)].  Among these same 
17 genes, only Plaur and Glrx1 (highlighted in Table 2) also exhibited a 
significantly reduced (≥ 50% reduction) response to NGF in PC12-
SH2B1β(R555E) cells compared to control cells.  Plaur and Glrx1 encode 
urokinase plasminogen activator receptor (uPAR) and glutaredoxin 1, 
respectively.  Plaur was of particular interest because of its being identified 
previously as a primary response gene for NGF critical for NGF-induced neurite 
outgrowth and biochemical differentiation of PC12 cells (121, 122).  Glutaredoxin 
1 has not been previously shown to be upregulated by NGF, much less by 
SH2B1, but was intriguing because it is found in neurons and modulates cellular 
redox status, important for cell survival against oxidative stress (189). 
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Table 3.2.  NGF-responsive genes whose expression is enhanced by 
SH2B1β . 
Control PC12, PC12-SH2B1β, or PC12-SH2B1β(R555E) cells were incubated with vehicle or 
NGF for 6 h and gene expression profiles were assessed as described in MATERIALS AND 
METHODS.  Gene symbols, gene titles and unigene numbers are listed for the 17 known genes 
for which NGF induces at least a doubling of expression in control PC12 cells (C+/C- ≥ 2) and at 
least a further doubling of NGF-induced expression in PC12-SH2B1β (ΔS/ΔC ≥ 2), arranged in 
order of decreasing ability of SH2B1β to enhance NGF-induced gene expression.  An additional 
18 ESTs (unlisted) met this criterion.  The two genes highlighted in grey (and four ESTs not listed) 
additionally show a reduction in the magnitude of NGF-induction of expression in PC12-
SH2B1β(R555E) cells to a level that is less than 50% that seen with control PC12 cells (ΔR/ΔC ≤ 
0.5). C+, C-, S+, S-, R+, R-, ΔC, ΔS and ΔR are defined in FIG. 3.1. “a”: Genes represented by 
more than one probe set; values listed are the average of the replicates.  The sorting criterion of 














45.24  7.15 1.19 
Stc1 stanniocalcin 1 Rn.10647 3.12 20.87 2.05 6.69 0.66 
Plaur Plasminogen activator, 
urokinase receptor 






Rn.54541 12.32 65.40 23.36 5.31 1.90 
Ca2(a) 
carbonic  anhydrase 
2 
Rn.26083 14.81 76.20 7.90 5.13 0.55 
























early gene protein 4 
(ania-4) 












Rn.10677 4.83 10.70 4.29 2.22 0.89 
Basp2 
brain abundant, 
membrane attached  
signal protein 2 
Rn.10928 2.23 4.64 1.40 2.08 0.63 
Gprk5 
G protein-coupled 
receptor kinase 5 




Rn.13007 2.20 4.51 2.03 2.05 0.92 
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 In addition, there were 12 genes whose NGF-induced level of expression 
in PC12-SH2B1β cells did not meet our criterion of being substantially greater (at 
least a doubling) than in control cells but whose NGF-induced expression was 
substantially reduced (by ≥ 50%) in PC12-SH2B1β(R555E) cells (1<(S+/S-
)/(C+/C-)<2, (R+/R-)/(C+/C-)<0.5) (Table 3).  Among those genes, Mmp3 
exhibited the greatest NGF-induction of expression in control PC12 cells (+NGF/-
NGF ~ 115) as well as one of the greatest reductions (68%) in NGF-stimulated 
expression in PC12-SH2B1β(R555E) cells.  Mmp3 was of interest because it 
encodes matrix metalloproteinase 3 (MMP3), a proteolytic enzyme present in 
growth cones of NGF-treated PC12 cells and previously implicated in neurite 
penetration through the extracellular matrix (123).   
 NGF inhibits the expression of almost as many genes as it enhances the 
expression of, suggesting that for neuronal differentiation to occur, reduction of 
gene expression is as important as enhancement of gene expression.  Twelve 
known genes exhibited more than a 50% decrease in expression in response to 
NGF in control cells and a further 50% or greater decrease in NGF-
responsiveness in PC12-SH2B1β cells (Table 4).  Consistent with SH2B1β 
enhancing NGF-induced neuronal differentiation, a process associated with 
decreased cellular proliferation, this group of down-regulated genes includes two 
that encode for proteins involved in DNA replication:  Pola2 (polymerase α 
subunit II) and Pold1 (DNA polymerase δ, catalytic subunit).  Polymerase α 
subunit is required for DNA replication while DNA polymerase δ possesses 3’ 
exonuclease activity that is important for repair during DNA replication (190).  
Expression of SH2B1β(R555E) dampened NGF-induced inhibition of expression 
of only one EST.  Dampening of NGF-induced expression of no known genes 
(Suppl Table S4) achieved our predetermined criterion of ≥ 50%. 
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Table 3.3.  NGF-responsive genes whose expression is inhibited by 
SH2B1β(R555E). 
Control PC12, PC12-SH2B1β, or PC12-SH2B1β(R555E) cells were incubated with vehicle or 
NGF for 6 h and gene expression profiles were assessed as described in MATERIALS AND 
METHODS.  Gene symbols, gene titles and unigene numbers are listed for the 14 known genes 
whose NGF-induced expression was at least doubled in control cells (C+/C- ≥ 2), greater in 
PC12-SH2B1β cells than in control PC12 cells (ΔS/ΔC > 1) and reduced in PC12-
SH2B1β(R555E) cells to a level that is less than 50% that seen with control PC12 cells (ΔR/ΔC ≤ 
0.5), arranged in order of decreasing ability of SH2B1β(R555E) to impair NGF-induced gene 
expression (decreasing ΔR/ΔC).  An additional 11 ESTs (unlisted) met this criterion. C+, C-, S+, 




Sym Gene Title Unigene C+/C- S+/S- R+/R- ΔS/ΔC ΔR/ΔC 
Pai1 
serine (or cysteine) 
proteinase inhibitor, 
member 1 Rn.29367 46.58 53.54 7.63 1.15 0.16 
Vldlr 
Very low density 
lipoprotein receptor Rn.9975 2.25 2.35 0.65 1.04 0.29 
Klf5 
Kruppel-like factor 5 
(intestinal) Rn.17478 5.50 10.64 1.76 1.93 0.32 
Mmp3 matrix metalloproteinase 3 Rn.32086 114.81 119.00 37.17 1.04 0.32 
Pou2f1 
POU domain, class 2, 




cytosolic Rn.8273 2.73 3.72 1.00 1.36 0.37 
Cryab crystallin, alpha B Rn.54554 2.28 2.32 0.92 1.02 0.40 
Ecel1 
endothelin converting 
enzyme-like 1 Rn.45803 3.47 5.57 1.43 1.61 0.41 
Glrx1(a) 
Glutaredoxin1 




1 protein Rn.8163 3.26 3.46 1.36 1.06 0.42 
TA1 tumor-associated protein 1 Rn.32261 2.18 3.11 0.93 1.43 0.42 
Nmrk 
non MHC restricted killing 
associated Rn.53994 2.24 2.44 1.00 1.09 0.45 
Plaur 
Plasminogen activator, 
urokinase receptor Rn.82711 9.78 56.16 4.44 5.74 0.45 
Sv2b 
synaptic vesicle 
glycoprotein 2 b Rn.9940 2.30 2.84 1.07 1.23 0.47 
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 SH2B1β  increases the expression of a subset of NGF-responsive 
genes.  To systematically identify genes whose expression was substantially 
increased in response to NGF and whose NGF-induced expression was further 
substantially increased by overexpression of SH2B1β and/or substantially 
dampened by overexpression of SH2B1β(R555E), we applied a hierarchical 
clustering algorithm based on Pearson correlation coefficients to group genes 
based on the similarity of NGF-dependent expression patterns among the three 
stable cell lines (FIG. 3.3).  Red represents increased mRNA levels, green 
denotes decreased mRNA levels, and color intensity represents the magnitude of 
the expression ratio.  This analysis revealed, in addition to Plaur and Glrx1 which 
met our most stringent criteria of opposing two-fold or greater differences in NGF-
regulated gene expression in PC12-SH2B1β and PC12-SH2B1β(R555E) cells 
versus control PC12 cells, several genes whose regulation followed the same 
pattern but did not quite meet the criteria of ≥ two-fold differences (in opposing 
directions) for both PC12-SH2B1β and PC12-SH2B1β(R555E) cells.  NGF-
regulated (known) genes that fit both of our criteria (greatly increased NGF 
induction in PC12-SH2B1β cells and significantly reduced NGF induction in 
PC12-SH2B1β[R555E] cells) include Fosl1 (encoding Fos-like antigen 1), Plaur 
(uPAR), Ca2 (carbonic anhydrase 2), Pai1 (serine or cysteine proteinase 
inhibitor, member 1), Stc1 (stanniolcalcin 1), Glrx1 (glutaredoxin 1) and Klf5 
(kruppel-like factor 5).  NGF-sensitive genes fitting just one of the criteria 
(increased NGF-responsiveness in PC12-SH2B1β cells or decreased 
responsiveness in PC12-SH2B1β[R555E] cells compared to control cells) 
included Mmp10 (increased NGF-responsiveness in PC12-SH2B1β cells) and 
Mmp3 and Crh (corticotropin releasing hormone) (decreased responsiveness in 
PC12-SH2B1β[R555E] cells). The NGF-induced expression (+NGF/-NGF) for 
genes representing each of these categories is listed in FIG. 3B.  NGF-induced 
expression of Scn6a (sodium channel, voltage-gated, type 6, alpha polypeptide) 
and Egr1 (early gene response 1) was also greatly enhanced in PC12-SH2B1β 
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Table 3.4.  Genes whose expression is suppressed by NGF and further 
suppressed by SH2B1β . 
Control PC12, PC12-SH2B1β, or PC12-SH2B1β(R555E) cells were incubated with vehicle or 100 
ng/ml NGF for 6 h and gene expression profiles were assessed as described in MATERIALS 
AND METHODS.  Gene symbols, gene titles and unigene numbers are listed for the 12 known 
genes whose expression in control cells is both reduced by NGF treatment to less than 50% of 
basal levels (C+/C- ≤ 0.5) and whose NGF-induced reduction is further reduced by at least an 
additional 50% in PC12-SH2B1β cells (C+/C- ≤ 0.5, ΔS/ΔC ≤ 0.5), arranged in the order of 
decreasing SH2B1β-dependent inhibition of gene expression (decreasing ΔS/ΔC).  34 ESTs (not 
listed) fulfilled these criteria. C+, C-, S+, S-, R+, R-, ΔC, ΔS and ΔR  are defined in FIG. 3.1.  (a): 
Genes represented by more than one probe set; values are the average of the replicates.  The 




Gene Title Unigene C+/C- S+/S- R+/R- ΔS/ΔC ΔR/ΔC 
Pola2 
DNA polymerase  alpha  
subunit II 
Rn.31773 0.44 0.10 0.30 0.23 0.69 
Sord Sorbitol dehydrogenase Rn.11334 0.13 0.04 0.12 0.28 0.89 
Gcgr glucagon receptor Rn.11225 0.24 0.07 0.30 0.31 1.23 
Prkwnk4 
protein kinase, lysine 
deficient 4 








Rn.50506 0.47 0.17 0.59 0.35 1.24 




Rn.11020 0.39 0.15 0.43 0.39 1.10 
Cldn3 claudin 3 Rn.4513 0.48 0.19 0.48 0.40 1.01 
U91561 
pyridoxine  5-phosphate 
oxidase 
Rn.6299 0.45 0.20 0.40 0.44 0.89 
Rab3a Ras-related  small  GTP Rn.44409 0.37 0.17 0.46 0.46 1.26 
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binding protein 3A 
Pold1 
DNA polymerase  delta, 
catalytic   subunit 
Rn.88690 0.27 0.13 0.32 0.48 1.21 
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Table 3.5.  Sequences of the QT-PCR primers used in this study. 
 
Gene   Sequences 
Mmp3 forward 5' TGAAGATGACAGGGAAGCTGG 3' 
  reverse 5' GGCTTGTGCATCAGCTCCAT 3' 
Mmp10 forward 5' GAAATGGTCACTGGGACCCTC 3' 
  reverse 5' TGCGCAGCAACCAGGAATA 3' 
GAPDH  forward 5' ATGACTCTACCCACGGCAAGTT 3' 
  reverse 5' TCCCATTCTCAGCCTTGACTGT 3'  
Plaur forward 5' ACAGGACCATGAGCTACCGC 3' 
  reverse 5' TCTCGGTGAGGCTGACGATC 3' 
Stc1 forward 5' AACATGGCCAGCCTCTTCC 3' 
  reverse 5' TGTCTGGGCACAGTGGTCTG 3' 
Glrx1 forward 5' AGCATGGCTCAGGAGTTTGTG 3' 
  reverse 5' CGACCACCTTTCCAGACTGAA 3' 
Ca2  forward 5' TGGACATTGACACCGGGACT 3' 
  reverse 5' GCAGAGGCTGTAGGGAAGGG 3' 
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cells compared to control cells but these genes were not explored further 
because their NGF-induced expression was also enhanced, albeit to a lesser 
extent, in PC12-SH2B1β(R555E) cells.   
 Quantitative real-time PCR confirms SH2B1 enhancement of 
expression of NGF-regulated genes identified using microarray analysis.  
To confirm NGF- and SH2B1β-regulation of expression of genes identified from 
the Affymetrix gene array analysis, we performed QT-PCR on representative 
genes from among the above genes showing by hierarchical clustering algorithm 
significantly increased (4 to 7 times greater) NGF-induced expression in PC12-
SH2B1β cells vs control cells (Mmp10), substantially decreased (by 33-68%) 
NGF-induced expression in PC12-SH2B1β(R555E) cells vs control cells (Mmp3), 
or both (Plaur, Ca2, Stc1, Glrx1) (FIG. 3.3C).  In general, the levels of NGF-
induced gene expression in PC12-SH2B1β cells or PC12-SH2B1β(R555E) cells 
relative to control cells determined by QT-PCR paralleled those found by 
microarray analysis.  Thus, the expression of all 6 genes was substantially 
increased in response to NGF in control PC12 cells.  Also as predicted, 
compared to control cells, the NGF-stimulated response was substantially greater 
in PC12-SH2B1β cells for Plaur, Ca2, Stc1, Glrx1 and Mmp10 and lower in 
PC12-SH2B1β(R555E) cells for Plaur, Ca2, Glrx1, and Mmp3.  In addition, NGF-
induced expression was modestly greater in PC12-SH2B1β cells than in control 
cells for Mmp3 and modestly lower in PC12-SH2B1β(R555E) cells vs control 
cells for Mmp10.  Thus, all 6 of the genes showed an increased NGF-induced 
expression when SH2B1β was overexpressed and 5 of the 6 genes showed 
decreased NGF-induced expression when the dominant negative 
SH2B1β(R555E) was expressed, consistent with these genes being regulated by 




FIG. 3.3A, B.  NGF-responsive genes that are highly regulated by SH2B1β .   
(A) NGF-induced gene expression profiles in control PC12 (“C”), PC12-SH2B1β (“SH2B1β”), and 
PC12-SH2B1β(R555E) (“R555E”) cells were clustered and visualized using Eisen software 
(http://rana.lbl.gov/EisenSoftware.htm).  Four different clusters of genes that show NGF-induced 
gene expression in all three cell types are shown.  For each gene, black represents the average 
value of all six probe sets.  The relative intensity of red represents the degree of increased mRNA 
levels and the relative intensity of green represents the degree of decreased mRNA levels.  The 
number of arrows represents the relative levels of increase.  (B) Microarray data for selected 
genes from each of the four clusters.   
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FIG. 3.3C.  NGF-responsive genes that are highly regulated by SH2B1β .   
(C) Gene expression levels for six of the genes shown in (A) were verified by QT-PCR, 
normalized first to levels of GAPDH gene expression and then to levels of gene expression seen 
in control PC12 cells treated with NGF.  Means ± SEM from 3-4 experiments are shown.  
Asterisks represent statistically significant differences (p<0.05) using a one-tailed, paired Student 
T-test. 
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 Time course of NGF-induced expression of SH2B1β  regulated 
genes.  To determine whether overexpression of SH2B1β increases overall 
NGF-induced expression of genes or simply shifts the time course of NGF-
induced changes in expression, we used QT-PCR to compare the time course of 
NGF-inducement of expression of Stc1, Plaur, Mmp3, Mmp10, Ca2 and Glrx1 
genes in control and PC12-SH2B1β cells (FIG. 3.4).  For all genes tested, the 
time of onset of NGF-induced gene expression appeared similar in control and 
PC12-SH2B1β cells.  Similarly, expression of all tested genes was elevated at 
multiple time points in PC12-SH2B1β compared to cells and the majority of the 
tested genes had their highest level of induction at 4 or 6h in both control and 
PC12-SH2B1β cells.  Thus, for no gene could the difference in level of NGF 
induction in PC12-SH2B1β cells compared to control cells seen after 6 h of NGF 
be attributed to a different time course of NGF responsiveness.  However, it is 
interesting to note that NGF-induced expression of both Mmp3 and Mmp10 was 
prolonged in PC12-SH2B1β cells compared to control cells.    In contrast to 
control cells in which Mmp3 and Mmp10 expression declined to near basal 
values after 24h of NGF, Mmp3 and Mmp10 expression in PC12-SH2B1β cells 
remained elevated (Mmp3) or may have even been still rising (Mmp10) after 24 
h.  These data indicate that SH2B1β both enhances and prolongs NGF-induction 
of expression of a subset of NGF-sensitive genes. 
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FIG. 3.4.  Time course of SH2B1β  enhancement of expression of 
representative NGF-regulated genes.   
Control PC12 or PC12-SH2B1β cells were treated with 100 ng/ml NGF for 0, 30 min, 1h, 2h, 4h, 
6h, or 24h.  Relative gene expression levels were determined using QT-PCR, and normalized to 
levels of GAPDH gene expression. 
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 Effect of SH2B1β  on NGF-induced uPAR protein level and uPAR 
subcellular distribution.  Strikingly, proteins encoded by three of the genes 
showing the greatest induction by NGF at 6 h as well as the greatest 
enhancement of that induction by SH2B1β or diminishment of that induction by 
SH2B1β(R555E) (uPAR, MMP3 and MMP10) fall in the same protease cascade 
(FIG. 3.5).  In this cascade, uPAR binds the enzymatically inactive proform of 
urokinase plasminogen activator (pro-uPA), allowing it to be cleaved by 
cathepsins and thereby activated.  The activated uPA proteinase subsequently 
cleaves inactive plasminogen to form enzymatically active plasmin which in turn 
cleaves inactive pro-MMPs to form enzymatically active MMPs. This cascade has 
been implicated in neurite outgrowth and more generally in cell differentiation, 
tissue remodeling, cell invasiveness and wound healing [reviewed in (191, 192)].  
Because of the high level of both NGF and SH2B1β regulation of gene 
expression for uPAR, MMP3, and MMP10, the identification of Plaur as a primary 
response gene, and the previously documented critical role of uPAR  in NGF-
induced neuronal differentiation, we studied further the effect of SH2B1β on 
uPAR, MMP3 and MMP10.  To confirm  that the changes  in NGF-induced Plaur 
gene expression levels seen in PC12-SH2B1β and PC12-SH2B1β(R555E) cells 
results in corresponding changes in the levels of uPAR protein, we examined 
levels of uPAR protein in control, PC12-SH2B1β and PC12-SH2B1β(R555E) 
cells by both western blot and immunocytochemistry.  In western blots of lysates 
from control cells, 4h of NGF treatment transiently increased levels of uPAR 
protein (Fig 3.6A).  In PC12-SH2B1β cells, NGF increased levels of uPAR protein 
at both 4 and 6 h, with the 6 h levels being significantly greater than in control 
cells. Compared to control cells, PC12-SH2B1β(R555E) cells showed reduced 
levels of both basal and NGF-induced uPAR protein at all time points.  Levels of 
expression of SH2B1β and SH2B1β(R555E) were similar to each other and all 3 
cell lines expressed similar levels of actin, indicating that the differences seen in 
uPAR levels were not due to differences in the amount of protein loaded. The 
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reason why the magnitude of the uPAR signal in PC12-SH2B1 cells relative to 
control PC12 cells was lower than what the gene expression studies would 
predict is not known. However, the fact that the difference in levels in NGF-
induced protein expression between control and SH2B1β PC12 cells is greatest 
at 6 h raises the possibility that even greater differences would be detectable at 
later times. 
 To confirm the relative levels of NGF-induced uPAR expression and to 
determine whether SH2B1β affects the spatial distribution of uPAR, we 
immunostained control PC12, PC12-SH2B1β and PC12-SH2B1β(R555E) cells 
for uPAR after 0, 7h or 24h of 100ng/ml NGF.  Immunostaining was performed 
under non-permeabilizing conditions to allow better visualization of uPAR 
associated with the plasma membrane.  In all three cell lines, uPAR was 
observed at the cell surface in adhesion complex-like puncta (FIG. 3.6G, I, K, M, 
O), consistent with uPAR being a glycosyl-phosphatidyl inositol (GPI)-linked 
protein and its known interaction with proteins (e.g. integrins) in adhesion 
complexes [reviewed in (193)].  In all three cell lines, plasma membrane uPAR 
was present throughout the cell body of the neurite and at growth cones (FIG. 3.6 
G, I, K, M, and a darker exposure of FIG. 3.6O, data not shown).  NGF treatment 
increased levels of uPAR at the plasma membrane of PC12-SH2B1β cells at 
both 7 and 24 h (compare FIGS. 3.6G and 3.6I to 3.6E) as well as in control and 
SH2B1β(R555E) cells (data not shown).  At 24 h following NGF addition, plasma 
membrane uPAR immunostaining was clearly greater in PC12-SH2B1β cells 
(FIG. 3.6L) and lower in PC12-SH2B1β(R555E) cells (FIG. 3.6O) than in control 
PC12 cells (FIG. 3.6K).  The previously reported requirement of uPAR for NGF-
induced neurite outgrowth (122) combined with the ability of SH2B1 to greatly 
enhance both expression of Plaur gene and plasma membrane levels of uPAR 
protein reported here suggest that SH2B1 enhances NGF-induced neurite 





FIG. 3.5.  Physiological functions of uPAR/MMP activation cascade.   
Cell surface-localized uPAR, together with cathepsins, binds to pro-uPA and converts inactive 
pro-uPA to active uPA.  The active uPA converts plasminogen to plasmin and the active plasmin 





FIG. 3.6.  SH2B1β  enhances NGF-induced uPAR protein expression but 
does not affect the subcellular distribution of cell surface-localized uPAR.   
(A) PC12 cells stably expressing GFP, GFP-SH2B1β or GFP-SH2B1β(R555E) were incubated 
with 100 ng/ml NGF for 0, 4h, and 6h.  Proteins in a whole cell lysate were separated by SDS-
PAGE under non-reducing conditions and uPAR protein levels were determined by 
immunoblotting with antibody to rat uPAR.  Expression levels of GFP-SH2B1β, GFP-
SH2B1β(R555E) and actin were determined under reducing conditions by immunoblotting 
proteins in whole cell lysates with αGFP or αactin, respectively.  The molecular weight markers 
are noted on the left (n=2).  (B) PC12 cells stably expressing GFP, GFP-SH2B1β or GFP-
SH2B1β(R555E) plated on Matrigel-coated coverslips were incubated with 100 ng/ml NGF for 0, 
7h or 24h as indicated and fixed with 4% paraformaldehyde but not permeabilized before addition 
of monoclonal uPAR antibody and anti-mouse Alexa Fluor 555.  Representative confocal images 
are shown.  The insert in Panel I is an image of a different focal plane that focused more on the 
neurite. The experiment was repeated three times with similar results. 
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 NGF-induced MMP 3/10 activity is elevated in PC12-SH2B1β cells 
and suppressed in PC12- SH2B1β(R555E) cells.  We next examined the effect 
of NGF and SH2B1β on the protease activity of MMP3 and MMP10.  Because of 
their similar size and substrate specificity and in the absence of 
immunoprecipitating antibodies that could distinguish between MMP3 and 
MMP10, we assayed MMP3 and MMP10 together. Conditioned medium was 
collected from cells treated with 100 ng/ml NGF for various times, concentrated, 
and assayed for the presence of MMP3 and MMP10 using a zymogram gel 
containing casein as substrate.  When purified human MMP3 was used as a 
positive control, as expected, a cleared band was observed at Mr ~ 50,000 (non-
reducing condition), consistent with MMP3 degrading the casein (FIG. 3.7A).  Rat 
MMP3 migrates as a 60, 62 kDa doublet under reducing conditions.   It was 
therefore expected to migrate slightly slower than human MMP3 (194).  MMP3 
and MMP10 are approximately the same size and cannot be differentiated in this 
assay.  By 6 h of NGF treatment, control cells showed noticeable NGF-induced 
casein degrading activity at a molecular weight consistent for MMP3/10.  This 
protease activity continued to increase with increasing incubation times (8h, 10 h) 
with NGF.  Consistent with SH2B1β increasing NGF-induced levels of 
Mmp3/Mmp10 gene expression, this NGF-dependent protease activity was 
greater in magnitude in NGF-treated PC12-SH2B1β cells and substantially 
decreased in magnitude in NGF-treated PC12-SH2B1β(R555E) cells compared 
to control cells.  
 SH2B1β  enhances NGF-induced neurite outgrowth of PC12 cells 
through Matrigel.  Like uPAR activity, MMP3 activity has been associated with 
neurite outgrowth.  However, unlike uPAR, its downregulation (by use of anti- 
sense RNA) did not affect the number or length of neurites produced by PC12 
cells on a 2-dimensional tissue culture surface. Rather, downregulation of MMP3 
blocked the ability of neurites to penetrate through a Matrigel barrier (123).  
Combined with the finding that SH2B1β enhances the activity of  
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FIG. 3.7.  SH2B1β  enhances NGF-induced MMP3/MMP10 activity.   
(A) Control PC12, PC12-SH2B1β or PC12-SH2B1β(R555E) cells were treated with 100 ng/ml 
NGF for 0, 3, 6, 8 and 10h.  Proteins in concentrated conditioned medium were separated in 
casein-containing, pre-stained zymogram gels and then developed for 16h.  A representative gel 
is shown.  (B) The MMP3/10 activity in panel A was quantified by band intensity using NIH Image 
software.  (C) NGF-induced MMP3/10 activity was quantified for 3 independent experiments.  
Means ± SEM are shown.  MMP3/10 activity levels of the three cell lines are significantly different 
(p<0.05, one-tailed, paired Student T-test) at 10 h and by 8h, MMP3/10 activity in PC12-SH2B1β 
cells was elevated above control cells (p>0.05). 
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 MMP3/10, this latter finding suggests that SH2B1β should enhance growth cone 
migration and invasion through an extracellular matrix barrier.  To test this, 
control PC12 cells and PC12-SH2B1β cells were plated onto the cis-plane of a 
transwell membrane overlaid with growth factor-reduced Matrigel (FIG. 3.8A).  
NGF (100 ng/ml) was added every other day to the outer chamber for 4 days.  
Cells were then fixed and immunostained for neuronal β-tubulin.  Neurites that 
traversed to the trans-plane of the membrane were counted.  The number of 
neurites that invaded through the Matrigel to the trans-plane in cells expressing 
GFP-SH2B1β was found to be over twice (230%) the number of invading neurites 
from control cells (FIG. 3.8B).  The neurons themselves were found not to 
traverse the trans-plane of the membrane. 
 Inhibition of SH2B1 suppresses NGF-induced expression of Plaur, 
Mmp3 and Mmp10.  The ability of overexpression of wild-type SH2B1β to 
enhance and the dominant negative SH2B1β(R555E) to inhibit NGF-induced 
expression of Plaur, Mmp3 and Mmp10 indicates that endogenous SH2B1β 
regulates the NGF-induction of these three genes.  To test this more directly, we 
used an RNA interference approach to stably reduce levels of endogenous 
SH2B1 in PC12 cells.  As shown in FIG. 3.9A, the level of endogenous SH2B1 in 
cells stably expressing a 21-nucleotide long small hairpin RNA duplex targeted 
against SH2B1 (PC12-shSH2B1 cells) was reduced to < 50% the level in cells 
stably expressing the vector only (shControl cells), when normalized to levels of 
β-tubulin.  As predicted from the experiments using PC12-SH2B1β and PC12-
SH2B1β(R555E) cells, PC12-shSH2B1 cells exhibited substantially reduced 
NGF-induced neurite outgrowth compared to control cells (Maures, T, Chen, L 
and Carter-Su, C, manuscript in preparation).  In support of endogenous SH2B1 
enhancing NGF-induced expression of Plaur, Mmp3 and Mmp10, PC12-
shSH2B1 cells exhibited substantially suppressed NGF-induced levels of 
expression of Plaur (by 56%), Mmp3 (by 47%) and Mmp10 (by 76%) compared 
to control cells (FIG. 3.9B), levels of reduction consistent with the level of 
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reduction in SH2B1β protein.  Levels of GAPDH gene expression were not 
affected by NGF nor were they significantly different for the two cell lines, 
indicating that the differences in NGF-induction seen in Plaur, Mmp3 and Mmp10 
expression in the different cell lines were not due to non-specific effects of the 
shRNAi on gene transcription or cell viability. 
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FIG. 3.8.  SH2B1β  enhances NGF-induced neurite invasiveness of PC12 
cells.   
(A) Schematic of transwell system used to measure neurite invasiveness.  Cells were added onto 
growth factor-reduced Matrigel on the cis-plane of a transwell insert.  Neurite invasiveness was 
assessed by counting the neurites appearing on the trans-plane of the transwell insert.  (B) 
Control PC12 cells or PC12-SH2B1β cells were added to the Matrigel on the cis-plane of a 
transwell insert and 100 ng/ml NGF was added to the outer chamber.  After 4 days, the cells on 
the insert were fixed and immunostained with anti-β tubulin and Alexa Fluor 555.  Neurites that 




FIG. 3.9.  SiRNA mediated knockdown of endogenous SH2B1β  inhibits 
NGF-dependent induction of Plaur, Mmp3, and Mmp10.   
(A) Proteins in lysates of PC12 cells stably expressing the control shRNA (“shControl”) or shRNA 
targeted against SH2B1 (“shSH2B1”) were separated by SDS-PAGE and immunoblotted with 
αSH2B1 and then anti-αtubulin as a loading control.  (B) After incubation in serum-free medium 
overnight, PC12 cells expressing control shRNA or shRNA targeted against SH2B1 were 
incubated with or without 50ng/ml NGF for 6h.  The NGF-dependent induction of mRNA for Plaur, 
Mmp3, and Mmp10 was quantified via QT-PCR.  Gene expression in the presence of NGF was 
divided by expression in the absence of NGF, and then normalized to levels of GAPDH 
expression in the presence of NGF divided by expression in the absence of NGF.  Results were 
then further normalized to those obtained using shControl cells.  Means ± S.E.M. are shown for n 
= 3.  Asterisks represent p values of <0.05 using a one-tailed, paired Student T-test.  # denotes a 




 Microarray analysis identifies novel NGF-responsive genes likely to 
be important for NGF-induced neuronal differentiation.  In this study, we 
applied genome-scale gene expression analysis to identify SH2B1β-regulated 
genes and to gain insight into whether the adaptor protein SH2B1β enhances 
NGF-induced regulation of all NGF-sensitive genes, as predicted if SH2B1 simply 
potentiates NGF activation of TrkA, or whether it alters expression of a subset of 
NGF-sensitive genes as predicted if SH2B1 were acting downstream of TrkA.  
Because we were interested in the early events of NGF-induced neuronal 
differentiation, including neurite outgrowth, we looked at the gene expression 
profiles of the well-defined sympathetic neuron model PC12 cells before and after 
6h treatment of NGF.   
 Although our main goal was to identify genes that are regulated by 
SH2B1β, our microarray analysis also identified over 1000 genes whose 
expression was substantially regulated by NGF, many more than identified 
previously.  Several other studies have reported NGF-induced gene expression in 
large scale (195-202), however, most of these studies focused on the late 
response genes induced by 4 or more days of NGF treatment.  The few studies 
looking at earlier time points identified a limited number of NGF-sensitive genes, 
the majority of which were also identified as NGF-sensitive genes in our 
microarray analysis.  For example, Chou et al. (203) used gene expression 
profiling of PC12 cells at 1, 6 and 24 h after NGF treatment to identify nine genes 
out of 588 genes and ESTs that were highly regulated (> 300% or <33% of 
control) in response to NGF.  Expression of the two genes (Mmp10 and Vgf 
encoding VGF nerve growth factor inducible/VGF8a protein/neurosecretory 
protein VGF precursor) found to be highly upregulated after 6 h treatment with 
NGF were also highly upregulated (7 and 38 fold respectively) by 6 h of NGF in 
our microarray study.  Among the NGF-regulated genes identified by Brown et al. 
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(202) using targeted display to identify NGF-sensitive genes after 2, 4 and 6 h, 
our microarray data showed similar upregulation by NGF of Catna1 encoding α 
catenin, Odc1 encoding ornithine decarboxylase, Gsr encoding glutathione 
reductase, and Nup54 encoding p54 nucleoporin; and down-regulation of 
Gucy1b3 encoding β subunit of soluble guanylate cyclase and Chaf1A encoding 
p150 chromatic assembly factor.  Finally, our microarray also identified as highly 
NGF-dependent six genes identified by Hershman’s group (122, 201, 204) as 
being induced by 1-4 h of NGF but not EGF treatment using representational 
difference analysis:  Arc (encoding activity-regulated cytoskeletal protein), 
Mmp13 (encoding MMP13/collagenase-3), Serpine1 (encoding plasminogen 
activator inhibitor-1 precursor/PAI-1), VH6/MKP-3/Dusp6 (encoding dual 
specificity phosphatase 6/Map kinase phosphatase 3), Plaur, and Nid67 
(encoding NGF-induced differentiation clone 67 protein). 
 In addition to these previously identified NGF-induced genes, our 
microarray data identified close to 500 additional genes and ESTs whose 
expression was at least doubled with 6 h of NGF treatment and close to 150 
additional genes and ESTs whose expression was at least tripled.  More than 
500 genes and ESTs showed an NGF-induced decrease in expression of 50% or 
greater, with over 100 showing a 66% or greater decrease.  The NGF-sensitive 
genes identified in our study that were upregulated at least two-fold were 
overrepresented in the GO categories of morphogenesis, organogenesis, cell 
death, intracellular signaling and cell differentiation, consistent with NGF 
promoting differentiation and survival of sensory and sympathetic neurons.  
Those genes that were downregulated at least 50% by NGF were 
overrepresented in the categories of cell cycle, proliferation and migration, 
consistent with the known decrease in cell proliferation and movement that 
occurs during differentiation.  Some of these NGF-regulated genes  [e.g. genes 
encoding integrin α1; lectin, galactose binding, soluble 3 (198), bradykinin B2 
receptor (199), Bip3 (205)] had been shown previously to be regulated by NGF in 
PC12 cells using a variety of techniques, although not always at such an early 
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time point (6 h) after NGF addition.  Other genes (e.g. Glrx1 encoding 
glutaredoxin 1, Ca2 encoding carbonic anhydrase-II, and Stc1 encoding 
stanniolcalcin 1) were revealed for the first time to be highly responsive to NGF.  
Many of the proteins encoded by our newly identified NGF-regulated genes, 
including Glrx1, Stc1 and Ca2, had, however, been previously identified in 
neurons and in some cases, been implicated in neuronal differentiation and/or 
function.  For instance, glutaredoxin 1 is thought to play an important role in 
maintaining nerve cell function in the presence of oxidative stress, at least in part 
by catalyzing the removal of glutathione from S-glutathionylated proteins 
[reviewed in (206)].  Since even small changes in the redox state of a cell have 
been shown to switch cells from proliferation to differentiation or vice versa 
[reviewed in (207)], our finding that NGF greatly upregulates glutaredoxin 1 
expression raises the possibility that glutaredoxin 1 also plays an important role 
in NGF-induced neuronal differentiation.  Proteins that regulate cellular pH, such 
as carbonic anhydrase II, are also thought to be especially important in the 
nervous system because electrical activity can elicit rapid changes in cellular pH 
(208).  Our finding that carbonic anhydrase II, found in certain subsets of nerves, 
is rapidly and profoundly upregulated by NGF in differentiating PC12 cells and 
the finding of Dickens et al. (209) that tips of extending neurites appear to be 
more alkaline (by 0.2-0.3 pH units) than the cell body raise the possibility that 
carbonic anhydrase II plays a specific role in neurite outgrowth.  Although not 
previously reported to be induced by NGF, stanniolcalcin-1, a glycoprotein 
hormone implicated in the regulation of calcium and phosphate homeostasis, has 
been reported to be induced during differentiation of a variety of cell types, 
including human neural crest-derived Paju cells (stimulated by phorbol esters) 
(210) and murine Neuro-2A neuroblastoma cells (stimulated by dibutyryl cAMP) 
(211).  Decreasing its expression in Neuro-2A cells using anti-sense 
oligodeoxynucleotides reduces in neurite outgrowths the level of varicoses, a 
phenotypic marker of axon formation.  This finding led to the suggestion that 
stanniolcalcin-1, which is found in neurons in human and adult mouse brain, is 
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involved in axonal formation.  Clearly, knowledge and further exploration of these 
proteins and the proteins encoded by the large number of other genes newly 
found to be NGF-sensitive should greatly facilitate our understanding of how NGF 
induces neuronal differentiation and promotes neuronal survival.  
 SH2B1β  enhances the NGF-regulation of a subset of genes likely to 
be involved in neuronal differentiation.  Comparison of the gene expression 
profiles of control cells and cells stably expressing SH2B1β or the dominant 
negative SH2B1β(R555E) revealed a number of NGF-induced and -depressed 
genes that are differentially regulated by SH2B1β and SH2B1β(R555E).  Some 
genes whose expression is substantially upregulated by SH2B1β have been 
reported previously to be expressed in neurons but were not known to be 
regulated by NGF (i.e. Stc1, Glrx1(a), Scn6a) (212-214).   Other NGF-sensitive 
genes whose NGF stimulation is increased by SH2B1β (e.g. Arc, Fosl1/Fra1, 
Dusp6, Egr1, Plaur) have been shown previously to be regulated by NGF in 
neuronal cells (122, 201, 215). The gene products of a few (i.e. Plaur, Gap-
43/Basp2) have even been implicated previously in NGF-induced neurite 
outgrowth (122, 216).  For the six genes tested (Glrx1, Ca2, Stc1, Mmp3, 
Mmp10, Plaur), QT-PCR analysis confirmed both their upregulation by NGF and 
the ability of SH2B1β to increase the magnitude of that upregulation.  QT-PCR 
analysis further revealed that for all 6 of the genes tested, SH2B1β significantly 
enhanced levels of expression at multiple time points after NGF addition, 
indicating that the SH2B1β-stimulated levels of expression seen at 6 h of NGF 
treatment in the microarray were not simply a consequence of a shift in the time 
course of NGF activation.  Western blotting, activity assays, and/or 
immunocytochemistry indicated that increased expression of Plaur, Mmp3 and 
Mmp10 genes in PC12-SH2B1β cells results in increased protein expression of 
uPAR and MMP3/10 and that decreased gene expression of Plaur, Mmp3 and 
Mmp10 genes in PC12-SH2B1B(R555E) cells results in decreased protein 
expression of uPAR and MMP3/10. 
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 It is important to note, however, that while the NGF-responsiveness of a 
number of NGF-sensitive genes was enhanced by overexpressing SH2B1, there 
were similar numbers of NGF-sensitive genes whose expression was not 
substantially altered by overexpressing SH2B1β.  Genes in this latter category 
included some genes whose expression is considered critical for NGF-induced 
neuronal differentiation.  For example, NGF-induced expression of Anxa2 
encoding Annexin II/calpactin 1 heavy chain is thought to be critical for NGF-
induced neuronal differentiation of PC-12 cells.  Polyclonal and monoclonal 
antibodies directed against Annexin-II and overexpression of antisense Annexin-
II mRNA inhibit NGF-induced PC12 neurite outgrowth on a plate and within a 
three-dimensional matrix (217).  Annexin II is reported to be a co-receptor for 
plasminogen and tissue plasminogen activator (t-PA) that promotes and localizes 
plasmin generation near the cell surface (218, 219).  Although in our microarray, 
NGF was observed to stimulate the expression of Anxa2 to three times the level 
seen in the absence of NGF, NGF-induction of expression was similar in control, 
PC12-SH2B1β and PC12-SH2B1β(R555E) cells.  Like Plaur, Vgf, encoding VGF 
nerve growth factor inducible protein, is a primary response gene that is specific 
for NGF and not EGF and peaks in expression in PC12 cells after 2-8 h of NGF 
(122).  Ret encoding the common receptor for GDNF family ligands is thought to 
be required for GDNF to instruct a subset of TrkA+ sensory neurons to adopt a 
nonpeptidergic sensory neuron fate (220).  Although in control cells we observed 
NGF to substantially increase expression of both Vgf and Ret (by ~7 fold), the 
NGF-induced expression of these two genes was not altered in PC12-SH2B1β or 
PC12-SH2B1β(R555E) cells.   Taken together, these findings suggest that 
SH2B1β enhances the expression of a critical subset of NGF-responsive genes 
implicated in neuronal differentiation. 
 SH2B1β enhances the ability of nerves to express uPAR and MMP3/10, 
which in turn enhances the ability of neurites to invade the extracellular matrix.  
When we looked at the top 5 genes whose NGF-induced expression at 6 h by 
microarray analysis was most highly upregulated in PC12-SH2B1β cells or 
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downregulated in PC12-SH2B1β(R555E) cells compared to control cells, we 
were impressed by the fact that three of the protein products (uPAR, MMP3 and 
MMP10) are involved in the same pathway of extracellular matrix degradation, a 
pathway critical for neurite outgrowth.  What was even more striking is that the 
genes encoding these three proteins were also among the top 12 genes 
upregulated by NGF at 6 h in control cells.  One of these genes (Plaur) is a 
known early response gene regulated by NGF (which promotes neuronal 
differentiation of PC12 cells) but not EGF (which does not promote neuronal 
differentiation of PC12 cells), shown previously to be essential for NGF-induced 
neurite outgrowth and biochemical differentiation (121, 122).   These combined 
observations caused us to focus on uPAR, MMP3 and MMP10 as key mediators 
of the stimulatory effect of SH2B1 on NGF-induced neurite outgrowth. 
 The key features of NGF-dependent neuronal growth, such as the 
initiation and extension of the axon, are contingent upon the formation and 
motility of the growth cones.  uPAR and MMPs 3 and 10 function together in a 
pathway to modulate the cell’s degradation of the surrounding extracellular matrix 
(ECM), allowing the axon to “invade” or penetrate the extracellular matrix.  uPAR 
is a GPI-linked protein that binds to and activates urokinase plasminogen 
activator (uPA) at the cell surface.  uPAR has been implicated as being vital for 
NGF-induced differentiation of PC12 cells.  Thus, in PC12 cells, anti-uPAR 
antibody to the extracellular domain of uPAR and anti-sense RNA targeted to 
uPAR message both block NGF-induced neurite outgrowth and appearance of 
biochemical markers of neuronal differentiation (121).  uPAR is also thought to be 
an essential player for neuronal differentiation in vivo.  uPAR is found in primary 
neurons and has been implicated in the differentiation of primary neurons.  
Hayden and Seeds (221) report that uPAR mRNA levels greatly increase during 
differentiation of cultured cells from mouse dorsal root ganglia (DRGs).  The time 
course of the transient increase (maximum at 30 h) directly correlated with the 
differentiation of neurons and the formation of a neuritic network in the 
regenerating cultures.  Levels of uPAR mRNA also increase in sensory neurons 
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after sciatic nerve crush in adult mice (222) and the neocortex of uPAR-/- adult 
mice has fewer GABAergic interneurons during embryonic and postnatal periods 
(223, 224). 
 Activated uPA converts plasminogen to plasmin, which subsequently 
cleaves inactive MMPs into active extracellular proteases.  There are currently 28 
identified enzymes in the MMP family, each displaying a propensity for the 
cleavage of specific substrates.  MMP3 and 10 are secreted proteinases that are 
cleaved by plasmin; they are both capable of degrading a broad spectrum of 
substrates, including collagen I, III, IV, V and fibronectin (188).  In response to 
signals like NGF, neurons position these extracellular matrix proteases to their 
growth cones.  In PC12 cells, the time course of NGF-induced Mmp3 expression 
is largely coincident with neuronal differentiation (225) and MMP3 has been 
implicated in the motility of the growth cone (123, 226).  Knocking down MMP3 in 
PC12 cells blocks NGF-induced neurite “invasion” or extension through Matrigel, 
suggesting that MMP3 is vital for axon outgrowth through the extracellular matrix.  
In support of a role of MMPs in axonal outgrowth in vivo, MMP3 and MMP10 are 
found in primary neurons.  MMPs have also been implicated in penetration of 
DRG neurites through the extracellular matrix (227). Thus, in the most simplistic 
explanation of how uPAR, MMP3 and MMP10 mediate neurite outgrowth, NGF 
causes an increased transcription/translation of uPAR and MMPs, bestowing the 
cell with a greater proteolytic potential which allows the growth cones to cut 
through the ECM, clearing a pathway for the neurite.  The ability of SH2B1β to 
greatly increase the expression of uPAR and increase and prolong the 
expression of both MMP3 and MMP10 suggests that SH2B1β is required for the 
degradation of the ECM required for axonal outgrowth of NGF sensitive nerves.  
This is supported by our finding that both overexpression of the dominant 
negative SH2B1β(R555E) and reduction of expression of endogenous SH2B1 
using shRNA to SH2B1 substantially decrease the expression of  uPAR, MMP3 
and MMP10.  It is further supported by the finding that cells overexpressing 
SH2B1β both increased the amount of enzymatically active MMP3/10 over levels 
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associated with control PC12 cells in response to NGF as well as NGF-induced 
neurite “invasion” through Matrigel. 
 However, the contribution of uPAR and MMPs, and thus, SH2B1, to 
neurite outgrowth may extend beyond this simple explanation.  The requirement 
for functional uPAR during NGF-dependent differentiation of PC12 cells is 
transient and essential only for the initial hours of NGF exposure (121, 122).  
Furthermore, not only does depletion or inhibition of plasma membrane uPAR 
block NGF-induced neurite outgrowth in a culture plate, but it also blocks 
biochemical differentiation assessed as expression of COX-1 and type II sodium 
channel and expression of both MMP3 (Transin) and MMP1 (Collegenase I) 
(122). These observations suggest that uPAR is an immediate early gene 
product of NGF whose function may be required for induction of a wave of 
secondary response genes important for differentiation.  Indeed, uPAR has also 
been reported in other cell types to activate a variety of intracellular signaling 
pathways and increase levels of a variety of signaling molecules.  The pathways 
and molecules include JAK1/Stat1 (228), MEK/ERK (229), the Src family kinase 
hck (230) and protein kinase Cε (231) pathways as well as diacylglycerol (232, 
233), cAMP (234), calcium released from internal stores (235) and inositol 
phosphate turnover (236).  In other cell model systems, uPAR has been reported 
to form stable complexes with integrins that alter the adhesive properties of the 
cells (237, 238).  Thus, NGF-induced neuronal differentiation and enhancement 
of that differentiation by SH2B1β may also require uPAR activation of cellular 
signaling pathways.   
 In a similar vein, both axons and growth cones appear to require MMPs to 
not only extend into the extracellular matrix, but also to remove inhibitor proteins 
and process guidance cues [reviewed in (239)].  MMP3 has been implicated in 
synaptogenesis (240) and found to confer neuronal survival properties by 
removing FasL from the neuronal surface, thereby protecting against Fas-
induced apoptosis (241).  Thus, in intact neurons, as a consequence of 
promoting and prolonging the NGF-induced expression of Mmp3 and Mmp10, 
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SH2B1β may not only be enhancing neurite invasion of the extracellular matrix, it 
may also be enhancing neuronal survival and affecting synaptogenesis.  A 
specific role for SH2B1 in neuronal survival is consistent with the finding of Qian 
et al. (34) that antibodies to SH2B1α introduced into dissociated sympathetic 
neurons maintained in the presence of NGF promote cell death and that 
introduction of a dominant negative form of SH2B1α into explants of sympathetic 
ganglia maintained in the presence of NGF result in axonal degeneration. 
 Cellular mechanism by which SH2B1β  enhances expression of uPAR 
and MMP3.  Mmp3 expression has been shown to be dependent upon uPAR 
expression (122, 201), making it likely that SH2Bβ1 enhancement of MMP3 
expression is secondary to SH2B1β enhancement of uPAR expression.  The 
molecular mechanism by which SH2B1β enhances NGF-induced Plaur gene 
expression is unknown.  As discussed previously, one hypothesis is that SH2B1 
increases NGF-induction of TrkA (96),  which would be expected to result in an 
increase in all cellular responses to NGF, including expression of Plaur. 
However, our data showing that SH2B1β increases expression of only a subset 
of NGF-induced genes and previous data showing that NGF-induction of TrkA is 
not enhanced in PC12-SH2B1β(R555E) cells (33, 79) argue against this being 
the primary explanation for how SH2B1β stimulates expression of Plaur. Recent 
findings suggest that NGF causes the recruitment of c-Fos and JunB to an AP-1 
regulatory element within the uPAR promoter (242), raising the possibility that 
SH2B1 somehow facilitates that process either directly in its role as an adapter 
protein or indirectly by promoting expression of c-Fos or JunB.  
The work of Qian and colleagues (34)((96) is consistent with SH2B1 enhancing 
NGF activation of ERKs 1 and 2, which would be expected to increase the 
expression of c-Fos. Arguing against this hypothesis, however, is that while 
overexpression of SH2B1β has a modest enhancing effect on NGF activation of 
phosphorylation of ERKs 1 and 2 (33, 79), neither overexpression of 
SH2B1β(R555E) (33) nor reduction of endogenous SH2B1 (Maures, T, Chen, L 
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and Carter-Su, C, manuscript in preparation) inhibits NGF-induced ERK 
phosphorylation. In support of the conclusion that SH2B1β does not enhance 
NGF-induced Plaur expression and neuronal differentation solely by enhancing 
NGF-induced activation of TrkA or ERKs 1/2, glial-derived neurotrophic factor 
(GDNF)-induced neuronal differentiation of PC12 cells stably overexpressing 
GDNF receptor α1 and RET is also enhanced by overexpression of SH2B1β but 
suppressed by overexpression of SH2B1β(R555E) and by reduction of 
endogenous SH2B1 using shRNA to SH2B1(35).  However, GDNF stimulation of 
phosphorylation of Erks 1 and 2 and Akt was not appreciably suppressed by 
overexpression of SH2B1β(R555E). 
 Taken together, these findings suggest that SH2B1 enhances both NGF 
and GDNF-induced neuronal differentiation at a point downstream of or parallel to 
ERKs.  The additional findings that SH2B1β enhancement of NGF-induced Plaur 
expression and neurite outgrowth appear  to require nuclear cytoplasmic shuttling 
of SH2Bβ1 [(79); Maures, T, Chen, L and Carter-Su, C, manuscript in 
preparation] open up the possibility of a novel pathway that requires SH2B1 to 
cycle through the nucleus. 
 Conclusion.  In conclusion, our microarray analysis of PC12 cells treated 
with or without NGF for 6 h identified  ~ 1000 genes and ESTS whose expression 
was increased or decreased by NGF by a factor of 2 or more, many of which 
were not previously recognized as being NGF responsive genes. NGF-induced 
regulation of a substantial subset of these genes was enhanced by 
overexpressing wild-type SH2B1β and/or suppressed by overexpressing 
dominant negative SH2B1β(R555E).  Another subset of NGF-sensitive genes 
implicated previously in NGF-induction of neuronal differentiation were unaffected 
by overexpression of SH2B1β or SH2B1β(R555E), suggesting that SH2B1β acts 
primarily downstream of TrkA.  Three of the upregulated genes (Plaur, Mmp3 and 
Mmp10) were noted to be particularly sensitive to both NGF and SH2B1β.  Their 
regulation by both NGF and SH2B1β at the gene level was confirmed by QT-PCR 
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and at the protein level by immunoblotting, immunocytochemistry, and/or 
functional assays.  The protein products of these three genes lie in the same 
functional pathway of extracellular matrix degradation critical for neurite 
outgrowth; uPAR has been shown previously to be critical for NGF-induced 
neuronal differentiation and MMP3 for NGF-induced neurite growth through a 3-
dimensional matrix.  These observations suggest that uPAR, MMP3 and MMP10 
are likely to play a critical role in the ability of SH2B1 to facilitate NGF-induced 
neuronal differentiation and neurite outgrowth.  A critical role is further suggested 
by our findings that depletion of endogenous SH2B1β suppresses the ability of 
NGF to enhance expression of all three genes and that overexpression of 
SH2B1β promotes neurite extension through a three dimensional matrix.  The 
additional finding that nuclear cytoplasmic shuttling of SH2B1β is required for 
SH2B1β to promote NGF-dependent neuronal differentiation makes it intriguing 
to speculate that nuclear SH2B1β directly facilitates expression of a subset (e.g. 
Plaur) of NGF-sensitive genes. 
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This Chapter has been published in Molecular Endocrinology (2008) 22(2) pgs. 
454-476, under the title “SH2B1β (SH2-Bβ) Enhances Expression of a Subset of 
Nerve Growth Factor-Regulated Genes Important for Neuronal Differentiation 
Including Genes Encoding UPAR and MMP3/10” by Linyi Chen, Travis J. 
Maures, Hui Jin, Jeffrey S. Hou, Shafaat A. Rabbani, Jessica Schwartz, and 
Christin Carter-Su.  Linyi Chen provided FIGs 3.2, 3.3A and B, 3.5, 3.6-3.8, and 
Table 3.5.  I provided FIGs 3.1, 3.3C, and 3.9.  Linyi Chen and I collaborated on 




Nucleocytoplasmic Shuttling of the Adapter Protein SH2B1β  
(SH2-Bβ) is Required for Nerve Growth Factor (NGF)-dependent 
Neurite Outgrowth and Enhancement of Expression of a Subset 
of NGF-responsive Genes 
Abstract 
 
 The adapter protein SH2B1 (SH2-B, PSM) binds to active nerve growth 
factor (NGF) receptor TrkA and enhances NGF-mediated differentiation of 
preneuronal cells.  Our previous finding that SH2B1β contains a nuclear export 
sequence (NES) and cycles between the cytoplasm and nucleus raised the 
possibility that nuclear localization of SH2B1β facilitates NGF-dependent neurite 
outgrowth.  Here we used deletion and substitution mutants to map a functional 
monopartite nuclear localization signal within SH2B1.  Expression of the nuclear 
localization defective SH2B1β(mNLS) inhibited NGF-dependent neurite 
outgrowth without inhibiting NGF-induced activation of TrkA and ERKs 1 and 2.  
Disruption of SH2B1β translocation into or out of the nucleus abolished the ability 
of SH2B1β to enhance transcription of the NGF-responsive genes encoding 
urokinase plasminogen activator receptor (uPAR/Plaur), matrix metalloproteinase 
3 (Mmp3), and matrix metalloproteinase 10 (Mmp10).  Nuclear translocation of 
the highly homologous family member SH2B2 (APS) was not observed, 
indicating that the ability to translocate to the nucleus is specific to SH2B1.  
Depleting endogenous SH2B1 using short hairpin RNA against SH2B1 
proportionately blocked NGF-dependent neurite outgrowth, but did not impede 
NGF-mediated phosphorylation of Akt or ERKs 1 and 2.  Together, these findings 
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suggest that SH2B1β promotes NGF-mediated neuronal differentiation at least in 




 Ligand activation of the TrkA receptor tyrosine kinase by nerve growth 
factor (NGF) initiates several well studied signaling pathways, which ultimately 
mediate survival as well as the development and target innervation of both 
sympathetic and sensory neurons.  The range of physiological responses 
governed by the activation of TrkA underscores the importance of determining 
the molecular mechanisms responsible for these critical physiological outcomes.  
Much of our current understanding about NGF-induced (dependent) neuronal 
differentiation and the responsible signaling pathways comes from work using the 
PC12 cell model.  Derived from a rat adrenal pheochromocytoma, PC12 cells 
cease proliferation in response to NGF, exhibit somatic hypertrophy, and acquire 
neurites (16).  The resulting NGF-dependent morphological and biochemical 
changes of the PC12 cell are highly analogous to that of a true sympathetic 
neuron as the NGF-treated PC12 cells express neuronal specific genes (17) and 
are capable of forming synapses with primary neurons from rat cortex (18).  
Additionally, en route to NGF-mediated differentiation, the PC12 cells develop a 
dependence on NGF for survival as has been documented for both sympathetic 
and sensory neurons (180).   
 Initiation of NGF-dependent neuronal differentiation begins with the 
binding of NGF to TrkA, which activates TrkA, resulting in autophosphorylation of 
TrkA at several tyrosines.  These newly and transiently phosphorylated residues 
function to recruit a number of different signaling molecules and initiate a variety 
of signaling pathways, including pathways involving phospholipase C-γ (PLC-γ); 
NFκB; phosphatidylinositol-3-kinase (PI3K)/Akt; Ras/Raf/MEK/extracellular 
regulated kinases (ERKs) 1 and 2; Jun N-terminal kinase (JNK); p38; and 
atypical protein kinase C (reviewed in (19, 20)).  The cell’s ability to specifically 
induce and propagate the appropriate signaling pathways is thought to arise, at 
least in part, from interactions of activated TrkA with specific adaptor and/or 
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scaffolding proteins.  Indeed, the NGF-dependent binding between TrkA and the 
scaffolding protein FRS2 has been shown to form a complex of proteins in PC12 
cells, including Crk, C3G, Rap1 and B-Raf (31, 243) that leads to the prolonged 
phosphorylation of ERKs required for differentiation (27).  Epidermal growth 
factor (EGF) activation of EGF receptor, on the other hand, is unable to recruit 
FRS2 and results in a transient activation of ERKs, leading to the proliferation of 
PC12 cells instead of their differentiation (31).   
 We and others identified the putative adapter protein SH2B1 (SH2-B, 
PSM) as one of the signaling proteins that bind to the NGF-activated form of TrkA 
(33, 34).  NGF promotes the rapid association of SH2B1 with TrkA and 
subsequent phosphorylation of SH2B1 on tyrosines as well as serines/threonines 
(33, 68).  SH2B1 belongs to a family of adapter proteins that includes APS 
(SH2B2) and Lnk (SH2B3) (44-46, 244).  Each of the family members contains 
several proline-rich domains, at least one N-terminal dimerization domain (DD), a 
pleckstrin homology (PH) domain, and a C-terminal Src homology (SH2) domain 
(183) through which SH2B1 and SH2B2 are thought to interact with activated 
TrkA(34) (33).  Splice variation leads to the formation of four SH2B1 isoforms, α, 
β, γ, and δ, which differ only in their C-termini after the SH2 domain (37) (46).  
The overexpression of both SH2B1β and SH2B1γ enhances NGF-dependent 
neurite outgrowth in PC12 cells (34) (33).  However, the molecular mechanism by 
which SH2B1 enhances neurite outgrowth remains largely unknown.  Previous 
efforts to elucidate this mechanism have been largely centered on the interaction 
between SH2B1 with TrkA.  The apparent membrane localization of SH2B1β (68) 
and its recruitment to NGF-activated TrkA (33) support a mechanism in which 
SH2B1 enhances the kinase activity of TrkA and/or recruits essential NGF 
effector molecules to the activated receptor complex (34, 96), thereby driving the 
prolonged activation of ERKs required for NGF-dependent differentiation (27).  
However, expression of SH2B1β containing a point mutation within its SH2 
domain critical for phosphotyrosine-dependant binding to TrkA 
(SH2B1β(R555E)), blocks NGF-dependent differentiation without affecting NGF-
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induced phosphorylation of TrkA, PLC-γ, Akt, ERK1 or ERK2 (33, 245).  This 
finding indicated that the dominant negative effect of overexpressed 
SH2B1β(R555E) on NGF-dependent neurite outgrowth is unlikely to be a result of 
reduced TrkA activation or a diminished ability of TrkA to phosphorylate the 
substrates responsible for the Shc/Ras/MEK/ERK cascade, PI3K/Akt, or PLCγ 
pathways.  These results suggested that SH2B1β might facilitate NGF-dependent 
differentiation through a novel pathway at a point downstream of or parallel to 
ERKs 1 and 2. 
 Indeed, another layer of complexity was evidenced by the finding that 
SH2B1β contains a functional nuclear export sequence (NES) (79).  
Overexpressed SH2B1β as well as endogenous SH2B1 was found to accumulate 
in the nucleus of cells incubated in the presence of a nuclear export inhibitor, 
leptomycin B (LMB) (79), indicating that SH2B1β undergoes nucleocytoplasmic 
shuttling.  This raised the possibility that nuclear localization of SH2B1 is required 
for its stimulatory effects on NGF-induced neuronal differentiation. 
 Recently, using microarray analysis of PC12 cells, we established that the 
overexpression of SH2B1β leads to altered transcription of only a specific subset 
of NGF-responsive genes, including uPAR (Plaur), Mmp3 (stromelysin-1; transin-
1), and Mmp10 whose gene products encode urokinase plasminogen activator 
receptor (uPAR), matrix metalloproteinase 3 (MMP3), and matrix 
metalloproteinase 10 (MMP10) (124).  Interestingly, uPAR present in the plasma 
membrane of both the cell body and neurites (79) has been shown to be required 
for NGF-mediated neuronal differentiation (121, 122) and MMP3, present in 
growth cones of NGF-treated PC12 cells, has been implicated in neurite 
penetration through the extracellular matrix (123).  Additionally, uPAR, MMP 3, 
and MMP 10 are all situated in the same proteolytic cascade responsible for 
extracellular matrix degradation required for neurite penetration through the 
extracellular matrix) (reviewed in (124)).  Overexpression of the dominant 
negative SH2B1β(R555E) blocks both NGF-dependent neurite outgrowth as well 
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as NGF-induced transcription of the genes encoding uPAR, MMP3, and MMP10 
(124).  These results suggest that SH2B1β mediates NGF-induced neuronal 
differentiation and neurite outgrowth at least in part by enhancing NGF-
dependent expression of uPAR, MMP3, and MMP10.  In light of these findings, 
we questioned whether the nucleocytoplasmic shuttling by SH2B1β is required 
for SH2B1β enhancement of NGF-induced neuronal differentiation and the ability 
of SH2B1β to facilitate transcription of the genes encoding uPAR, MMP3, and 
MMP10.  
 Herein, we provide the first characterization of a nuclear role for SH2B1β.  
Specifically, we demonstrate that endogenous SH2B1β is required for NGF-
dependent neurite outgrowth, although nonessential for NGF activation of Akt 
and ERKs 1 and 2.  Deletion and mutational analysis revealed that SH2B1β 
contains a monopartite nuclear localization sequence (NLS) in addition to its 
previously reported NES.  The adjacent motifs of the NLS and the NES direct the 
cycling of SH2B1β between the nucleus and cytoplasm.  Expression of a nuclear 
import defective SH2B1β inhibits NGF-dependent neurite outgrowth to the same 
extent as SH2B1(R555E).  Interestingly, mutation of the SH2 domain of SH2B1β 
renders it unable to translocate to the nucleus.  Using QT-PCR, we show that 
NGF-dependent transcription of uPAR, Mmp3, and Mmp10 is enhanced in cells 
overexpressing SH2B1β(WT), but not in cells expressing SH2B1β(R555E), or the 
nuclear import mutant of SH2B1β, and substantially decreased in cells 
expressing the nuclear export mutant of SH2B1β.  Collectively, these data 
indicate that SH2B1β cycling between the nucleus and cytoplasm is required for 
both the enhanced NGF-induced transcription of uPAR, Mmp3, and Mmp10 and 
for NGF-dependent neurite outgrowth.  In turn, this finding suggests that SH2B1β 
promotes NGF-mediated neuronal differentiation at least in part by directly 
facilitating enhancement of NGF-mediated gene expression.   
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Materials and Methods 
 
 Antibodies and reagents.  Polyclonal antibody to rat SH2B1 (αSH2B1), 
kind gift of Dr. Liangyou Rui (University of Michigan), was raised against an 
SH2B1β glutathione S-transferase fusion protein and used at a dilution of 1:1000 
for Western blotting (93).  Antibodies that recognize the following proteins were 
used for Western blotting at a dilution of 1:1000:  phospho-44/42 MAPK that 
recognizes both ERK1 and ERK2 that are doubly phosphorylated on T202/Y204 
(apERK; E10), total Erk (aERK), and phospho-Akt (Ser473) (αpAkt-Ser473) from 
Cell Signaling Technology (Beverly, MA), and  phospho-TrkA (Tyr 490) 
(αpTrkA(Tyr490)) (catalog item T9691) from Sigma-Aldrich (St. Louis, MO).  
IRDye800 conjugated, affinity purified anti-GFP (Rockland Immunochemicals 
Inc., Gilbertsville, PA) was used at a dilution of 1:20,000 to visualize GFP.  IRDye 
800 and IRDye 700 conjugated affinity purified anti-mouse IgG and anti-rabbit 
IgG (Rockland) and Alexa Fluor 680-conjugated anti-rabbit IgG (Invitrogen, 
Carlsbad, CA) were used at a dilution of 1:20,000.  Ascites containing anti-mouse 
myc monoclonal antibody, produced by the Michigan Diabetes Research and 
Training Center Hybridoma Core, was used for immunostaining (dilution of 
1:1000).  Anti-myc staining was visualized using Alexa Fluor 594-conjugated anti-
mouse IgG (Invitrogen).  NGF and rat-tail collagen I were purchased from BD 
Bioscience (San Diego, CA).  Fluorescein was from Bio-Rad (Hercules, CA) and 
SYBER Green I was from Sigma-Aldrich Chemical Co. (St. Louis, MO).  TaqMan 
RT-PCR kit (Cat#N808-0234) was purchased from Applied Biosystem (Roche, 
Indianapolis, IN). 
 
 Plasmids.  All SH2B1β cDNAs were subcloned into pEGFP C1 
(CLONTECH Laboratories, Inc.).  cDNAs encoding GFP-tagged SH2B1β, 
SH2B1β(198-268), and SH2B1β(R555E) have been described previously (33, 
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79).  GFP-SH2B1β(147-198) was created from the GFP-SH2B1β(WT) parental 
plasmid using QuikChange Site-Directed Mutagenesis Kit (Stratagene, La Jolla, 
CA).  Two BamH1 restriction sites (at 147 and 198) were put into SH2B1β(WT) 
cDNA, flanking the desired region to be deleted.  The construct was digested with 
BamH1 and the resulting insert was omitted during re-ligation.  The primers 
(sense strand, mutations in lower case) used for generating the deletion in GFP-
SH2B1β(147-198) was (5’-
CAACGTCCTCAAAGCCGggatcCAAGAAACGCTTCTCCC-3’) for site 147 and 
(5’-GTTCTAGGTGGAAACggatcCTCCAACTCCTCTGGTGGT for site 198.  GFP-
SH2B1β(147-268) was created in a manner similar to the previously mentioned 
GFP-SH2B1β(147-198).  The primers (sense strand, mutations in lower case) 
used to generate the BamH1 mutation at site 268 was (5’-
CCTGACCCAGCAGGAtccGGTCGTGGAGGAGGG-3’).  Critical basic residues 
K148, K150, K151, and R152 were mutated to alanines in the mutant cDNA 
encoding GFP-SH2B1β(mNLS), which was created from the GFP-SH2B1β(WT) 
expression vector using site directed mutagenesis.  The primer (sense strand, 
mutations in lower case) used for GFP-SH2B1β(mNLS) was (5’-
CGTCCTCAAAGCCGgcGCTCgcGgcAgcCTTCTCCCTCCGC-3’).  cDNA 
encoding GFP-SH2B1β(mNLS+ΔNES) was similarly created through site-directed 
mutagenesis using GFP-SH2-Bβ(198-268) and the primers above.  The cDNA 
encoding myc-tagged rat SH2B2 was kindly provided by Dr. David D. Ginty 
(Johns Hopkins University).  To create myc-SH2B2(ΔNES), two HindIII sites were 
introduced into myc-SH2B2(WT) at amino acid positions 167 and 184 using site-
directed mutagenesis.  Primers used to introduce HindIII sites were (5’-
GAGCCTCGTGACAAgcttACGCGACGTCTG-3’) and (5’-
GCAGCCAAAGTGaAGcTtGTGGACATCCAGCGC-3’), respectively.  The 
resulting myc-SH2B2 mutant contained two HindIII sites flanking the putative 
NES.  The construct was digested with HindIII restriction enzyme (New England 
Biolabs, Boston, MA), purified, and then re-ligated.   The four residues within the 
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putative NLS of myc-SH2B2 were mutated to alanines, using site-directed 
mutagenesis from Stratagene.   The primer used to produce myc-SH2B2(mNLS) 
was (5’-CACGTGGCTACCgcGGCCgcTGTCgcCgcAGGCTTCTCACTG-3’).  All 
mutations were verified by DNA sequencing. 
 
 Stable cell lines and cell culture.  The parental PC12 cells were 
obtained from American Type Culture Collection (ATCC) (Rockville, MD).  Pools 
of PC12 cells stably expressing GFP-SH2B1β(mNLS) and GFP-SH2B1β(R555E) 
were made as described previously (79).  The PC12 cell lines stably expressing 
GFP, GFP-SH2B1β(WT), GFP-SH2B1β(R555E), and GFP-SH2B1β(NLS) were 
cultured as described previously (79).  PC12 cells were plated on collagen-
coated plates (0.1 mg/ml rat tail collagen in 0.02 N acetic acid) and grown at 
37°C in 10% CO2 in normal growth medium consisting of; Dulbecco’s Modified 
Eagles Medium (DMEM) (Invitrogen),  containing 10% heat-inactivated horse 
serum (ICN), 5% fetal bovine serum (Invitrogen), 1 mM L-glutamine, and 1 mM 
antibiotic-antimycotic (Invitrogen).   
 
 Silencing of SH2B1 gene.  SH2B1 siRNA vector was constructed by 
inserting an oligonucleotide containing the SH2B1 sequence (5’-
CATCTGTGGTTCCAGTCCA-3’) corresponding to nucleotides 1771-1789 of rat 
SH2B1 (GenBankTM accession number AF047577) into the pSuper retro vector 
containing the puromycin resistance gene (pSuper retro puro) (OligoEngine).  A 
pSuper vector containing a non-targeting siRNA with a low sequence similarity to 
known genes was used as a control.  The SH2B1 and control siRNA vectors 
were transfected into subconfluent PC12 cells using a BioRad Gene Pulser Xcell 
electroporator (400V, 500µF, 0.4 cm cuvette).  After 14h, cells were washed with 
1X phosphate-buffered saline (PBS) pH 7.4 and fresh growth medium was 
added.  Twenty-four hours later, growth medium containing 5 µg/ml puromycin 
was added to the cells and selected for pSuper positive PC12 cells for 30 days.   
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 Differentiation of PC12 cells.  PC12 cells were plated on six-well, 
collagen-coated plates.  The cells were grown in differentiation medium (DMEM 
containing 2% horse serum, 1% fetal bovine serum) and 50 ng or 100 ng of NGF 
per ml was added.  Cells were replaced every 2 days until cellular differentiation 
was assessed.  Cells with neurite length at least twice the diameter of the cell 
body were scored as differentiated cells.  The percentage of differentiated cells 
was determined by dividing the number of morphologically differentiated cells by 
the total number of cells counted.  
 
 Immunolocalization.  PC12 cells were transfected using a Gene Pulser 
Xcell electroporator (400V, 500µF) (Bio-Rad) in a 0.4 cm cuvette.  After 5 h, cells 
were washed with PBS and fresh growth medium was added.  Cells were 
incubated for 24 h before cells were fixed with 4% paraformaldehyde.  Coverslips 
were mounted onto slides with Prolong (Molecular Probes).  Cells were incubated 
with 2 ng of DAPI per ml for 10 min to visualize nuclei.  The subcellular 
distribution of the various GFP-SH2B1β proteins was determined by GFP 
fluorescence.  The cells were visualized by fluorescence microscopy (Nikon 
Eclipse TE200) with either 20X or 40X objectives.  Images were captured using a 
CoolSnap HQ digital camera (Roper Scientific) and viewed using MetaVue 
imaging software (Molecular Devices, Sunnyvale, Ca).  
 
 RNA preparation and QT-PCR.  Total RNA was isolated from control and 
NGF-treated PC12 cells using Stat60 (Tel-Test, Inc.) according to the 
manufacturer’s instructions.  RNA from four experiments was prepared and the 
quality of each RNA was checked by optical density.  cDNA was generated from 
each RNA preparation using One-Step RT-PCR Kit with SYBR Green (Bio-Rad, 
catalog item 170-8892) according to the manufacturer’s instructions.  NGF-
induced gene expression of uPAR, Mmp3, Mmp10 was assessed by QT-PCR 
using SYBR green I and the iCycler system with iCycler iQ Real Time Detection 
System software (Bio-Rad).  Primer sequences were designed using 
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PrimerExpress software, as described in (124).  Amplicons generated from each 
primer pair were 50-52bp.  The PCR well volume of each sample was normalized 
with fluorescein.  All readings were normalized to the expression of 
glyceraldehyde-3-phosphate dehydrogenase (GAPDH).  Results are shown as a 
ratio of gene expression in NGF-treated cells to gene expression in control (no 
NGF) cells. 
 
 Cell lysis, immunoprecipitation and immunoblotting.  Cells were 
washed three times with chilled PBSV (10 mM sodium phosphate, 137 mM NaCl, 
1 mM Na3VO4, pH 7.4) and solubilized in lysis buffer (50 mM Tris, 0.1% Triton X-
100, 150 mM NaCl, 2 mM EGTA, 1 mM Na3VO4, pH 7.5) containing 1 mM 
phenylmethylsulfonyl fluoride, 10 mg/ml aprotinin, 10 mg/ml leupeptin, and 25 
mM NaF.  The solubilized material was centrifuged at 16,750 x g at 4oC for 10 
min.  The lysates were boiled for 5 min in a mixture (80:20) of lysis buffer and 
SDS-PAGE sample buffer (250 mM Tris-HCl, 10% SDS, 10% b-mercaptoethanol, 
40% glycerol, 0.01% bromophenol blue, pH 6.8).  Equal amounts of the 
solubilized proteins were separated on SDS-PAGE gels, transferred to 
nitrocellulose, immunoblotted with the indicated antibody, and detected using an 
Odyssey Infrared Imaging System (LI-COR Biosciences, Lincoln, NE).  
Immunoblots were quantified using LiCor Odyssey 2.0 software and normalized 





SH2B1 is required for NGF-dependent differentiation of PC12 cells.   
 In our ongoing attempts to elucidate the mechanism by which SH2B1 
enhances NGF-dependent neurite outgrowth, we wanted to determine whether 
endogenous SH2B1 is required for NGF-dependent neurite outgrowth.   To do so, 
we used an RNA interference approach to stably reduce endogenous levels of 
SH2B1 in PC12 cells.  As demonstrated previously (124) and in FIG. 4.2, 
endogenous SH2B1 levels in cells stably expressing a 21-nucleotide long small 
hairpin RNA targeted against all isoforms of SH2B1 (shSH2B1) was reduced to 
less than 50% the level in cells stably expressing the vector only (shControl), 
when normalized to the levels of α-tubulin (based on quantification of 3 
experiments).  We compared the ability of the shControl and shSH2B1 PC12 cell 
lines to differentiate in the presence of NGF.  The shControl and shSH2B1 cell 
lines were incubated in serum-free medium overnight before treatment with 50 
ng/ml NGF for four days.  Cells were assessed for differentiation on each of the 
four days.  They were considered differentiated if they had neurites at least twice 
the length of their cell diameter.  As shown in FIG. 4.1, there was little difference 
in neurite outgrowth between the two cell lines on day 1.  However, every day 
thereafter (days 2, 3, and 4), we observed approximately half as many neurites in 
the SH2B1 knockdown cells as compared to the control cells, a decrease similar 
to that of the SH2B1 protein levels.  These results indicate that endogenous 






FIG. 4.1.  Endogenous SH2B1 is required for NGF-dependent neurite 
outgrowth.   
PC12 cells stably expressing control shRNA (shControl) or shRNA targeted against SH2B1 
(shSH2B1) were incubated in serum-free medium for 14 h and then treated with 50 ng/ml of NGF 
for 4 days.  The percentage of differentiated cells (y-axis) was calculated on days 1, 2, 3, and 4 of 
the 4-day assay (x-axis).  The values are means ± standard error of the mean from three different 
experiments.  Asterisks represent p values of <0.05 using a one-tailed, paired Student T-test.  At 
least 250 cells were counted for each condition. 
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 Next, we wanted to address the critical question of whether or not 
endogenous SH2B1 is required for NGF-dependent activation of ERKs 1 and 2, 
since ERK activation is critical for NGF-induced neurite outgrowth of PC12 cells 
(28-30).  Both shControl and shSH2B1 PC12 cells were treated with NGF (50 
ng/ml) for 0, 15, 120, 240, and 360 min.  As mentioned above, FIG. 4.2, top 
panel, reveals a ~50% reduction of endogenous SH2B1β in the shSH2B1 versus 
shControl cells.  Additionally, this panel reveals that the mobility of endogenous 
SH2B1β is dramatically reduced after 15 min of treatment with NGF, as a result 
of its extensive tyrosyl and serine/threonine phosphorylation, as reported 
previously (68).  In order to assess the NGF-dependent activation of ERKs 1 and 
2, we blotted the membrane with αpERK which recognizes only the doubly 
phosphorylated, activated form of ERKs 1 and 2 as well as an antibody against 
total ERK (αERK).  As shown in FIG. 4.2, middle panel, the extent and duration 
of phosphorylation of ERKs 1 and 2 in response to NGF was similar in the 
shControl and shSH2B1 cell lines.  The membrane was reblotted with an 
antibody to pAkt (αpAkt) that recognizes phosphorylated Ser 473.  Akt, which lies 
downstream of PI3 kinase, requires phosphorylation on Ser 473 to be active 
(246).  Similarly, we observed no significant difference in phosphorylated Akt 
levels in the shSH2B1 line compared to the shControl line.  These results 




FIG. 4.2.  Effect of shRNA-mediated knockdown of endogenous SH2B1 on 
NGF-induced phosphorylation of Akt and ERKs 1 and 2.   
PC12 cells stably expressing control shRNA (shControl) or shRNA targeted against SH2B1 
(shSH2B1) were incubated in serum-free medium for 14 h before treatment with 50 ng/ml NGF for 
0, 15, 120, 240, or 360 min.   Proteins in cell lysates were separated by SDS-PAGE and 
immunoblotted with (A) αSH2B1, (B) αpAkt(Ser473), (C) αpERK, (D) αErk, and (E) α-αTubulin as 
a loading control. 
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Identification of a region within SH2B1 required for nuclear translocation.   
 We have shown previously (79) that deletion of amino acids 198-268 
results in the nuclear accumulation of SH2B1β, an otherwise 
membrane/cytoplasmic localized protein (33).  Close examination of the 
sequence contained within amino acids 198-268 revealed a match (79) to the 
nuclear export sequence (NES) motif (LX2-3LX2-4LXL) (118, 247, 248).  Indeed, 
point mutations of two key leucine residues (L231 and 233) in this sequence 
rendered SH2B1β defective in nuclear export, resulting in SH2B1β’s nuclear 
accumulation (79).  The dramatic localization shift observed with these SH2B1β 
mutants suggested that SH2B1β undergoes rapid and continual shuttling 
between the nucleus and cytoplasm, with the rate of nuclear export greatly 
exceeding the rate of its nuclear import, giving rise to a steady-state 
membrane/cytoplasmic appearance.  While we had shown that SH2B1β 
contained a functional NES, it was still unclear how exactly SH2B1β localized to 
the nucleus in the first place.  To address this, the dramatic nuclear accumulation 
of GFP-SH2B1β(Δ198-268) lacking the NES (henceforth designated as GFP-
SH2B1β(ΔNES)) (FIG. 4.3A, b) or GFP-SH2B1β(WT) treated with the nuclear 
export inhibitor leptomycin B (LMB) (FIG. 4.3A, a), was used as the readout of a 
screen to identify the region(s) necessary for SH2B1β’s nuclear import.  In this 
screen in which nuclear export is blocked, nuclear accumulation of SH2B1β 
represents functional nuclear import of SH2B1β whereas nuclear exclusion 
represents defective nuclear import of SH2B1β.  Initially, a series of truncation, 
deletion, and point mutations were made on top of GFP-SH2B1β(ΔNES) and 
transiently expressed in COS-7 cells.  COS-7 cells were used for the initial 
screen because of their high transfectional efficiency and flat morphology which 
lends itself to rapid and unambiguous identification of subcellular localization of 
the fluorescent proteins.  Regions in SH2B1β(ΔNES) that contained mutations or 
deletions that resulted in the failure of GFP-SH2B1β(ΔNES) to accumulate in the 
nucleus were considered implicit for nuclear import.  We made the same series of 
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mutations in a GFP-tagged, wild-type SH2B1β and incubated the cells 
expressing those mutants in the absence or presence of LMB.   
 As mentioned previously, overexpressed GFP-SH2B1β(WT) appears to 
have a membrane and cytoplasmic localization (FIG. 4.3A, a; left panel).  After 
incubation with LMB, GFP-SH2B1β(WT) was found to accumulate in the nucleus 
(FIG. 4.3A, a; right panel), as shown previously (79).  The GFP-SH2B1β(ΔNES) 
mutant retains the ability to translocate to the nucleus, but is unable to cycle to 
the cytoplasm without the sequence responsible for nuclear export (FIG. 4.3A, b).  
Another mutant of SH2B1β [SH2B1β(Δ147-268)] which contains a slightly larger 
region of deletion than SH2B1β(ΔNES) (Δ198-268) was observed in the 
cytoplasm with or without LMB (FIG. 4.3A, c).  This suggests that the region 
required for nuclear import of SH2B1 lies within amino acids 147-198.  As 
predicted, GFP-SH2B1β(Δ147-198) failed to accumulate in the nuclei of COS-7 
cells in the absence or presence of LMB (FIG. 4.3A, d).  Examination of the 
amino acid sequence between 147 and 198 in SH2B1β (FIG. 4.3B) revealed a 
small stretch of highly basic residues that resembles the classical basic amino 
acid motif (PKKKRKV) of the SV40 large T antigen (249, 250). This putative 
nuclear localization sequence is almost perfectly conserved in all known 
vertebrate SH2B1 homologues from zebrafish to human (FIG. 4.3B). The basic 
region identified in SH2B1 spans from amino acid 146-152, thus four basic 
residues likely to be critical for nuclear import were missing from the nuclear 




FIG. 4.3.  The region between amino acids 147-198 is essential for nuclear 
translocation.    
(A) COS-7 cells were transiently transfected with cDNA encoding GFP-SH2B1β(WT) (a), GFP-
SH2B1β(ΔNES) (b), GFP-SH2B1β(Δ147-268) (c), or GFP-SH2B1β(Δ147-198) (d).  Fourteen 
hours post transfection, the cells were either mock treated with vehicle (left panels) or treated with 
20 nM leptomycin B (LMB) (right panels) for 7 h.  Cells were then fixed and visualized using 
epifluorescence microscopy.  The schematic representations of SH2B1β indicate the positions of 
internal deletions and/or previously defined domains within SH2B1, including the dimerization 
domain (DD), nuclear export sequence (NES), pleckstrin homology domain (PH), and Src 
homology domain (SH2).  (B) MacVector ClustalW sequence alignment of multiple species of 
SH2B1 between residues 145 and 193. 
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 SH2B1 requires an NLS and a functional SH2 domain for nuclear 
translocation. 
 To confirm that this basic region found between amino acids 146-152 is 
responsible for nuclear import of SH2B1β in PC12 cells, a series of GFP-SH2B1β 
constructs encoding point mutations and/or deletions in this region were 
expressed in PC12 cells in the presence or absence of LMB.  As shown above in 
FIG. 4.3A, GFP-SH2B1β(WT) appears to localize exclusively to the membrane 
and cytoplasm (FIG. 4.4A, top left panel).  Incubation with LMB, however, results 
in the accumulation of GFP-SH2B1β(WT) in the PC12 nucleus (FIG. 4.4A, top 
right panel).  Similarly as shown above in FIG. 4.3A, b, the localization of GFP-
SH2B1β(ΔNES) was found to be nuclear whether or not it was incubated with 
LMB (FIG. 4.4B).  We used site directed mutagenesis to change the putative NLS 
from K148/K150/K151/R152 to A148/A150/A151/A152 in SH2B1β.  This mutant 
SH2B1β will be referred to as SH2B1β(mNLS).  The mutation of the putative NLS 
resulted in a failure of GFP-SH2B1β to localize to the nucleus even in the 
presence of LMB (FIG. 4.4C) or when combined with deletion of the NES (FIG. 
4.4D).  We therefore concluded that the basic residues K148/K150/K151/R152 
are required for the nuclear localization of SH2B1β and constitute a previously 
unrecognized monopartite NLS present within all isoforms of SH2B1.   
 During our attempts to find the region required for SH2B1β nuclear import, 
we found that GFP-SH2B1β(R555E) displayed a significantly reduced, or 
possibly, a complete inability to translocate to the nucleus.  FIGS. 4.4E and 4.4F 
illustrate that GFP-SH2B1β(R555E) does not accumulate in the nucleus when 
treated with LMB (FIG. 4.4E) or when the NES is deleted (FIG. 4.4F).  As 
described previously (39), the mutation of the critical arginine within the SH2 
domain to a glutamate (SH2B1β(R555E)) abolishes the phospho-tyrosine binding 
ability of SH2B1, and the expression of SH2B1β(R555E) in PC12 cells results in 
the “dominant negative” inhibition of NGF-dependent differentiation.   
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FIG. 4.4.  Point mutations in the putative NLS motif inhibit nuclear 
accumulation of SH2B1β .   
PC12 cells were transiently transfected with cDNAs encoding GFP-SH2B1β(WT) (A), GFP-
SH2B1β(ΔNES) (B), GFP-SH2B1β(mNLS) (C), GFP-SH2B1β(mNLS+ΔNES) (D), GFP-
SH2B1β(R555E) (E), and GFP-SH2B1β(R555E+ΔNES) (F).  Fourteen h post transfection, the 
cells were either mock treated (left panels) or treated with 20 nM leptomycin B (LMB) for 7 h (right 
panels).  Cells were then fixed and stained with DAPI to visualize nuclei (blue color in overlay 
image, lower panels) and then visualized using epifluorescence microscopy.  The schematic 
representations of SH2B1β indicate the positions of internal deletions and/or previously defined 
domains within SH2B1, including the dimerization domain (DD), nuclear export sequence (NES), 
pleckstrin homology domain (PH), and Src homology domain (SH2).  The open white box 
represents the putative NLS motif within SH2B1 and the corresponding sequence is indicated 
below.  Single basic amino acid substitutions to alanines within the NLS are indicated in red. 
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SH2B2 does not undergo nucleocytoplasmic shuttling  
 The finding that SH2B1 contains functional nuclear export and localization 
signals raises the question as to whether other SH2B gene family members 
[SH2B2 (APS), SH2B3 (Lnk)] can also undergo nucleocytoplasmic shuttling. The 
ClustalW multiple sequence alignment of several species of SH2B1 family 
members revealed that SH2B2, but not SH2B3, shares a high degree of 
homology in both the nuclear localization (FIG. 4.5A) and nuclear export 
sequences (FIG. 4.5B) of SH2B1.  The alignment also revealed that three of the 
four basic residues required for SH2B1 nuclear localization  (indicated with 
arrows) are conserved in rat, mouse, and human SH2B2 (R119, R121, and 
K122).  Further, SH2B2 contains a putative NES between the residues 168 and 
174, based on the loosely defined NES motif, LX2-3LX2-4LXL (118, 247, 248).  
The putative NES of SH2B2 contains three of the four hydrophobic residues, 
including the amino acid motif LXL (FIG. 4.4B), that has been shown to be 
required for nuclear export of SH2B1 (79) as well as of 14-3-3 (118). 
 In agreement with previous findings (63, 251), SH2B2(WT) appears to be 
localized at the plasma membrane as well as the cytoplasm, as shown in FIG. 
4.5C, a.  The subcellular localization of myc-SH2B2 resembled closely the 
localization of GFP-SH2B1β (FIG. 4.5C, b). However, while GFP-SH2B1β(ΔNES) 
is localized to the nucleus (FIG. 4.5B, c), myc-tagged SH2B2 mutant carrying a 
deletion of the putative NES (Δ167-184) [SH2B2(ΔNES)] did not accumulate in 
the nucleus (FIG. 4.5C, d).  To confirm the inability of SH2B2 to undergo 
nucleocytoplasmic shuttling, we expressed myc-tagged SH2B2(WT) and 
incubated the cells in the presence of LMB for 24 h.  As shown in FIG. 4.5C, e, 
LMB treatment did not cause the nuclear accumulation of myc-SH2B2(WT). 
Mutations to the putative NLS (K117A, R119A, R121A, and K122A) 
[SH2B2(mNLS)] also did not alter the subcellular localization of SH2B2 (FIG. 




FIG. 4.5A, B.  Subcellular distribution of internal deletion and point mutants 
of SH2B2 in PC12 cells.   
MacVector ClustalW multiple sequence alignment was used to compare several species of 
SH2B1, SH2B2, and SH2B3.  (A) Inter-species conservation among SH2B family members within 
the region corresponding to the NLS of SH2B1.  Arrows designate the basic residues required for 
nuclear import.  (B) Inter-species conservation among SH2B family members within the region 
corresponding to the NES of SH2B1. Asterisks denote the general NES motif and arrows 
designate the hydrophobic residues that have been shown to be required for SH2B1β nuclear 
export.   
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FIG. 4.5C.  Subcellular distribution of internal deletion and point mutants of 
SH2B2 in PC12 cells.   
(C) PC12 cells were transiently transfected with cDNAs encoding (i) myc-SH2B2(WT), (ii) GFP-
SH2B1β(WT), (iii) GFP-SH2B1β(ΔNES), (iv) myc-SH2B2(ΔNES), (v) myc-SH2B2(WT), and (vi) 
myc-SH2B2(mNLS).  Fourteen hours post transfection, the cells were either treated with vehicle 
(methanol) (panels i, ii, iii, iv, and vi) or treated with 20 nM leptomycin B (LMB) (panel v) for 7 h.  
Cells transiently expressing myc-tagged constructs were stained with αmyc and anti-mouse IgG 
Alexa 594 and are visualized in the TRITC channel (panels i, iv, v, and vi).  GFP-SH2B1 
expression is visualized in the FITC channel (panels ii and iii).  Images were taken using 
epifluorescence microscopy. 
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only in response to NGF stimulation or possibly serum deprivation, myc-
SH2B2(ΔNES) expressing cells were incubated in serum-free medium for 14 h 
and incubated in the absence or presence of NGF for 5 min, 30 min, 1 h, and 6 h.  
None of the conditions tested resulted in nuclear accumulation of myc-
SH2B2(ΔNES) (data not shown).  The failure to detect even the slightest nuclear 
localization of SH2B2 after inhibiting nuclear export with LMB or removing its 
putative NES, suggests that the cytoplasmic appearance of SH2B2 reflects a 
more-or-less static localization.  This is in contrast to SH2B1β(WT) which is 
seemingly in a constitutive flux between the plasma membrane/cytoplasm and 
nucleus.  Consequently, we have concluded that in spite of the high degree of 
sequence similarity between family members SH2B1 and SH2B2, the ability to 
undergo nucleocytoplasmic shuttling is unique to SH2B1.   
 
Ability of nuclear localization defective SH2B1β  mutants to regulate NGF-
induced differentiation.   
 To determine whether the nuclear localization of SH2B1β is required for 
NGF-dependent differentiation of PC12 cells, we tested the effects of the nuclear 
localization sequence deficient SH2B1β mutant, SH2B1β(mNLS), on NGF-
induced neurite outgrowth.  PC12 cells stably expressing vector control, 
SH2B1β(WT), SH2B1β(R555E) or SH2B1β(mNLS) were incubated in 
differentiation medium in the absence or presence of 50 ng/ml of NGF for a total 
of 5 days (FIG. 4.6A).  In agreement with previous findings, stable 
overexpression of SH2B1β(WT) resulted in more than a doubling of the number 
of cells exhibiting NGF-dependent neurite outgrowth (38% compared to 18% for 
control cells) (FIG. 4.6B).  Likewise, the stable expression of the dominant 
negative form of SH2B1β, SH2B1β(R555E), resulted in inhibition of NGF-
dependent neurite outgrowth (13% of cells) compared to GFP alone (18% of 
cells) (FIG. 4.6B).  Strikingly, as shown in FIGS. 4.6A and 4.6B, expression of 
SH2B1β(mNLS) inhibited NGF-dependent neurite outgrowth to the same extent 
152 
as expression of SH2B1β(R555E) (13%).  The cell lines were created by pooling 
together the top 5% GFP positive cells, using FACS sorting after 4 weeks of 
selection in G418 containing growth medium.  The resulting stable PC12 cell 
lines display a spectrum of GFP expression levels and in FIG. 4.6A, only PC12 
cells expressing “high” levels of GFP can be seen after merging the fluorescent 
and bright-field images, although all cells are GFP positive and were counted as 
such.  The inhibition of NGF-dependent differentiation resulting from GFP-
SH2B1β(mNLS) is even more evident when the “high” GFP-SH2B1β(WT) 
expressing cells which exhibit enhanced neurite length, are compared to the 
growth stunted neurites of the “high” GFP-SH2B1β(mNLS) expressing cells. 
 
 Effect of overexpression of SH2B1β(mNLS) on NGF-induced tyrosyl 
phosphorylation of TrkA and activation of ERKs 1 and 2  
 In PC12 cells, prolonged activation of ERK is thought to mediate 
differentiation, whereas transient activation of ERK is thought to promote 
proliferation (27).  Because overexpression of SH2B1β(mNLS) inhibits NGF-
dependent neurite outgrowth, it was of interest to establish whether the 
overexpression of SH2B1β(mNLS) affects the kinetics of NGF-dependent 
activation of TrkA and ERKs 1 and 2.  PC12 cell lines stably expressing GFP, 
GFP-SH2B1β(WT), or GFP-SH2B1β(mNLS) were incubated in serum free-
medium and then stimulated with NGF for 0, 15, 120, 240, and 360 min.  Proteins 
from cell lysates were resolved by SDS-PAGE and immunoblotted first with 
αEGFP to verify the presence of GFP-SH2B1β(WT) and GFP-SH2B1β(mNLS).  
Importantly, FIG. 4.7 reveals that expression levels of GFP-SH2B1β(WT) and 
GFP-SH2B1β(mNLS) are similar, therefore eliminating the potential for SH2B1β 
dosage dependent differences.  Figure 7 also reveals 
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FIG 4.6.  Stable expression of the SH2B1β  nuclear import mutant inhibits 
NGF-dependent neurite outgrowth of PC12 cells.   
(A) PC12 cells stably expressing GFP, GFP-SH2B1β(WT), GFP-SH2B1β(R555E), or GFP-
SH2B1B(mNLS) were incubated in serum-free medium overnight before incubation in the 
absence (top panels) or presence (bottom panels) of 50 ng/ml NGF for 5 days.  Representative 
pictures of each condition were imaged by overlaying the FITC channel (GFP) on top of standard 
bright field illumination.  (B) The percentage of differentiated cells was scored on day 5.  Means ± 
standard errors of the mean from 6 different experiments are shown.  Asterisks represent p 
values of <0.05 using a one-tailed, paired Student T-test.  A combined total of at least 400 cells 




FIG. 4.7.  Effects of SH2B1β(mNLS) expression on NGF-induced 
phosphorylation of TrkA and ERKs 1 and 2.   
PC12 cells stably expressing GFP, GFP-SH2B1β(WT), or GFP-SH2B1β(mNLS) were incubated 
in serum-free medium overnight before treatment with 50 ng/ml NGF for 0, 15, 120, 240, and 360 
min.   Proteins in cell lysates were separated by SDS-PAGE and immunoblotted with αGFP to 
visualize the relative levels of expression of GFP-SH2B1β(WT) and GFP-SH2B1β(mNLS).  The 
blots were also immunoblotted with αpTrkA(Y490), αpERK1/2, and αERK1/2. 
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similar upward shifts in migration of GFP-SH2B1β(WT) and GFP-
SH2B1β(mNLS), consistent with the 2 forms of SH2B1β undergoing similar 
degrees of phosphorylation in response to NGF.  Immunoblotting with an 
antibody that recognizes phosphotyrosine 490 (αpY490 TrkA), a primary 
autophosphorylation site within TrkA, revealed a similar NGF-dependent 
phosphorylation of TrkA in the SH2B1β(WT) and SH2B1β(mNLS) expressing cell 
lines.  Likewise, the extent of phosphorylation of ERKs 1 and 2 after NGF 
treatment, as well as the duration of phosphorylation, was comparable between 
SH2B1β(WT) and SH2B1β(mNLS) expressing cell lines.  Collectively, these data 
strongly suggest that the neurite outgrowth defect observed in the cells 
expressing SH2B1β(mNLS) is not secondary to a defect in NGF-dependent 
activation of TrkA or ERKs 1 and 2.   
 
Nuclear import and export of SH2B1β  are required for NGF-induced 
enhancement of gene expression required for neuronal differentiation 
 In a recent publication (124), we reported that SH2B1β enhances NGF-
dependent neurite outgrowth in part by amplifying the expression of a specific 
subset of NGF-responsive genes.  The genes identified included uPAR, Mmp3, 
and Mmp10.  These proteins were of particular interest because uPAR has been 
shown to be required for NGF-mediated neuronal differentiation (122) and 
MMP3/10 are both situated in the same proteolytic cascade as uPAR, 
responsible for extracellular matrix degradation (reviewed in References (191) 
and (192)).  Consistent with our finding that endogenous SH2B1β is required for 
NGF-dependent neurite outgrowth (FIG. 4.2), shRNA mediated knockdown of 
SH2B1β suppressed the NGF-dependent induction of uPAR, Mmp3, and Mmp10 
(124).  To test the hypothesis that nuclear translocation of SH2B1β facilitates the 
transcription of genes required for NGF-induced neuronal differentiation, we used 
QT-PCR to assay the NGF-dependent transcription of uPAR, Mmp3, and 
Mmp10.  PC12 cells stably expressing vector control, SH2B1β(WT), 
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SH2B1β(R555E) and SH2B1β(mNLS) were incubated in serum-free medium for 
14 h and then incubated with or without NGF (100 ng/ml) for 0 or 6 h.  Untreated 
PC12 cells displayed very little basal transcription of uPAR, Mmp3, or Mmp10 
(FIG. 4.8).  After 6 h of NGF treatment, transcription of these genes was 
dramatically elevated.  In agreement with our previous findings (124), NGF-
induced transcription of uPAR, Mmp3, and Mmp10 was enhanced in cells stably 
expressing SH2B1β(WT), and reduced in cells stably expressing 
SH2B1β(R555E) (FIG. 4.8 A-C).  Overexpression of SH2B1β(mNLS) failed to 
enhance NGF-induced transcription of uPAR, Mmp3, or Mmp10, as shown in 
FIGS. 4.8A, B, and C, respectively.  The inability of SH2B1β(mNLS) to enhance 
transcription of uPAR, Mmp3, or Mmp10, implies that the nuclear translocation of 
SH2B1β is critical for SH2B1β enhancement of NGF-induced transcription of 
these genes. The aforementioned results indicate that SH2B1β has the capacity 
to translocate into the nucleus and enhance the transcription of specific NGF-
responsive genes.  Although SH2B1β does not contain any presently discernable 
DNA binding or transactivation domains, the findings raise the possibility that 
SH2B1β may be acting as a transcription factor or co-activator for these genes.  
If this were the case, expression of the constitutively nuclear localized 
SH2B1β(ΔNES) mutant might enhance the transcription of these genes over that 
of cells expressing SH2B1β(WT).  To determine the effects of expressing 
SH2B1β(ΔNES), we compared the NGF-dependent transcription of Plaur, Mmp3, 
and Mmp10 in the same stable lines control, SH2B1β(WT), and SH2B1β(ΔNES).  
Again, the cells were serum deprived for 14h before treatment with 100ng/ml of 
NGF for 0 and 6h.  Consistent with our previous results, the expression of 
SH2B1β(WT) enhanced, while the expression of SH2B1β(R555E) inhibited, NGF-
induced transcription of Plaur, Mmp3, and Mmp10 without affecting the 
transcription of GAPDH (FIG. 4.9).  We observed a modest, but not statistically 




FIG. 4.8.  Stable expression of the SH2B1β  nuclear import mutant 
(SH2B1β(mNLS)) fails to enhance NGF-induced transcription of uPAR, 
Mmp3, and Mmp10.   
After incubation in serum-free medium overnight, PC12 cells stably expressing GFP, GFP-
SH2B1β(WT), GFP-SH2B1β(R555E), or GFP-SH2B1B(mNLS) were incubated with or without 50 
ng/ml NGF for 6h.  The NGF-dependent induction of mRNA for (A) Plaur (uPAR), (B) Mmp3, (C) 
and Mmp10 was assessed using QT-PCR.  Target gene expression was normalized first to levels 
of GAPDH and then to levels of gene expression seen in GFP control cells treated with NGF.  
Means ± standard errors of the mean from 4-6 separate experiments are shown. 
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 (FIG. 4.9A) and Mmp10 (FIG. 4.9C) in the SH2B1β(ΔNES) expressing cells 
compared to control.  However, the NGF-dependent transcription of Plaur, 
Mmp3, and Mmp10 in the SH2B1β(ΔNES) cells was significantly reduced 
compared to SH2B1β(WT) cells.  These findings demonstrate that constitutively 
nuclear localized SH2B1β is significantly less effective than SH2B1β(WT) at 
enhancing NGF-dependent transcription of genes required for neurite outgrowth.  
Collectively, the QT-PCR data indicate that SH2B1β requires both a functional 





FIG. 4.9.  Stable expression of the SH2B1β  nuclear export mutant 
(SH2B1β(ΔNES)) fails to enhance NGF-induced transcription of uPAR, 
Mmp3, and Mmp10.   
PC12 cells stably expressing GFP, GFP-SH2B1β(WT), GFP-SH2B1β(R555E), or GFP-
SH2B1B(ΔNES) were incubated in serum-free medium overnight and then incubated with or 
without 50 ng/ml NGF for 6h.  The NGF-dependent induction of mRNA for (A) uPAR, (B) Mmp3, 
and (C) Mmp10 was quantified using QT-PCR.  Target gene expression was normalized first to 
levels of GAPDH and then to levels of gene expression seen in GFP control cells treated with 




 In this work, we investigated the mechanism by which SH2B1β enhances 
NGF-dependent neurite outgrowth in PC12 cells.  We report here that SH2B1β is 
required for NGF-dependent neurite outgrowth in a manner that is distinct from 
the activation of the PI3K/Akt and/or Ras-ERK pathways.  Previous studies have 
attempted to answer the question of whether SH2B1β is required for neurite 
outgrowth, but have relied upon the overexpression of dominant negative 
mutants of SH2B1 (33, 96).  Here, we have addressed this question more directly 
by showing that when endogenous levels of SH2B1 are reduced in PC12 cells 
using shRNA targeted against all isoforms of SH2B1, NGF-dependent 
differentiation is inhibited proportionate to the extent of SH2B1 knockdown.  
Importantly, the knockdown of SH2B1 did not alter the extent and/or duration of 
NGF-induced phosphorylation of Akt or ERKs 1 and 2.  Recent work regarding a 
highly analogous signaling system to that of NGF/TrkA (35) demonstrated that 
SH2B1 is also required for glial-cell-line-derived neurotrophic factor (GDNF)-
dependent neurite outgrowth (35).  The inhibition of GDNF-dependent neurite 
outgrowth that resulted from either the overexpression of the dominant negative 
SH2B1β(R555E) or SH2B1β RNAi was similarly not a consequence of reduced 
signaling, as the respective levels of GDNF-induced phosphorylation of Akt and 
ERKs 1 and 2 were the same as in control cells (35).  Collectively, these data 
strongly suggest that endogenous SH2B1 is critical for NGF-induced neuronal 
differentiation and enhances NGF-induced differentiation at a point downstream 
of or parallel to ERKs 1 and 2. 
 Consistent with the idea that SH2B1β may function downstream or parallel 
to ERK1/2 activation, we show that nuclear SH2B1β is required for NGF-
dependent differentiation of PC12 cells.  In addition to the previously described 
NES, we have identified within SH2B1 a functional nuclear localization sequence 
contained within a stretch of basic amino acids (a.a. 146-152).  Internal deletion 
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of these amino acids blocked SH2B1β accumulation in the nucleus, even when 
nuclear export was blocked by the deletion of the NES or the presence of LMB.  
Specific mutation of four basic amino acids to alanines within the putative NLS 
[SH2B1β(mNLS)] blocked SH2B1β nuclear translocation in PC12 cells and all 
other cell lines tested (293T, COS-7, and NIH 3T3, data not shown).  The nuclear 
localization sequence is almost perfectly conserved in all SH2B1 isoforms as well 
as all known vertebrate SH2B1 homologues from human to zebrafish, suggesting 
that the NLS bestows an important function to the SH2B1 protein.   
 Based upon the high degree of sequence similarity between SH2B1 and 
SH2B2, we were somewhat surprised to find that SH2B2 did not also cycle 
between the cytoplasm and nucleus.  After the initial identification of SH2B1 and 
SH2B2 in neurons (34), early conclusions drawn from their characterization 
indicated a large amount of functional overlap between the two proteins.  SH2B1 
and SH2B2 were both shown to associate with activated TrkA as well as 
enhance NGF-dependent neuritogenesis (33, 34).   In recent years, however, 
functionally distinct differences between SH2B1 and SH2B2 have been 
observed, including structural differences within their SH2 domains, which 
account for phosphotyrosine binding site specificity (252), and the identification of 
unique binding partners (e.g. enigma for SH2B2 but not SH2B1 or SH2B3 (76); c-
cbl for SH2B2, SH2B3 but only the SH2B1α isoform of SH2B1 (64, 65, 252)).  
The ability to cycle between nucleus and cytoplasm is a property of SH2B1 not 
shared by SH2B2, and represents another distinction between the two family 
members.  
 Directional transport between the nucleus and the cytoplasm occurs in an 
energy-dependent manner through the nuclear pore complex.  For the vast 
majority of proteins, crossing the nuclear pore complex from the cytoplasm 
requires interaction with importinα (Impα) of the Impα/β complex.  The nuclear 
localization signal endows a protein with a binding motif that is recognized by 
Impα (253).  The main types of known NLSs are monopartite and bipartite 
sequences.  The monopartite NLS contains a single cluster of basic amino acids 
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that is often preceded by a proline and followed by a hydrophobic residue, as is 
found in the first NLS identified within simian virus 40 Large-T antigen 
(PKKKRKVE) (249) (250).  The bipartite NLS contains two clusters of basic 
amino acids separated by a variable length spacer (10-12 a.a.) (254).  Although 
we have yet to test for the interaction, the sequence responsible for nuclear 
import of SH2B1β closely resembles that of a classical monopartite NLS 
(KPKLKKRF).  SH2B1β is thus presumed to be transported into the nucleus via 
the Impα/β complex.  Because there is substantial mixing of cytoplasmic and 
nuclear proteins after nuclear envelope breakdown during mitosis (253), the 
presence of a NES alone within a protein is not sufficient evidence to ascribe a 
nuclear role for that protein.  In fact, an NES in the absence of an NLS is thought 
to function to assure that a protein stays out of the nucleus. Thus, the 
identification of the NLS within SH2B1, in addition to the previously described 
NES, adds credibility to the hypothesis that SH2B1 possesses a nuclear function.   
 Although SH2B1β has the capacity to constantly move between the 
nucleus and cytoplasm, it is for the most part detected at the membrane and 
within the cytoplasm. Evidence from our previous (79) and current findings 
suggests that the NES and NLS within SH2B1β account for its ability to undergo 
nucleocytoplasmic shuttling and that this shuttling is required for NGF-dependent 
neurite outgrowth.  Mutations directed at the NES through internal deletion [GFP-
SH2B1β(Δ198-268)] or point mutation [GFP-SH2B1β(L231A, L233A)] of the NES 
result in significant nuclear accumulation of SH2B1β, to the extent that 
cytoplasmic detection of the SH2B1β export mutant is relatively difficult.  The 
finding that the ability of SH2B1β to enhance NGF-dependent neurite outgrowth 
is also lost when these mutations were made to the NES suggest that SH2B1β is 
either required in the cytoplasm or at the plasma membrane to enhance 
differentiation (79).  However, expression of the nuclear import mutant SH2B1β 
[SH2B1β(mNLS)] also inhibits NGF-dependent neurite outgrowth in PC12 cells to 
the same extent as the previously established dominant negative 
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SH2B1β(R555E).  This result suggests that NGF-mediated neurite outgrowth also 
requires SH2B1β to cycle through the nucleus. 
 Previous findings have implicated SH2B1β in both platelet-derived growth 
factor (PDGF) and growth hormone (GH)-induced membrane ruffling and motility 
in 3T3 F442A pre-adipocytes (74) (73).   These findings raise the possibility that 
SH2B1β might mediate similar cytoskeletal changes in response to NGF.  Most 
compelling is the observation that the N-terminal portion of SH2B1β directly or 
indirectly binds to the small GTPase Rac, and that this binding is required for GH-
induced actin rearrangement (73).  Even though it is thought that the small 
GTPase Cdc42 is responsible for neurite outgrowth and formation of the growth 
cone (255), Rac has been shown to be important for resisting growth cone 
collapse (Kuhn, Brown J. Neurosci 1999) and appropriately correct target 
innervation (256).  Thus, a plausible ERK independent role for SH2B1β could be 
to function as an adapter protein that recruits Rac and possibly other small 
GTPases to activated TrkA complexes in order to facilitate appropriate changes 
to the cytoskeleton required for neurite outgrowth.  However, overexpression of a 
truncation mutant of SH2B1β lacking the Rac binding domain is still able to 
enhance NGF-dependent neurite outgrowth (79).  While this result indicates that 
Rac binding is dispensable for SH2B1β function in neurite outgrowth, until our 
most recent finding using the SH2B1β nuclear import mutant, there remained a 
distinct possibility that SH2B1β is required only at the membrane to direct NGF-
induced morphological differentiation.  Because the cytoplasm and plasma 
membrane constrained SH2B1β(mNLS) inhibits NGF-induced neurite outgrowth, 
we currently believe that even if SH2B1β has direct effects on the actin 
cytoskeleton in PC12 cells, the ability of SH2B1β to facilitate neurite outgrowth in 
response to NGF requires SH2B1β to cycle in and out of the nucleus.   
 This interpretation is in agreement with a recent finding that SH2B1β 
promotes more than localized changes to the cytoskeleton after NGF treatment.  
In fact, overexpression of SH2B1β was found to enhance the transcription of a 
164 
subset of NGF-responsive genes, several of which are biochemical markers of 
neuronal differentiation (124).  Among the genes that displayed the most 
dramatic regulation by SH2B1β were uPAR, Mmp3, and Mmp10 (124).  
Interestingly, the protein products of these genes fall within the canonical 
pathway responsible for extracellular matrix (ECM) degradation, required during 
neurite outgrowth.  The glycosylphosphatidylinositol (GPI)-linked protein uPAR is 
thought to initiate a proteolytic cascade through binding to and activating 
urokinase plasminogen activator (uPA) at the surface of the cell.  The activated 
form of uPA converts zymogen plasminogen to plasmin, which then cleaves 
several of the matrix metalloproteinases, resulting in their activation (reviewed in 
(192)).  In response to neurotrophic signals, neurons position these extracellular 
matrix (ECM) proteases to their growth cones, allowing the growth cone to 
penetrate the ECM en route to its intended target (257).  Farias-Eisner et al. 
(122) demonstrated that NGF-induced transcription of uPAR, in particular, is an 
essential event for NGF-dependent differentiation of PC12 cells.  Both antisense 
oligoncleotide mediated knockdown of uPAR transcript as well as functional 
inhibition of uPAR using an anti-uPAR antibody, blocks NGF-dependent PC12 
neurite outgrowth (122).  uPAR is an immediate-early gene (IEG) in neurotrophin-
driven neuronal differentiation and its transcription is specifically induced by NGF, 
but not EGF, treatment of PC12 cells (122).  Correspondingly, blocking uPAR 
function inhibited the transcription of NGF-induced secondary response genes, 
COX-1, type II sodium channel, Mmp1 (collagenase-1), and Mmp3 (stromelysin-
1; transin-1) (122).  The ability of uPAR to initiate a secondary wave of 
transcription important for differentiation is thought to arise from its capacity to 
activate intracellular signaling machinery, even though it lacks a cytosolic domain 
(258).  Activation of uPAR by uPA is coupled to the cytoplasm through 
interactions with transmembrane proteins including integrins, G-protein coupled 
receptors (GPCR) and caveolin, resulting in the activation of a variety of kinases, 
including Lck, Src, FAK and ERK (258).     
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 Because uPAR plays a multifaceted and critical role during NGF-
dependent differentiation, we were particularly intrigued by our previous finding 
that SH2B1β influences the expression of uPAR in response to NGF (124).  The 
overexpression of SH2B1β greatly enhances both the NGF-dependent increase 
in levels of uPAR transcript and neurite outgrowth.  Conversely, overexpression 
of SH2B1β(R555E) inhibits both NGF-dependent transcription of uPAR and 
neurite outgrowth, compared to control cells.  These data suggest that SH2B1β 
facilitates neuronal differentiation at least in part by enhancing the NGF-
dependent transcription of the immediate early gene uPAR encoding uPAR and 
either directly or indirectly enhances transcription of the genes encoding MMP-3 
and 10.   In support of this hypothesis, we show here that knocking down the 
levels of endogenous SH2B1 blocks NGF-dependent neurite outgrowth in 
addition to inhibiting the NGF-dependent expression of uPAR, Mmp3, and 
Mmp10 (124).  Because the expression of SH2B1β(mNLS) also blocks NGF-
induced neurite outgrowth, we postulate that SH2B1β is required in the nucleus 
for the appropriate transcription of uPAR and potentially other genes required for 
NGF-dependent differentiation.  Our finding that expression of SH2B1β(mNLS) 
fails to enhance transcription of uPAR mRNA after NGF stimulation supports the 
notion that nuclear import of SH2B1β is required for that transcription and 
suggests a more direct role for SH2B1β in NGF-induced transcription of uPAR.  
We also show that expression of the nuclear export mutant [SH2B1β(ΔNES)] also 
fails to enhance uPAR transcription after NGF treatment, which suggests that 
nucleocytoplasmic shuttling of SH2B1β is required for the enhanced transcription 
of critical NGF-target genes required for enhanced neurite outgrowth.  The stable 
expression of the mutants SH2B1β(mNLS) (FIG. 4.8) or SH2B1β(ΔNES) (79) did 
not result in appreciable differences in the NGF-mediated phosphorylation of 
ERKs, when compared to the stable expression of SH2B1β(WT).  Therefore, we 
believe the deficits observed in neurite outgrowth and transcription of NGF-target 
genes upon expression of these mutants are specific to the inability of SH2B1β to 
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enter and or exit the nucleus, and are not a consequence of SH2B1β(mNLS) or 
SH2B1β(mNES) compromising an NGF/TrkA signaling cascade.  The precise 
mechanism by which nuclear SH2B1β facilitates the NGF-dependent induction of 
specific genes is unknown.  However, in a previous study, overexpression of 
SH2B1β(WT) enhanced the nuclear translocation of FoxO1 to the cytoplasm in 
response to NGF (245), which raises the possibility that SH2B1β could shuttle 
activators or repressors of transcription into or out of the nucleus.  Alternatively, 
one could envision SH2B1β serving as a co-activator protein which functions to 
recruit specific transcriptional regulators to the promoter of NGF immediate-early 
genes.  Further study is required to determine the precise nuclear function of 
SH2B1β. 
 The finding that SH2B1β is required to shuttle into and out of the nucleus 
to facilitate NGF-dependent differentiation is especially interesting when 
considering the “dominant negative” nature of the SH2B1β(R555E) mutant.  
SH2B1β(R555E) was previously hypothesized to block neurite outgrowth by 
competing with endogenous SH2B1β for downstream effector(s) and 
sequestering these putative effector(s) in an inactive state (68).  The current 
finding that SH2B1β(R555E) is unable to translocate to the nucleus and thus 
undergo nucleocytoplasmic shuttling, offers an additional or alternative 
explanation as to why SH2B1β(R555E) inhibits NGF-dependent neurite 
outgrowth.  Nucleus excluded SH2B1β mutants would still be expected to 
dimerize with endogenous SH2B1β in the cytoplasm through the N-terminal 
phenylalanine-zipper (259), potentially preventing endogenous SH2B1β from 
entering the nucleus.   
 For proteins that contain both an NLS and NES, one would expect the 
balance between nuclear export and import to be subjected to some type of 
regulatory mechanism(s). Phosphorylation in particular has been shown to alter 
NLS and/or NES activity (260) (261).  In SH2B1, the NLS appears more likely 
than the NES to be a target for regulatory post-translational phosphorylation as 
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the NLS is surrounded by several putative Ser/Thr phosphorylation sites.  If NGF-
dependent phosphorylation of the NLS proximate sites is required for the nuclear 
translocation of SH2B1, it could explain why the phosphorylation deficient 
SH2B1β(R555E) is excluded from the nucleus.  Charge disruption at the critical 
arginine residue within the FLVR motif abolishes the phosphotyrosine binding 
ability of an SH2 domain (262).  The arginine to glutamate mutation, therefore, 
abolishes the NGF-dependent association between SH2B1β(R555E) and 
activated and tyrosyl phosphorylated TrkA (33).  As a result, the SH2B1β(R555E) 
is devoid of any detectable tyrosyl phosphorylation and its Ser/Thr 
phosphorylation is also dramatically reduced (33).  The R555E mutation in 
SH2B1β might also alter its folding and/or binding to a separate, currently 
unknown protein, which results in the masking of the NLS. 
   The continuous compartmental cycling of SH2B1β is consistent with a 
newfound trend for signaling molecules.  In contrast to conventional thought that 
signaling molecules only translocate to the nucleus after their “activation” by a 
particular signal, the latent unphosphorylated and “inactive” STAT2 is now 
thought to undergo constant shuttling between the cytoplasm and nucleus (263).  
Similarly, what was once believed to be a TGF-β-mediated translocation from the 
cytoplasm to the nucleus of the receptor-regulated Smad (R-Smad) family of 
proteins, has recently been shown to be a continuous cycling process 
independent of TGF-β stimulation (264) (265).   A TGF-β-dependent 
phosphorylation of the R-Smads allows a nuclear R-Smad/Smad4 complex to 
persist, giving rise to a prolonged and observable nuclear presence (264).  
Conversely, functional NESs have been described for several transcription 
factors originally thought to localize only in the nucleus.  For transcriptional 
regulators Oct-6, Sox9, and Sox10, disabling their nuclear export reduced their 
transactivation abilities (266) (267) (268).  It is not clear as to what, access to the 
cytoplasm and nucleus affords these transcription factors.   
 In summary, we have demonstrated that the adaptor protein SH2B1β is 
required for NGF-mediated differentiation of PC12 cells in a manner distinct from 
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that of facilitating the activation ERKs 1 and 2.  In addition to the previously 
described nuclear export sequence, we identified a functional nuclear localization 
sequence in SH2B1.  Blocking SH2B1β nuclear localization resulted in the 
inhibition of NGF-dependent neurite outgrowth.  Furthermore, the recently 
identified ability of SH2B1β to enhance transcription of the NGF-responsive 
genes uPAR, Mmp3, and Mmp10 was blocked by disrupting either the nuclear 
import or export of SH2B1β.  These findings suggest that SH2B1β requires 
access to both the nucleus and cytoplasm in order to facilitate NGF-mediated 
morphological and biochemical changes, raising the possibility that SH2B1β 
directly facilitates transcription of genes required for differentiation.   
 Our findings are consistent with an increasing amount of recent 
experimental evidence that signaling molecules actively undergo dynamic 
translocations and reversible bindings in order for specific and successful signal 
transmission (269).  Such findings exemplify a major departure from the classical 
“hardwired signaling concept” wherein receptors and their corresponding 
signaling/adapter proteins stay more-or-less in place while secondary 
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Chapter 5 
SH2B1 Associates with Transcription Factor CDCA7 upon NGF 
Stimulation and Rescues Inhibition of Neurite Outgrowth 




 For several years, SH2B1β has been known to cycle in and out of the 
nucleus, although its precise function within the nucleus was unknown.  In this 
report, we describe the identification of a novel nuclear binding partner for 
SH2B1.  Using a biochemical screen in NGF-treated PC12 cells, we pulled down 
the putative oncogenic transcription factor CDCA7 with a TAP-SH2B1β fusion 
protein.  The association between CDCA7 and SH2B1 was confirmed by co-
immunoprecipitation of overexpressed CDCA7 with endogenous SH2B1 after 
NGF stimulation.  The co-immunoprecipitated SH2B1 has a molecular weight of 
110,000, appropriate for a highly phosphorylated form of SH2B1β or possibly a 
different SH2B1 isoform.  The delta isoform of SH2B1 was tested for its capacity 
to bind CDCA7, because SH2B1δ has a similar molecular weight as the co-
precipitating SH2B1.  We observed steady-state localization of SH2B1δ at the 
plasma membrane, nucleoplasm, and nucleolus.  Overexpressed CDCA7 was 
able to co-immunoprecipitate SH2B1δ in an NGF-dependent manner.  
Interestingly, we found that overexpression of CDCA7 inhibits NGF-induced 
neurite outgrowth and that SH2B1β is able to rescue that inhibition.  In contrast, 
overexpression of SH2B1δ with CDCA7 caused a new NGF-dependent 
phenotype of large flattened cells and increased filapodia.  Collectively, these 
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findings suggest that SH2B1β may relieve the actions of a pro-mitogenic 
transcription factor, allowing the cells to undergo neurogenic changes in 




 A substantial portion of our understanding concerning the differentiation 
and survival of sympathetic neurons in response to nerve growth factor (NGF) 
has come from work using the PC12 cell line.  This cell line was derived from a 
rat pheochromocytoma and has been used extensively as a model of both 
neuronal function and neuronal differentiation.  Upon NGF-mediated activation of 
the PC12 cell’s endogenous receptor tyrosine kinase TrkA, the PC12 cells 
undergo a dramatic transformation from a rounded appearance into a neurite 
bearing sympathetic-like neuron (16).  Additionally, the NGF-mediated 
differentiation of the PC12 cells leads to the transcription of many neuronal 
specific markers (17) as well as a dependence upon NGF for survival, both of 
which have been well documented in sympathetic and sensory neurons (180).  At 
a molecular level, several pathways relevant to the process of NGF-mediated 
differentiation and survival have been elucidated.  In response to the NGF-
induced activation and autophosphorylation of TrkA, several signaling proteins 
directly associate with TrkA at conserved phosphotyrosine residues (28), 
including phosphatidylinositol 3-kinase (PI3K), Shc (102), phospholipase Cγ 
(PLCγ) (104), FRS2 (243), Grb2 (270), Csk homologous kinase (CHK) (271), and 
the atypical PKC-interacting protein (129).  Several of these proteins form 
signaling complexes that precisely regulate the activity of downstream targets 
such as ERK.  Indeed, prolonged ERK signaling has been reported to play an 
essential role in NGF-induced differentiation as opposed to the transient 
activation of ERK by epidermal growth factor (EGF), which leads to cell 
proliferation (24-27).  Active ERKs translocate to the nucleus to phosphorylate 
and transcriptionally activate several transcription factors, including Elk1 (272, 
273) and cAMP response element-binding protein (CREB) (274).  Interestingly, 
within an hour of NGF treatment, PC12 cells induce transcription of early growth 
response-1 (Egr1) (122) a known immediate-early gene of both NGF and EGF 
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(201, 275-277).  However, within the same time period, NGF also induces 
transcription of the immediate-early gene VGF and urokinase plasminogen 
activator receptor (uPAR), neither of which are induced by EGF (122).  Several 
subsequent studies have focused on uPAR because it is one of the only known 
immediate-early genes that is required for NGF-mediated differentiation.  Recent 
characterization of the uPAR promoter revealed that NGF-induction of uPAR 
depends upon an AP-1 site that is preferentially bound by transcription factors 
JunB and c-Fos (242) whose expression is known to be induced by ER1/2 
phosphorylation of .  However, it is unclear how the cell translates the temporal 
differences in ERK activity into the resulting ligand-specific transcription causal 
for neuronal differentiation.  For this reason it seems likely that there is an 
additional, as of yet unidentified, receptor specific control that works in concert 
with the NGF-dependent prolonged ERK activation. 
 We recently reported that SH2B1β, an adaptor molecule that binds to 
NGF-activated TrkA (33, 34), contains both a nuclear localization sequence 
(NLS) and nuclear export sequence (NES) and undergoes nucleocytoplasmic 
shuttling (79) [Maures, T., Chen, L., and CarterSu, C., submitted manuscript].  
This was a surprising finding because SH2B1β was thought to localize and 
function only at the plasma membrane.  Further examination of SH2B1β revealed 
that nuclear shuttling of SH2B1β is required for NGF-dependent differentiation of 
PC12 cells, suggesting that NGF-induced differentiation involves direct 
enhancement of NGF-induced gene expression by SH2B1.  In support of this, the 
overexpression of SH2B1β was found to enhance a subset of NGF-responsive 
genes including the immediate-early gene uPAR.  Disruption of either the nuclear 
import or nuclear export of SH2B1β blocks its ability to enhance uPAR 
transcription in response to NGF [Maures, T., Chen, L., and CarterSu, C., 
submitted manuscript].  We hypothesized that SH2B1β cycling between the 
nucleus and plasma membrane provides needed inter-compartmental 
communication to preferentially activate NGF-induced immediate-early genes.   
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 To gain insight into SH2B1β’s role in the nucleus, we sought to identify 
nuclear SH2B1 binding partners.  Here we report the discovery of cell division 
cycle associated (CDCA7/JP01) protein as a novel nuclear binding partner for 
SH2B1.  CDCA7 was initially identified as a c-Myc responsive gene that 
participates in neoplastic transformation (125).  Recently, CDCA7 was found to 
contain a potent transactivation domain within its C-terminal end, and was 
concluded to function as a transcriptional regulator in the oncogenic pathway 
(278).  CDCA7 overexpression was also reported to drive anchorage 
independent growth in Rat1a cells (125).  While there have been no published 
roles for CDCA7 in neurons, several NCBI GEO microarray profiles have 
revealed CDCA7 transcript in mouse astrocytes as well as in PC12 cells.  
Interestingly, a particular GEO profile (GDS1038) demonstrated a significant 
reduction in CDCA7 transcript levels after forskolin treatment of PC12 cells, 
which is known to facilitate neurite outgrowth (279).   
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 Consistent with this finding, we demonstrate that CDCA7 expression in 
PC12 cells inhibits NGF-dependent neurite outgrowth.  We show that in response 
to NGF, CDCA7 associates with an endogenous form of SH2B1 that has a 
molecular weight of 110,000.  This 110 kDa form of SH2B1 most likely represents 
a highly phosphorylated SH2B1β (the predominant isoform in PC12 cells) but 
could also be a larger molecular weight isoform of SH2B1 (i.e. SH2B1δ).  We 
show that SH2B1δ is also able to associate with CDCA7 in a NGF-dependent 
manner.  Curiously, we found that SH2B1δ localizes to the nucleolus as well as 
the plasma membrane.  The sub-nuclear localization of SH2B1δ is most likely 
mediated by an isoform specific bipartite NLS in its C-terminus.  We found that 
SH2B1β is able to rescue CDCA7 inhibition of NGF-neurite outgrowth.  While 
SH2B1δ does not similarly restore neurite outgrowth to CDCA7 expressing cells, 
SH2B1δ does cause an NGF-dependent morphological change characterized by 
large, flattened cellular bodies and increased filapodia.  Collectively, these 
findings suggest that SH2B1 may relieve the actions of a pro-mitogenic 
transcription factor, allowing the cells to undergo neurogenic changes in 
response to NGF. 
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Materials and Methods 
 
 Antibodies and reagents.  Polyclonal antibody to rat SH2B1 (αSH2B1), 
kind gift of Dr. Liangyou Rui (University of Michigan), was raised against an 
SH2B1β glutathione S-transferase fusion protein and used at a dilution of 1:1000 
for Western blotting (Duan, 2004).  Antibodies that recognize the following 
proteins were used for Western blotting: IRDye800 conjugated, affinity purified 
anti-GFP was used at a dilution of 1:20,000 to visualize GFP (Rockland 
Immunochemicals Inc., Gilbertsville, PA).  Ascites containing anti-mouse myc 
monoclonal antibody, produced by the University of Michigan Michigan Diabetes 
Research and Training Center Hybridoma Core, was used for immunoblotting (at 
a dilution of 1:10000) and immunostaining (at a concentration of 1:1000). The 
secondary antibodies IRDye 800 and IRDye 700 conjugated affinity purified anti-
mouse IgG and anti-rabbit IgG (Rockland) and Alexa Fluor 680-conjugated anti-
rabbit IgG (Invitrogen, Carlsbad, CA) were used at a final dilution of 1:20,000.  
For immuocytochemistry, anti-myc staining was visualized using Alexa Fluor 594-
conjugated anti-mouse IgG (Invitrogen).  NGF and rat-tail collagen I were 
purchased from BD Bioscience (San Diego, CA). 
 
 Plasmids.  All SH2B1β constructs were subcloned into pEGFP C1 
(CLONTECH Laboratories, Inc.).  cDNAs encoding GFP tagged SH2B1β, GFP-
SH2B1β(ΔNES) (lacking region required for nuclear export), GFP-
SH2B1β(mNLS1) (mutated nuclear localization sequence), and SH2B1β(R555E) 
have been described previously (33) (79) [Maures, T., Chen, L., and Carter-Su, 
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C., submitted manuscript]. The full coding region of CDCA7 was then PCR 
amplified to include the flanking restriction sites, XbaI and HindIII.  Using these 
same restriction sites, CDCA7 was subcloned into Prk5-myc vector.  This same 
method was used to clone CDCA7 into pEGFP-C1, using BglII and HindIII as the 
restriction sites.  The pmCherry-C1 construct was  purchased from Clontech, 
Mountain View, CA.  cDNA encoding the full length sequence of SH2B1δ 
(PSM/SH2-Bδ) was provided by Dr. Heimo Riedel (West Virginia University).  The 
full coding region of SH2B1δ was PCR amplified to include the flanking restriction 
sites, XbaI and HindIII.  The product was subcloned into the pmCherry-C1 vector 
using the same restriction sites.  Site directed mutagenesis was performed using 
the primers described previously to generate mCherry-SH2B1δ(R555E) (33), and 
mCherry-SH2B1δ(mNLS1) [Maures, T., L. Chen, and C. Carter-Su, submitted 
manuscript]. 
 
 N-terminal TAP-tag Construction.  Rat SH2B1β was subcloned into the 
pEBB-NTAP vector (gift from Dr. Colin Duckett, University of Michigan).  The 
NTAP-SH2B1β fusion protein was then digested from the pEBB vector and 
subcloned into the retroviral pLNCX2 vector using the restriction sites XhoI and 
NotI.  cDNA of an EST containing the full coding region of CDCA7 was 
purchased from Open Biosystems (AI:  BC098690.1).   
 
 Cell culture and Cell Lines.  The parental PC12 cells were obtained from 
American Type Culture Collection (ATCC) (Rockville, MD).  PC12 cells were 
plated on collagen-coated plates (0.1 mg/ml rat tail collagen in 0.02 N acetic acid) 
and grown at 37°C in 10% CO2 in normal growth medium containing Dulbecco’s 
Modified Eagles Medium (DMEM) (Invitrogen), 10% heat-inactivated horse serum 
(ICN) and 5% fetal bovine serum (Invitrogen), 1 mM L-glutamine, and 1 mM 
antibiotic-antimycotic (Invitrogen).  PC12 cells were transfected using a Gene 
Pulser Xcell electroporator (400V, 500µF) in a 0.4 cm cuvette (Bio-Rad).  After 
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5h, cells were washed with phosphate buffered saline and fresh growth medium 
was added. 
 PC12 cells stably expressing the TAP-SH2B1β fusion protein were made 
in the following manner:  PC12 cells were subjected to retroviral infection of 
pLNCX2-NTAP-SH2B1β, according to Erickson et al. (280).  In brief, the 
pLNCX2-NTAP-SH2B1β construct along with the viral packaging vectors SV-E-
MLV-env and SVΨ-E-MLV (281) was transfected into 293T cells by calcium 
phosphate precipitation.  Virus-containing medium was collected 16h after 
transfection and passed through a 0.45-µm syringe filter.  Polybrene was added 
to a final concentration of 8 µg/ml.  This medium was then applied to 
subconfluent (40%) PC12 cells.  The infection protocol was repeated 3X at 
intervals of 12 h.  When cells achieved 80% confluence, they were trypsinized, 
replated, and stably selected in medium containing 5 mg/ml G418 for 4 weeks.  
The surviving cells were cultured in normal growth medium supplemented with 5 
mg/ml G418. 
 
 Differentiation of PC12 cells.  To assess differentiation, PC12 cells were 
plated on six-well, collagen-coated plates.  The cells were grown in differentiation 
medium (DMEM containing 2% horse serum, 1% fetal bovine serum, and 50ng or 
100ng of NGF per ml medim was replaced every 2 days until cellular 
differentiation was assessed at day 4.  Cells with neurite length at least twice the 
diameter of the cell body were scored as differentiated cells.  The percentage of 
differentiated cells was determined by dividing the number of morphologically 
differentiated cells by the total number of cells counted.  
 
 TAP screening.  PC12 cells stably expressing pLNCX2-NTAP-SH2B1β 
were seeded in 22 plates (15 cm) and grown to near confluence.  The TAP 
procedure was performed as described previously (282, 283) with the following 
changes:  cells were incubated in serum-free medium overnight and then treated 
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with 100 ng/ml NGF for 1 h; Cell lysis was accompanied with two rounds of flash 
freezing with liquid nitrogen.  Proteins in the final eluate from the purification was 
precipitated by adding 10% TCA in acetone and incubating overnight at -20 °C.  
The precipitate was collected by centrifugation at 4 °C (10,000 x g for 30 min) 
and rinsed in 100% acetone.  The precipitate was then submitted to the Michigan 
State University Proteomics Core for tryptic digestion, HPLC separation and 
tandem mass spectrometry (MS/MS) to determine peptide sequences. 
 
 Immunolocalization.   After transfection of cDNA by electroporation the 
cells were incubated for 24h before cells were washed in PBS and fixed with 4% 
paraformaldehyde.  Coverslips were mounted onto slides with Prolong (Molecular 
Probes).  Cells were incubated with 2 ng of DAPI per ml for 10 min to visualize 
nuclei.  The subcellular distribution of the various GFP-SH2B1 or mCherry-
SH2B1 proteins was determined by fluorescence microscopy.  The cells were 
visualized by fluorescence microscopy (Nikon Eclipse TE200) with either 20X or 
40X objectives.  Images were captured using a CoolSnap HQ digital camera 
(Roper Scientific) and viewed using MetaVue imaging software.  In FIG 5.4B and 
C, analysis of SH2B1β and SH2B1δ was performed with an Olympus FluoView 
500 laser scanning confocal microscope using a 60X oil-immersion objective and 
FluoView software. 
 
 Cell lysis, immunoprecipitation and immunoblotting.  PC12 cells were 
washed three times with chilled PBSV (10 mM sodium phosphate, 137 mM NaCl, 
1 mM Na3VO4, pH 7.4) and solubilized in lysis buffer (50 mM Tris, 0.1% Triton X-
100, 150 mM NaCl, 2 mM EGTA, 1 mM Na3VO4, pH 7.5) containing 1 mM 
phenylmethylsulfonyl fluoride, 10 mg/ml aprotinin, 10 mg/ml leupeptin, and 25 
mM NaF.  The lysates were then sonicated 4X with a 15 sec pulse (level 4) using 
a Hert Systems sonicator (Misonix Inc., Farmingdale, NY).  The solubilized 
material was centrifuged at 16,750 x g at 4oC for 10 min.  For 
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immunoprecipitations, the supernatant (cell lysate) was incubated with the 
indicated antibody on ice for 2 h.  The immune complexes were collected on 40 
ml of protein A-agarose for 1 h.  The beads were washed three times with lysis 
buffer and boiled for 5 min in a mixture (80:20) of lysis buffer and SDS-PAGE 
sample buffer (250 mM Tris-HCl, 10% SDS, 10% b-mercaptoethanol, 40% 
glycerol, 0.01% bromophenol blue, pH 6.8).  The solubilized proteins were 
separated on SDS-PAGE gels, transferred to nitrocellulose, immunoblotted with 
the indicated antibody, and detected using an Odyssey Infrared Imaging System 
(LI-COR Biosciences, Lincoln, NE).  Immunoblots were quantified using LiCor 




Biochemical Screen for SH2B1 Interacting Proteins 
 To further understand the role of SH2B1β during NGF-mediated 
differentiation of PC12 cells, we employed a biochemical screen to identify 
binding partners of SH2B1β based on the TAP method that has been previously 
described (282).  Briefly, SH2B1β was cloned in-frame to N-terminal TAP-tag 
vector consisting of an N-terminal protein-A (ProtA) and a calmodulin binding 
domain (CBD) separated by a tobacco etch virus (TEV) cleavage site. The 
resulting TAP-tagged SH2B1β construct was then subcloned into the retroviral 
packaging vector, pLNCX2.  We created a PC12 cell line that stably expresses 
TAP-SH2B1β (see Methods), incubated the TAP-SH2B1β cells  in serum-free 
medium overnight, and then treated them with 100 ng/ml of NGF for 30 min.  
TAP-SH2B1β was purified from whole cell lysates using two sequential 
chromatography columns.  The first column contained IgG-beads that selectively 
bind and retain the protein-A tag (as shown in FIG. 5.1A).  The column was then 
incubated with tobacco etch virus (TEV) protease, which cleaves the fusion 
protein, thereby freeing the calmodulin binding domain (CBD)-tagged SH2B1β 
and associated proteins.  The eluate was then added to a column containing 
calmodulin beads and washed.  Bound proteins were eluted with calmodulin 
elution buffer containing 2mM EGTA.  The resulting proteins were TCA-
precipitated and subjected to tryptic digestion, HPLC separation, and 
identification by tandem mass spectrometry (MS/MS).  Several peptides 
corresponding to SH2B1β-binding proteins were identified.  As indicated in FIG. 
5.1B, SH2B1 was identified in this screen.  The presence of SH2B1 is mostly 
likely due to the overexpression of TAP-SH2B1β, but SH2B1 is known to 
homodimerize and thus may also represent endogenous SH2B1 pulled down in 
the purification.  In either case, the identification of SH2B1 serves as a proof of 
concept for the screen.  We also identified calmodulin, which is a well know  
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FIG. 5.1.  CDCA7 was identified in a biochemical screen for SH2B1 
interacting proteins.   
(A) Schematic representation of the TAP-tagged SH2B1β construct.  The TAP-tag consists of a 
Protein-A fragment (ProtA) and a Calmodulin Binding Domain (CBD), intersected by a tobacco 
etch virus (TEV) cleavage site.  (B) The indicated proteins from the screen were trypsinized and 
HPLC separated before their identification by mass spectrometry.  GI# of the matching peptides 
are indicated on the right.  Query number represents the number of times the protein was 
identified out of 734 total queries.  (C) Schematic representation of Cell Division Cycle 
Associated-7 (CDCA7) protein was pulled down in the screen.  CDCA7 has been previously 
characterized as a transcription factor, containing a leucine zipper (LeuZip), a cysteine-rich region 
(Cys), and a C-terminal transactivation domain. 
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artifact of the TAP procedure.  Interestingly, we identified 2 known nuclear 
proteins:  DNA polymerase (zeta) and cell division cycle associated-7 (CDCA7) 
(FIG. 5.1B).  In accordance with our hypothesis that SH2B1β may interact/shuttle 
transcriptional regulators into or out of the nucleus, we focused our efforts on 
CDCA7 which has been hypothesized to be a putative transcription factor. 
 
The Identification of CDCA7 as a Novel Nuclear Binding Partner of SH2B1  
 CDCA7 (JP01) has only been moderately characterized in the literature.  It 
was first identified as a c-Myc-responsive gene that is able to drive anchorage-
independent growth in Rat1a cells (125).  In addition to a leucine-zipper motif and 
a cysteine-rich region, CDCA7 was described as containing a C-terminal 
transactivation domain (includes the cysteine rich region) (278) (FIG. 5.1C).   
 To characterize CDCA7 localization and determine the morphological 
consequence of expressing CDCA7 within PC12 cells, we purchased an EST 
clone containing the full length coding sequence of CDCA7 from Open 
Biosystems.  Rat CDCA7 was then subcloned into both myc and EGFP vectors.  
We transiently transfected myc-CDCA7 into PC12 cells and incubated the cells in 
normal growth medium (FIG. 5.2A) or serum-free medium overnight before 
adding 100 ng/ml NGF or EGF for 24 h (FIG. 5.2B and C).  The cells were fixed 
and immunostained for the presence of endogenous F-actin (to show cell 
morphology) or myc-CDCA7.  In FIG. 5.2, A, myc-CDCA7 (red nuclei) is localized 
exclusively in the nucleus of the transfected cell.  Similarly, after 24 h of NGF 
stimulation, myc-CDCA7 was also nuclear.  Curiously, we observed, but did not 
quantify at this point, the absence of observable neurites and a more rounded 
morphology in the cells expressing myc-CDCA7 (red nuclei) compared to the 
adjacent untransfected cells (FIG. 5.2, B).  Moreover, in all conditions, myc-
CDCA7 expressing cells often lifted from the plate to form living suspension 
aggregates.  As expected, stimulation with EGF did not induce neurite formation  
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FIG. 5.2.  CDCA7 is a nuclear protein in PC12 cells.   
PC12 cells were transiently transfected with myc-CDCA7 (red).  The cells were either incubated 
in growth medium for the duration of the experiment (A) or the cells were incubated in serum-free 
medium for 14 h before the addition of 100 ng/ml NGF (B) or 100 ng/ml EGF (C) for 24 h.  The 
cells were fixed and stained with αmyc and anti-mouse IgG Alexa 594.  All cells were also stained 
with Oregon Green conjugated phalloidin that recognizes F-actin to show actin cytoskeleton 
(green).  The two images are overlayed in the bottom panels. 
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of the PC12 cells and myc-CDCA7 was localized to the nucleus (FIG 5.2, C).  
These results indicate that CDCA7 is a nuclear protein with little to no observable 
cytoplasmic localization.  The observed decrease in adherence of the cells 
expressing CDCA7 appears to be consistent with its role as a transcriptional 
regulator that promotes anchorage independence in Rat1a cells (125).  The 
anecdotal observation that myc-CDCA7 expression inhibited NGF-induced 
formation of neurites raised the possibility that CDCA7 plays an opposing role to 
NGF-action in PC12 cells. 
 Although SH2B1β has been previously described to undergo 
nucleocytoplasmic shuttling, the steady-state appearance of SH2B1β is within 
cytoplasm and at the plasma membrane (79) [Maures, T., Chen, L., and 
CarterSu, C., submitted manuscript].  It is currently unknown how much time 
SH2B1β spends within the nucleus, or how much SH2B1β is present in the 
nucleus at any given time.  The fact that our TAP screen identified CDCA7, a 
bona fide nuclear protein, insinuated that SH2B1β is capable of forming 
biochemically detectable nuclear interactions.  To verify the results of the TAP 
screen and determine whether NGF regulates the association of SH2B1 with 
CDCA7, we overexpressed myc-CDCA7 in PC12 cells, and incubated the cells 
first in serum-free medium overnight and then in the absence or presence of NGF 
(100 ng/ml) for 30 min.  Proteins in the cell lysates were immunoprecipitated with 
αmyc and immunoblotted with αSH2B1.  NGF stimulated the binding of myc-
CDCA7 to a 110 kD form of endogenous SH2B1 (FIG. 5.3, top panel).  As shown 
in FIG. 5.3 of lanes 1 and 2 (middle panel), in the absence of NGF, SH2B1β 
migrates as a ~90 kDa protein.  NGF induces a significant upward shift in the 
mobility of SH2B1β, up to 110 kDa (FIG. 5.3, lane 3, middle panel).  Previous 
studies indicate that the upward shift in mobility is due to phosphorylation of 
SH2B1β on tyrosines and serines/threonines (95).  Taken together, these results 
suggest that myc-CDCA7 associates with a 110 kDa, highly phosphorylated, form 




FIG. 5.3.  NGF stimulates the association of CDCA7 and a 110 kDa form of 
SH2B1.   
PC12 cells overexpressing myc-CDCA7 (lanes 2 and 3) were incubated with (+) or without (-) 100 
ng/ml NGF for 30 min.  Myc-CDCA7 present in cell lysates was immunoprecipitated with αmyc 
and coprecipitating SH2B1 was immunoblotted with αSH2B1 (top panel). present in (lanes 2 and 
3)Cell lysates were immunoblotted with αSH2B1 to show expression of endogenous SH2B1, and 
αmyc to show levels of expression of myc-CDCA7 (bottom panel). 
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Identification of SH2B1δ  as a Novel Nucleolar Protein in PC12 Cells  
 Although the aforementioned data is consistent with myc-CDCA7 
associating with a highly phosphorylated form of SH2B1β, it is possible that 
CDCA7 associates with a different isoform of SH2B1.  Of the other three SH2B1 
isoforms, SH2B1α and SH2B1δ have predicted molecular weights most similar to 
the band identified in the co-immunoprecipitation.  As previously reported, the 
different SH2B1 isoforms arise through alternate splicing and differ only at the C-
terminal end (46).  While each is predicted to have the same NLS and NES as 
SH2B1β, SH2B1δ possesses a unique region that contains two separate putative 
nuclear localization sequences (NLS)s (46).  Upon further examination of the 
motif, we found that this region more closely resembles that of a bipartite NLS, 
which contains two clusters of basic residues separated by a variable length 
spacer (10-12 a.a.) (254). Because SH2B1δ also contains the N-terminal NLS as 
described for SH2B1β [Maures, T., Chen, L., and CarterSu, C., submitted 
manuscript], the presence of a second NLS had the potential to shift the steady 
state localization of SH2B1δ to the nucleus.  To address this possibility, SH2B1δ 
was subcloned into an mCherry vector and expressed in PC12 cells.  As shown 
in FIG. 5.4A, i, Cherry expression is distributed evenly throughout the cell.  In 
contrast, Cherry-SH2B1δ(WT) demonstrates a striking localization to the sub-
nuclear region of the nucleolus as well as the plasma membrane (FIG. 5.4A, ii).  
To determine which of the two NLSs was responsible for localizing SH2B1δ to 
the nucleoulus, we next expressed SH2B1δ carrying mutations to the SH2 
domain (SH2B1δ(R555E)) and N-terminal NLS (SH2B1δ(mNLS1)) regions.  
Mutation of either domain halts the nuclear localization of SH2B1β, as previously 
described [Maures, T., Chen, L., and CarterSu, C., submitted manuscript].  In 
contrast to SH2B1β(R555E) and SH2B1β(mNLS1), SH2B1δ(R555E) and 
SH2B1δ(mNLS1) are still able to localize to the nucleus (FIG. 5.4A, iii and iv).  
While we have not yet directly tested it, this result indicates that the sequence 
resembling a bipartite NLS present in the  
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FIG. 5.4A and B.  Identification of SH2B1δ  as a novel nucleolar protein in 
PC12 cells.   
(A) PC12 cells were transiently transfected with (i) Cherry vector control, (ii) Cherry-SH2B1δ(WT), 
(iii) Cherry-SH2B1δ(R555E), or (iv) Cherry-SH2B1δ(mNLS1).  Images were taken using 
epifluorescence microscopy.  (B) PC12 cells were transiently transfected with (i) GFP-
SH2B1β(WT), (ii) GFP-SH2B1β(ΔNES), or (iii) GFP-SH2B1β(mNLS1).  Fourteen h post 
transfection, the cells were fixed and stained with DAPI to show nuclei.  GFP expression is 
visualized in the FITC panels on the left.  The images were obtained using a laser scanning 
confocal microscope.   
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unique C-terminus of SH2B1δ most likely mediates the nuclear localization of 
SH2B1δ.  The subcellular localization of SH2B1δ was so different from that of 
previously reported for SH2B1β, we reassessed the subcellular localization of 
GFP-tagged SH2B1β(WT), SH2B1β(ΔNES), and SH2B1β(mNLS1) using 
confocal microscopy.  As show in FIG. 5.4B, i, GFP-SH2B1β(WT) demonstrates 
a steady state subcellular localization at the plasma membrane.  Deletion of the 
nuclear export sequence within SH2B1β (SH2B1β(ΔNES)) results in its nuclear 
accumulation, however, SH2B1β(ΔNES) does not display any specific sub-
nuclear localization to the nucleolus (FIG. 5.4B, ii).  As expected, 
SH2B1β(mNLS1) localized to the plasma membrane an cytoplasm [Maures, T., 
Chen, L., and CarterSu, C., submitted manuscript]. 
 We next assessed using confocal microscopy whether there was any 
positional overlap between the isoforms.  In contrast to GFP-SH2B1β alone 
which localizes to the plasma membrane (FIG. 5.4B, i), Cherry-tagged SH2B1δ 
alone is found at the plasma membrane and in both the nucleoplasm and 
nucleolus (FIG. 5.4C, i).  However, the co-expression of Cherry SH2B1δ(WT) 
with GFP-SH2B1β(WT), led SH2B1β(WT) to co-localize with SH2B1δ(WT) within 
the nucleolus in addition to the plasma membrane (FIG. 5.4C, ii).  Co-expression 
of GFP-SH2B1β(ΔNES) with Cherry-SH2B1δ resulted in a similar nucleolar co-
localization (FIG. 5.4C, iii).  In contrast, GFP-SH2B1β mutants unable to undergo 
nuclear import (SH2B1β(R555E) and SH2B1β(mNLS)) failed to co-localize in the 
nucleolus with Cherry-SH2B1δ (FIG. 5.4C, 4 and 5).  These data regarding 
SH2B1δ indicate that the SH2B1δ isoform is a novel nucleolar protein.  However, 
SH2B1δ is also found at the plasma membrane and therefore is likely to cycle 
between these two locales.  Our data also indicate that SH2B1β and SH2B1δ co-
localize at the plasma membrane and that SH2B1β is capable of nucleolar 




FIG. 5.4C.  Identification of SH2B1δ  as a novel nucleolar protein in PC12 
cells.  
 (C) Confocal images of PC12 cells transfected with (i) Cherry-SH2B1δ(WT) alone or with the 
following (ii) GFP-SH2B1β(WT), (iii) GFP-SH2B1β(ΔNES), (iv) GFP-SH2B1β(mNLS1), (v) GFP-
SH2B1β(R555E).  As shown in Panel i), the Cherry signal (TRITC) does not cross into the GFP 
(FITC) channel.  Co-localization of the proteins produces a yellow color in the FITC+TRITC 
overlay.  The images were obtained using a laser scanning confocal microscope. 
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NGF Stimulates the Association of SH2B1δ  and CDCA7 
 Because the δ isoform is slightly larger and demonstrates a more 
pronounced nuclear localization than SH2B1β, SH2B1δ was considered the most 
likely alternative candidate for the endogenous 110 kDa SH2B1 pulled down by 
CDCA7.  To determine whether SH2B1δ is capable of associating with CDCA7, 
PC12 cells were transiently transfected with GFP-SH2B1δ and myc-CDCA7, 
incubated in serum-free medium for 14 h, and then in the absence or presence of 
NGF for 30 min.  Myc-CDCA7 was immunoprecipitated from cell lysates with 
αmyc and the presence of co-precipitating SH2B1δ assessed by immunoblotting 
with αSH2B1.  NGF treatment significantly enhanced the co-immunoprecipitation 
of GFP-SH2B1δ with myc-CDCA7 (FIG. 5.5).  Importantly, αmyc did not indirectly 
precipitate GFP-SH2B1δ when myc-CDCA7 was not expressed (FIG. 5.5, lane 
3).  Interestingly, myc-CDCA7 did not precipitate the 110 kDa form of SH2B1 in 
addition to GFP-SH2B1δ, which migrated as a ~140 kDa.  This may suggest that 
overexpressed GFP-SH2B1δ may out-compete endogenous SH2B1 for CDCA7 
binding or the transfection efficiency of myc-CDCA7 was too low to 
immunoprecipitate a sufficient amount of endogenous SH2B1.  
 
Preliminary Results Suggest SH2B1β  Rescues CDCA7-mediated Inhibition 
of NGF-Dependent Neurite Outgrowth 
 As mentioned previously, experiments designed to look at the subcellular 
localization of CDCA7 (FIG. 5.2) suggested that overexpression of CDCA7 might 
inhibit the formation of neurites in response to NGF treatment.   To test this more 
rigorously, we transiently expressed either GFP vector or GFP-CDCA7 in PC12 
cells and assessed the NGF-dependent neurite outgrowth of the GFP-positive 
cells after 4 days (FIG. 5.6A).  While ~24% of GFP expressing cells had neurites 
at least twice their cell body diameter, cells expressing GFP-CDCA7 had only 
~7% (FIG. 5.6A).  These results confirmed our earlier observation that GFP-  
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FIG. 5.5.  NGF stimulates the association of SH2B1δ  and CDCA7.   
PC12 cells were transiently transfected with cDNAs encoding GFP-SH2B1δ(WT) (lanes 1-3) and 
myc-CDCA7 (lanes 1-2).  The cells were incubated in serum-free medium overnight before 
stimulation with NGF for 30 min (lane 2).  Proteins from cell lysates were immunoprecipitated with 
αmyc and immunoblotted with either αSH2B1 or αmyc.  Cell Lysates (right panel) were 
immunoblotted with αSH2B1 to assess levels of GFP-SH2B1δ. 
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CDCA7 inhibits neurite outgrowth and suggest that CDCA7 may be a negative 
regulator of NGF-induced differentiation.  Because the nuclear localization of 
SH2B1β is required for NGF-dependent differentiation, it is possible that nuclear 
SH2B1 is required to relieve the inhibitory action of regulatory proteins which 
oppose NGF effects.  We therefore wanted to determine whether SH2B1β or 
SH2B1δ is able to rescue the inhibition of neurite outgrowth caused by CDCA7. 
The overexpression of myc-SH2B1β with GFP-CDCA7 not only rescued NGF-
mediated neurite outgrowth but it also enhanced it to ~40% (FIG 5.5A).  Co-
expression of myc-SH2B1β(R555E) with GFP-CDCA7 inhibited neurite outgrowth 
compared to GFP alone, as expected.  Next, we compared the ability of Cherry-
SH2B1δ to rescue GFP-CDCA7’s inhibition of NGF-dependent neurite outgrowth.  
After 4 days, there was no change in the morphology of the PC12 cells 
expressing both GFP-CDCA7 and Cherry-SH2B1δ cultured in the absence of 
NGF (not shown).  In contrast, after 4 days of NGF exposure, there was a 
significant morphological change in the cells co-expressing Cherry-SH2B1δ and 
GFP-CDCA7.  However, the phenotype that emerged from these cells was not 
quantifiable as differentiated neurons based on our criterion for morphological 
differentiation (neurite 2X length of cell body diameter) (FIG 5.6B).  The cells 
expressing both GFP-CDCA7 and Cherry-SH2B1δ were relatively large and 
displayed highly active cytoskeletons.  However, the processes at the leading 
edge of the cells were many, small, and disordered, which is more consistent 
with filapodia than neurite outgrowth.  Typically, after 4 days of NGF treatment, 
the filapodia are predominately concentrated at the leading edge of the neurite’s 
growth cone, although a discernable growth cone was not apparent in these cells 
(FIG 5.6).  Because of the difficulty in distinguishing between neurite outgrowth 
and filopodia as well as the confounding problem of the large cell body size, to 
address whether SH2B1δ overcomes the CDCA7-mediated inhibition of NGF-
induced differentiation, it will be necessary to test for the presence of neuronal 
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FIG. 5.6. Preliminary results suggest SH2B1β  rescues CDCA7-mediated 
inhibition of NGF-dependent neurite outgrowth.   
(A) PC12 cells transiently expressing GFP, GFP-CDCA7, GFP-CDCA7 + myc-SH2B1β, or GFP-
CDCA7 + myc-SH2B1β(R555E) were incubated in serum-free medium overnight before the 
addition of 100 ng/ml NGF for 4 days.  The percentage of differentiated cells was scored on day 
4.  The values represent the results from one experiment.  (B) PC12 cells expressing both 
Cherry-SH2B1δ and GFP-CDCA7 after 4 days of NGF treatment.  Panels 1 and 2 are images of 
representative phenotypes following the aforementioned conditions.  The TRITC (Cherry) panels 
are shown in gray-scale for better contrast. 
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specific markers found only in differentiated PC12 cells.  These preliminary 
results suggest that CDCA7’s inhibition upon NGF-dependent neurite outgrowth 




 SH2B1 was first identified in PC12 cells as a TrkA adaptor signaling 
protein that enhances NGF-mediated differentiation (33, 34).  Recent findings 
have indicated that SH2B1β enhances and is required for NGF-dependent 
differentiation in a manner that is independent of and/or possibly downstream of 
ERK signaling (33, 79, 124) [Maures, T., Chen, L., and CarterSu, C., submitted 
manuscript].  The ability of SH2B1β to elicit a novel pathway independent or 
downstream of ERKs 1 and 2 in response to NGF is underscored by the finding 
that SH2B1β undergoes nucleocytoplasmic shuttling.  Importantly, 
overexpression of nuclear import mutants of SH2B1β inhibit NGF-dependent 
neurite outgrowth and block the NGF-induced transcription of uPAR [Maures, T., 
Chen, L., and Carter-Su, C., submitted manuscript], an immediate-early gene 
required for NGF-mediated differentiation (122).  However, without any known 
nuclear target for SH2B1β, the mechanism by which SH2B1β facilitates this level 
of regulation was only speculative. 
 In this report, we describe the identification of CDCA7/JPO1, a novel 
nuclear binding partner for SH2B1.  CDCA7 was originally identified in a screen 
for c-Myc target genes (284).  As common with other c-Myc regulated genes, 
CDCA7 follows a cyclic expression profile that peaks during the G1/S phase 
transition of the cell cycle and was thus named cell division cycle associated-7 
(285).  CDCA7 contains a leucine zipper motif as well as a cysteine-rich region in 
the C-terminus that bares resemblance to a class of DNA binding proteins in 
plants (286).  In addition, the N-terminal region was reported to contain a 
transactivation domain capable of driving luciferase expression from a minimal 
promoter (278).  While thought to be a transcription factor, CDCA7 currently has 
no known target genes.  However, JPO2/R1, a protein with significant homology 
(45% identity) to CDCA7 (JPO1), demonstrates transcriptional repressor activity 
on the human monoamine oxidase A promoter (287).   
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 The identification of a putative transcription factor in our screen for 
SH2B1β interacting proteins was particularly interesting because of an earlier 
finding that SH2B1β influences the subcellular localization of FoxO1 (FKHR) 
transcription factor (245).  In the aforementioned study, SH2B1β promoted 
FoxO1 redistribution to the cytoplasm after NGF whereas SH2B1β(R555E), a 
mutant that cannot interact with TrkA, blocked NGF-dependent nuclear export of 
FoxO1 (245).  Because SH2B1β(R555E) did not block NGF-dependent 
phosphorylation of FoxO1, it did not appear that the failure of FoxO1 to 
redistribute to the cytoplasm was a result of deficient FoxO1 phosphorylation 
caused by SH2B1β(R555E) (245).  We recently demonstrated that 
SH2B1β(R555E) is unable to undergo nucleocytoplasmic shuttling [Maures, T., 
Chen, L., and Carter-Su, C., submitted manuscript], indicating that SH2B1β may 
need access to the nucleus in order to facilitate proper relocalization of FoxO1 to 
the cytoplasm.  In general, the FoxO1 results gave rise to our hypothesis that 
SH2B1β may regulate gene transcription by shuttling transcription factors into or 
out of the nucleus.  
  While we have been unable to establish an interaction between FoxO1 
and SH2B1β (data not shown), in this study, we have demonstrated an 
association between CDCA7 and SH2B1.  CDCA7 associates with an 
endogenous form of SH2B1 that migrates as a ~110 kDa protein.  Although the 
predominant SH2B1 isoform in PC12 cells is SH2B1β (245), the SH2B1 antibody 
used in this study cannot delineate between isoforms.  In an unstimulated state, 
SH2B1β migrates at a molecular weight of ~90 kDa.  A large mobility shift in 
SH2B1β is observed after stimulation with NGF, due to phosphorylation on Tyr 
and Ser/Thr residues (33, 68).  Peak phosphorylation of SH2B1β is reached 15-
30 min after NGF stimulation (68), resulting in the emergence of 3 or more 
variably phosphorylated species of SH2B1β, of which the largest runs as a 110 
kDa protein.  These results suggest that the 110 kDa SH2B1 co-precipitated with 
CDCA7 most likely represents the highest phosphorylated species of SH2B1β.  
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CDCA7 did not pull down any lesser phosphorylated forms of SH2B1, which 
indicates that the post-translational modifications of the 110 kDa SH2B1 are 
critical for the association.  These findings raise the possibilitiy that maximal 
phosphorylation of SH2B1 provides a conformational change required for the 
association of CDCA7 with SH2B1 and/or is required for nuclear translocation of 
SH2B1, allowing it to come in contact with nuclear CDCA7.   
 One of the reasons we tested the SH2B1δ isoform for its ability to 
associate with CDCA7 was that it potentially contained a second NLS.  SH2B1β 
contains a single NLS, although its presence in the nucleus is difficult to detect 
without inhibiting nuclear export.  We hypothesized that the presence of a second 
NLS might shift the steady state localization of SH2B1δ into the nucleus, making 
it more likely to interact with nuclear CDCA7.  Indeed, the overexpression of 
SH2B1δ in PC12 cells revealed a dramatic difference in the steady state 
subcellular localization of SH2B1δ versus SH2B1β..   
 The ability of SH2B1δ to localize within the nucleolus was, however, a 
surprising finding.  Although first observed over 200 years ago, the nucleolus is 
still a somewhat mysterious organelle.  The primary function of the nucleolus is 
thought to house ribosomal DNA (rDNA) as well as the machineries responsible 
for ribosomal subunit production (288).  However, the nucleolar presence of 
SH2B1δ does not necessarily implicate SH2B1 in ribosomal biogenesis.  Using 
confocal microscopy to analyze SH2B1δ localization within the nucleolus, we 
established that SH2B1δ is not homogeneously distributed (data not shown).  
SH2B1δ appears to localize in a similar manner as αnucleophosmin staining, 
which is a marker for the granular component of the nucleolus and the region 
containing most proteins.  Several lines of evidence suggest that the nucleolus 
has a wide range of roles in the cell, including the regulation of mitosis, 
proliferation, and stress response (288).   
 The insulin receptor substrate-1 (IRS-1) which was thought to function 
only at the plasma membrane, has also been observed to localize to the 
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nucleolus (289, 290).  In response to IGF-1, IRS-1 translocates to the nucleolus 
where it interacts with the upstream binding factor 1(UBF1) (289).  IRS-1 
stabilizes UBF-1 protein, thereby enhancing RNA polymerase-1 transcription of 
rRNA (290).  Because cell size is often determined by the amount of available 
protein, an increased production of rRNA (i.e. ribosome number) gives rise to 
increased protein synthesis and enlargement of the cell (290).  Wu et al. (290) 
concluded that the growth-promoting effects of IGF-1 on cell size are in part 
explained by the enhanced rRNA production by mediated by nucleolar localized 
IRS-1.  Much like overexpression of SH2B1β, the expression of SH2B1δ 
enhances NGF-dependent differentiation, but in the absence of NGF SH2B1δ 
does not result in significant phenotypic changes to the PC12 cell.  Only after its 
co-expression with CDCA7 and in the presence of NGF treatment was there 
observable morphological changes, without NGF, the cells displayed a typical 
undifferentiated morphology.  The noticeably large cell size after NGF treatment 
may indicate that SH2B1δ and CDCA7 work in concert to stimulate rRNA 
synthesis.   
 While these findings did not elucidate a function for SH2B1δ, they did 
identify SH2B1δ as a novel nucleolar protein in SH2B1δ.  In addition, the results 
from the co-expression of SH2B1δ and SH2B1β in PC12 cells may have 
important implications regarding what enables nucleolar localization.  Unlike 
membrane-bound organelles, the nucleolus is a freely diffusible entity (291).  
However, there is considerable controversy regarding what is responsible for 
keeping the protein in the nucleolus.  At the forefront of the debate is the 
questioned existence of a nucleolar localization signal (NoLS).  These NoLSs 
usually resemble that of a bipartite NLS (292).  Similarly, SH2B1δ contains a 
putative bipartite NLS and localizes to the nucleolus.  Does SH2B1δ stay in the 
nucleolus because of a NoLS or because it has a binding partner in the 
nucleolus?  SH2B1β does not contain a NoLS and it does not normally localize to 
the nucleolus, even after the NES is mutated (FIG. 5.4B, ii).  SH2B1β only 
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localizes to the nucleolus when SH2B1δ is present, which is most likely a result 
of dimerization between isoforms (259).  These results suggest two things:  1) 
SH2B1δ most likely localizes to the nucleolus via an NoLS; and 2) other isoforms  
of SH2B1 (e.g. SH2B1β) can access the nucleolus by binding to the δ isoform.  
This suggests that other proteins without NoLSs may reside in the nucleolus 
indirectly through interactions with nucleolar proteins. 
 CDCA7 does not appear to localize within the nucleolus.  In FIG. 5.6B, 2, 
the FITC panel demonstrates that GFP-CDCA7 is localized throughout the 
nucleoplasm except for the small dark indentation in the center of the nucleus, 
which corresponds to the nucleolar region (FIG. 5.6B, 2 right panel).  Instead, 
CDCA7 often appears to localize to the very outside perimeter of the nucleolus 
where we have identified a potential co-localization of SH2B1δ and CDCA7 (data 
not shown).  This resembles the finding that JPO2 (closely related to 
CDCA7/JPO1) forms ring-like structures around what appear to be nucleoli (293).  
Further immunocytochemistry experiments are required in order to confidently 
assess the co-localization.  Since only the very C-terminal portion of SH2B1 
differs among isoforms, it is likely that each isoform is capable of binding to 
CDCA7.  Thus, we were able to demonstrate an NGF-dependent association 
between overexpressed CDCA7 and overexpressed SH2B1δ.  The pertinent 
question is, which of the isoforms are expressed in PC12 cells?  While we have 
been unable to distinguish the presence of other isoforms by western blotting, 
RT-PCR detected transcripts of other SH2B1 isoforms (i.e. γ isoform), although to 
a lesser extent than SH2B1β (245). 
 In contrast to control PC12 cells that exhibit neurite outgrowth in response 
to NGF, the overexpression of CDCA7 resulted in rounded PC12 cells even after 
NGF treatment.  Additionally, the CDCA7 cells often lifted off the plate, forming 
living cell aggregates in the medium.  Characterized as an oncogenic 
transcription factor that drives anchorage independent growth, it is not surprising 
that CDCA7 would oppose the actions of NGF, which include cell growth, 
differentiation, and cessation of cell division.  However, the preliminary results of 
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the rescue experiment suggest that overexpression of SH2B1β(WT) is able to 
specifically restore NGF-dependent neurite outgrowth to CDCA7 expressing 
cells.  Moreover, SH2B1 associates with CDCA7 within 30 min of NGF and as 
mentioned previously, this is the critical window of time for transcriptional 
regulators to induce transcription of NGF-specific immediate-early genes.   
 Taken together, these results suggest SH2B1β shuttles continuously 
between the cytoplasm and nucleus of the PC12 cell.  Upon NGF stimulation, 
TrkA and downstream kinases are activated, which give rise to a maximally 
phosphorylated form of SH2B1β that cycles between the nucleus and cytoplasm.  
However, only this maximally phosphorylated form of SH2B1β associates with 
CDCA7 thereby relieving the actions of a pro-mitogenic transcription factor.  As 
hypothesized earlier for FoxO1, SH2B1β may facilitate CDCA7 inactivation by 
shuttling it out of the nucleus and into the cytoplasm.  Although we have not 
demonstrated cytoplasmic CDCA7 in the presence of SH2B1, it may be rapidly 
degraded once in the cytoplasm as reported for p53 (294).  The most obvious 
starting point for future experiments will be to assess whether CDCA7 affects 
NGF-induced transcription of uPAR, an immediate-early gene for NGF whose 
NGF-induced expression is dependent on SH2B1 cycling through the nucleus. 
202 
 
This Chapter represents a “manuscript in progress” and will be submitted for 
publication under the title “SH2B1 Associates with Transcription Factor CDCA7 
upon NGF Stimulation and Rescues Inhibition of Neurite Outgrowth Caused by 





 The overall goal of my thesis research was to identify the mechanism by 
which SH2B1β facilitates NGF-dependent differentiation and survival.  SH2B1 
had previously been shown to associate with TrkA in an NGF-dependent manner 
(33, 34) and was hypothesized to enhance TrkA autophosphorylation (upon 
SH2B1 multimerization) (96) and recruit to TrkA signaling proteins required for 
activation of the Ras-dependent pathway (34).  However, these proposed 
mechanisms could not account for the results observed using a dominant 
negative form of SH2B1β, lacking an intact SH2 domain (SH2B1β(R555E)).  The 
SH2B1β(R555E) mutant, which is no longer able to bind to TrkA, inhibits NGF-
mediated differentiation.  However, overexpression of SH2B1β(R555E) did not 
appear to affect NGF-induced TrkA autophosphorylation or activation of ERKs 1 
and 2 (33).  These results suggested that SH2B1β(R555E) inhibits the normal 
function of endogenous SH2B1β at a point that is distinct or downstream from 
that of ERK activation by TrkA.  Correspondingly, Rui et al (33). did not observe 
enhanced NGF-dependent TrkA or ERK1/2 activity when SH2B1β(WT) was 
overexpressed, although NGF-dependent differentiation was significantly 
enhanced.  Together these results suggested that SH2B1β potentially initiates a 
novel pathway in response to NGF stimulation, which is required for neuronal 
differentiation and potentially survival. 
 
SH2B1 Is a Positive Regulator of Nerve Growth Factor-mediated Activation 
of the Akt/Forkhead Pathway in PC12 Cells 
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 The identification of SH2B1 as an important factor for NGF-mediated 
survival of neurons (34) led us to hypothesize that SH2B1 may facilitate PI3K 
signaling in response to NGF.  In Chapter 2, we demonstrate that the 
overexpression of SH2B1β leads to a modest enhancement and prolongation of 
NGF-induced activation and phosphorylation of Akt.  SH2B1β overexpression 
also enhances NGF-dependent phosphorylation of the downstream targets of 
Akt: GSK-3, FoxO3a (FKHRL1), and FoxO1 (FKHR) (245).  The simplest 
explanation for this increase in Akt activity is that SH2B1β potentiates NGF-
dependent TrkA activity, giving rise to increased autophosphorylation of TrkA, 
recruitment of PI3K to TrkA, and thus increased Akt activity.  However, we do not 
favor such a mechanism because we have been unable to show that SH2B1β 
enhances TrkA autophosphorylation.  There also remains the possibility that 
SH2B1β may directly recruit PI3K to the activated receptor or that SH2B1β 
inhibits dephosphorylation of Akt.  In support of such a pathway, Deng et al. (66) 
recently demonstrated that endogenous SH2B1 interacts with the regulatory 
subunit of PI3K, p85, after stimulation with PDGF.  Overexpression of SH2B1α 
enhances PDGF-activated PI3K activity and enhanced activity requires both the 
SH2 and PH domains of SH2B1α (66).  These results suggest that SH2B1α 
might recruit p85 to the activated form of PDGF receptor.  Although, SH2B1β is 
known to interact with activated forms of several receptor tyrosine kinases, the 
interaction between SH2B1 and p85 was restricted to PDGF receptor and was 
not observed with insulin or IGF-1 receptors (66). At present, it remains to be 
seen whether SH2B1β is able to interact with p85 after stimulation of TrkA with 
NGF. 
 If enhanced recruitment of p85 to NGF-activated TrkA/SH2B1 is required 
for PI3K/Akt activity, then the overexpression of SH2B1β(R555E) does not inhibit 
the formation of this complex since it does not inhibit NGF-dependent activation 
of Akt (245).  This is despite the fact that overexpression of SH2B1β(R555E) is 
deleterious to PC12 survival (unpublished observation).  Furthermore, 
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SH2B1β(R555E) does not affect the ability of endogenous SH2B1β to be 
phosphorylated by TrkA in response to NGF (68).  Therefore, the mechanism by 
which SH2B1β(R555E) functions as a dominant negative is unlikely to be the 
result of its displacing endogenous SH2B1 away from TrkA.  This point is valid for 
the ability of SH2B1β(R555E) to inhibit NGF-dependent differentiation as well as 
well as its ability to promote PC12 cell death.  Based on these results, we felt it 
more likely that SH2B1β(R555E) inhibits at a point downstream of the activation 
of TrkA, and either downstream or independent of NGF-activation of ERKs 1 and 
2 or Akt or NGF-dependent phosphorylation of GSK-3, FoxO3a, or FoxO1 by Akt.  
Although, it did not appear to inhibit NGF-induced FoxO1 phosphorylation 
by Akt, SH2B1β(R555E) was found to affect the ability of FoxO1 to translocate 
from the nucleus to the cytoplasm in response to NGF after serum deprivation.  
Unfavorable cellular conditions, such as serum deprivation of cultured cells, lead 
to FoxO1 translocation to the nucleus.  Upon nuclear localization FoxO1, binds to 
response elements of growth inhibitory and pro-apoptotic genes such as those 
found in the promoters of IGFBP-1 (295-298), Fas ligand (117), and Bim (299).  
FoxO1 nuclear localization is dynamically controlled by at least three 
serine/threonine (Ser/Thr), identified as Akt phosphorylation sites (117, 148, 168, 
300-303).  NGF has been shown to suppress FoxO1’s pro-apoptotic effects 
through activation of Akt, which directly phosphorylates FoxO1 at these Ser/Thr 
(304).  The FoxO1 phosphorylation by Akt leads to association with 14-3-3 
protein, which results in nuclear export and possibly cytoplasmic retention of 
FoxO1 (117, 118, 303).   
At the time of the publication of Chapter 2, we had only recently identified 
the capability of SH2B1β to localize to the nucleus.  The finding that SH2B1β 
undergoes nucleocytoplasmic shuttling opened up the possibility that SH2B1β 
plays a direct role in the nuclear export of FoxO1, although we were unsure how 
SH2B1β fit into the process of FoxO1 export.  Interestingly, Steve Archer in the 
Carter-Su laboratory identified 14-3-3 as an SH2B1 binding partner in a yeast-2-
hybrid screen.  Although 14-3-3 has been shown to be required for FoxO1 
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nuclear export (303), 14-3-3 lacks a nuclear localization sequence (NLS) and 
thus would require “piggybacking” by a currently unknown shuttling protein (305).  
Consequently, I hypothesized that SH2B1β might function to shuttle 14-3-3 into 
the nucleus and/or facilitate the formation of the 14-3-3/FoxO1 complex.  Also, I 
hypothesized that SH2B1β’s influence over the NGF-dependent subcellular 
localization of FoxO1 and/or other potential transcription factors is important for 
NGF-dependent differentiation.  
Future Directions 
My attempts to test this hypothesis, however, were met with several 
technical difficulties, most of which stemmed from our inability to efficiently 
transfect PC12 cells.  In my numerous efforts to verify the association between 
SH2B1β and 14-3-3, I have been mostly unsuccessful in reproducing my initial 
finding that HA-tagged 14-3-3 co-immunoprecipitates GFP-SH2B1β in an NGF-
dependent manner.  The transfection efficiency of any single cDNA is 
approximately 20% in PC12 cells using Lipofectamine Plus reagent.  Attempts to 
transfect two or more cDNAs dropped the transfection efficiency to under 5%.  
Thus, the ability to detect co-immunoprecipitation of SH2B1β and 14-3-3 was 
often confounded by low expression.  Because the association was NGF-
dependent, I was not able to use a more easily transfectable cell line such as the 
293T cell line because they do not express endogenous TrkA.  For these 
reasons, I eventually discontinued my investigation into the SH2B1β/14-3-3 
interaction and focused on SH2B1β’s role during neuritogenesis. 
However, three advancements in our reagents/protocols have enhanced 
our ability to transfect and assess biochemical interactions within PC12 cells.  
First, I have developed a highly efficient protocol to transfect PC12 cells, using an 
electroporation method instead of lipid-based delivery of cDNAs (Lipofectamine).  
Although electroporation results in a significant amount of cellular death, I have 
attained transfection efficiencies of 60% and higher for two or more cDNAs.  
Second, in conjunction with the increased transfection efficiency, I have 
developed a reliable protocol to create stable PC12 cell lines.  Using this method, 
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I have established several cell lines stably expressing various SH2B1β mutants 
as well as PC12 cells stably expressing an shRNA targeted against endogenous 
SH2B1.  Third, I recently obtained a highly specific antibody for SH2B1 from the 
Rui laboratory.  This antibody unambiguously recognizes endogenous and 
overexpressed forms of SH2B1 in PC12 lysates, without the need to first 
immunoprecipitate SH2B1.   
As mentioned previously, I was also unable to detect an interaction 
between FoxO1 and SH2B1β.  Based on the results from Chapter 2, I believe 
there is enough evidence to suggest that SH2B1β interacts with 14-3-3, FoxO1, 
or both. Therefore, utilizing these new techniques and reagents, I would like to 
reexamine these potential SH2B1β interactions in PC12 cells. 
More importantly, I would like to more completely analyze SH2B1β’s 
influence over FoxO1 subcellular localization.  At the time of the publication of the 
results in Chapter 2, Dr. Chen had discovered a functional NES within SH2B1 
and demonstrated that the NES was required for nuclear export of SH2B1β, but 
we did not know how SH2B1 localized to the nucleus in the first place.  
Interestingly, I found that SH2B1β(R555E) is unable to translocate to the nucleus.  
If nucleocytoplasmic shuttling of SH2B1β is required to facilitate nuclear export of 
FoxO1 after Akt phosphorylation, then this finding offers an explanation of why 
overexpression of SH2B1β(R555E) blocks redistribution of FoxO1 to the 
cytoplasm.  Additionally, I have since identified the NLS within SH2B1 which is 
required for its translocation into the nucleus (Chapter 4).  Therefore, we can now 
properly assess whether nuclear export of FoxO1 requires nucleocytoplasmic 
shuttling of SH2B1β.  Flag-tagged FoxO1 would be electroporated into the PC12 
cell lines stably expressing GFP, GFP-SH2B1β(WT), GFP-SH2B1β(R555E), 
GFP-SH2B1β(ΔNES), and GFP-SH2B1β(mNLS).  The cells would then be 
incubated in serum-free medium overnight to induce FoxO1 nuclear localization.  
The cells would then be treated with or without NGF for 1 h before they were 
fixed, immunostained with αFlag for Flag-FoxO1, and scored for the presence of 
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FoxO1 in the nuclei.  If NGF-dependent nuclear export of FoxO1 depends upon 
the nuclear presence of SH2B1β, then I would expect that the cell lines 
expressing GFP-SH2B1β(R555E) and GFP-SH2B1β(mNLS) would demonstrate 
a reduced ability to export FoxO1 from the nucleus after NGF treatment, 
compared to GFP control.  I would, therefore, expect GFP-SH2B1β(mNLS) 
expressing cells to have significantly more nuclear FoxO1 after NGF treatment 
than GFP-SH2B1β(WT) expressing cells.  If SH2B1β requires cycling between 
the nuclear and cytoplasmic compartments to enhance nuclear export of FoxO1, 
I would expect the cell lines expressing nuclear import and export mutants of 
SH2B1β (GFP-SH2B1β(mNLS) and GFP-SH2B1β(ΔNES) respectively) to 
demonstrate a similar inability to redistribute FoxO1 to the cytoplasm after NGF 
stimulation.  However, if after treatment with NGF, the number of FoxO1 positive 
nuclei is the same between cells expressing GFP-SH2B1β(WT) and GFP-
SH2B1β(mNLS), then I would conclude that SH2B1β is not needed in the nucleus 
for NGF-mediated nuclear export of FoxO1 and is not likely to be shuttling 
partner for FoxO1. 
In conjunction with the aforementioned experiment, I would also like to 
address the requirement of endogenous SH2B1β for proper nuclear export of 
FoxO1.  This experiment will also rule out the possibility that FoxO1 remains 
nuclear after NGF treatment due to an artifact of SH2B1β(R555E).  cDNA 
encoding Flag-tagged FoxO1 would be electroporated into the PC12 cell line 
stably expressing an shRNA targeted against SH2B1 (shSH2B1) or the shRNA 
control cell line shControl.  The cells would be incubated in serum-free medium 
overnight to induce FoxO1 nuclear localization.  Then the cells would be treated 
with or without NGF for 1 h before they were fixed, immunostained with αFlag for 
FoxO1, and scored for the presence of FoxO1 in the nuclei.  If endogenous 
SH2B1 is required for nuclear export of FoxO1, after NGF treatment I should 
observe an increased amount of FoxO1 in the nuclei of shSH2B1 cells as 
compared to shControl cells.  
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SH2B1β  (SH2-Bβ) Enhances Expression of a Subset of Nerve Growth 
Factor-Regulated Genes Important for Neuronal Differentiation Including 
Genes Encoding UPAR and MMP3/10 
 The study presented in Chapter 3 was undertaken to identify whether 
SH2B1β affected NGF-induced gene transcription in PC12 cells.  At the time of 
this study, Dr. Chen had recently established that SH2B1β contains a functional 
NES and persists in continual flux between the cytoplasm and the nucleus (79).  
The prevailing dogma at this time was that adapter proteins set up static 
complexes at the activated receptor, which facilitate the specific activation of the 
more dynamic secondary messenger that is able to physically transduce the 
signal from the receptor complex to the nucleus.  Therefore, Dr. Chen’s finding 
represented a departure from the dogma surrounding “cytoplasmic” adapter 
proteins, and a major breakthrough in our understanding of SH2B1β’s function.  
Although the significance of SH2B1β nuclear localization was not established, the 
study gave rise to the possibility that SH2B1β plays a more direct role in NGF-
mediated differentiation.  SH2B1β lacking the region required for nuclear export 
was unable to enhance NGF-dependent differentiation.  Dr. Chen and I 
hypothesized that SH2B1β directly enhances transcription of genes required for 
NGF-dependent differentiation.   
 The results of the microarray performed in Chapter 3 indicated that 
overexpression of SH2B1β enhances NGF-induced expression of only a specific 
subset of NGF-responsive genes.  As expected, NGF stimulation induces 
transcription of hundreds of genes.  If SH2B1β functioned exclusively to 
potentiate TrkA activity, we would expect to see a general enhancement in the 
transcription of the NGF-responsive genes.  However, of the 511 genes whose 
expression doubled after treatment with NGF in control cells, only 34 
demonstrated a further doubling in the SH2B1β expressing cells.  Similarly, 
SH2B1β(R555E) expressing cells impaired by 50% or more the NGF-induced 
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transcription of only 153 of the 511 NGF-responsive genes.  Only 6 genes 
showed both an enhancement of transcription by SH2B1β and impairment by 
SH2B1β(R555E). 
 Interestingly, we identified uPAR (Plaur) as one of those 6 genes whose 
NGF-induced expression was both significantly enhanced by overexpression of 
SH2B1β and impaired by overexpression of SH2B1β(R555E).  We were 
especially intrigued by identification of uPAR, because it had previously been 
identified as an immediate-early gene of NGF.  The transcription of immediate-
early genes requires only preexisting transcriptional regulators and therefore 
represent the first wave of transcription required for NGF-dependent effects.  
Importantly, transcription of uPAR represents one of the earliest known 
differences between EGF and NGF-mediated gene induction and was 
demonstrated to be required for NGF-dependent differentiation of PC12 cells 
(122).  In the identification of uPAR, the microarray established a potential direct 
target for SH2B1β.  At least some of the other SH2B1β-responsive candidates 
identified from the microarray, such as matrix metalloproteinase-3 (Mmp3) and 
matrix metalloproteinase-10 (Mmp10), are most likely secondary response 
genes.  In fact, knocking down endogenous levels of uPAR blocked the NGF-
dependent transcription of several genes including Mmp3; Mmp10 was not one of 
the transcripts tested (122).   
 It is interesting to note that SH2B1β significantly affects the NGF-induced 
transcription of uPAR, Mmp3, and Mmp10, each of which has been previously 
implicated in the canonical pathway for extracellular matrix (ECM) degradation 
and neurite outgrowth.  uPAR is thought to initiate a proteolytic cascade that 
includes activation of the MMPs (192).  Thus, we initially envisioned that the 
NGF-dependent transcription of proteases enables the leading edge of growth 
cone to penetrate and/or move through the ECM during neurite elongation.  
Indeed, MMPs have been implicated in dorsal root ganglion axonal penetration 
through the ECM (227).  These findings suggested that SH2B1β may enhance 
the NGF-dependent transcription of uPAR and either directly or indirectly 
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enhance the transcription of Mmp3 and Mmp10, thereby augmenting the 
proteolytic potential of the growing neurites.   
 However, we were perplexed by the report that uPAR protein is required 
for differentiation within the first two hours of NGF exposure (121).  Strikingly, 
uPAR function can be blocked after this initial period and differentiation proceeds 
normally (121).  While we demonstrated that uPAR is present at the plasma 
membrane and growth cone (FIG. 3.6B), uPAR cannot be required at the growth 
cone because neurites are not yet present after only two hours of NGF treatment, 
and we were forced to reevaluate our proposed model.  The NGF-induced 
differentiation of PC12 cells can be divided into two distinct phases.  The first 
phase is marked by a significant increase in transcription to provide the cell with 
the specialized proteins it requires for the complete differentiated phenotype.  
During the first phase, neurite outgrowth is a transcription-dependent process 
(306).  After the cell generates an appropriate level of transcript, it moves into the 
second phase, in which elongation of the neurites no longer requires synthesis of 
mRNA, instead, neurite elongation requires the translation of the transcript 
generated in phase one (306).  Essentially, uPAR appears to be required during 
the first phase, to “prime” the cell for differentiation, although it appears to be 
dispensable for the second.  This would suggest that uPAR is more likely to be 
required for subsequent rounds of transcription in phase one, than provide a 
direct mechanical role for the developing neurites.   
 Accordingly, relatively recent publications have reported that uPAR is able 
to activate intracellular signaling pathways, even though uPAR is an extracellular 
membrane protein lacking a transmembrane and cytosolic domain (258).  
Activation of uPAR is tranduced to the cytoplasm through interactions with 
integrins, G-protein coupled receptors, caveolin (258), and PLCε (231), leading to 
the activation of JAK/STAT (228), Lck, Src, FAK, and the Ras/MEK/ERK pathway 
(258).  Notably, the activation of PLCε has previously been implicated in 
prolonging the NGF-dependent activation of ERKs 1 and 2, and thus neurite 
outgrowth (307).  Farias-Eisner et al. (121) favor a mechanism in which NGF-
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dependent expression of uPAR is required to activate PLCε to further prolong 
ERK activity and facilitate subsequent rounds of transcription (121), although this 
has yet to be substantiated.   
 The results from Chapter 3 support the possibility that SH2B1β can 
enhance transcription of genes required for NGF-dependent differentiation.  
Equally as important, the results of the microarray provided us with uPAR, a 
potential gene target for SH2B1β.   
 
Nucleocytoplasmic Shuttling of the Adapter Protein SH2B1β  (SH2-Bβ) is 
Required for Nerve Growth Factor (NGF)-dependent Neurite Outgrowth and 
Enhancement of Expression of a Subset of NGF-responsive Genes 
 As previously mentioned, at the time the experiments were performed in 
Chapters 2 and 3, we had not yet established the region responsible for SH2B1β 
nuclear import. Chapter 4 describes the identification of the N-terminal NLS 
within all isoforms of SH2B1.  Surprisingly, I also identified that a functional SH2 
domain is required for SH2B1β nuclear localization in PC12 cells, as 
SH2B1β(R555E) is unable to translocate to the nucleus.  This finding raises the 
possibility that the inhibition of NGF-dependent differentiation in PC12 cells 
overexpressing SH2B1β(R555E) is a consequence of the mutant’s inability to 
appropriately localize to the nucleus.  Taken together with the results from 
Chapter 3, this finding suggests that nuclear import of SH2B1β may be required 
for NGF-induced transcription of uPAR.  Indeed, QT-PCR results described in 
Chapters 3 and 4 demonstrated that PC12 cells stably expressing SH2B1β(WT) 
greatly enhance NGF-induced transcription of uPAR, while PC12 cells stably 
expressing SH2B1β(R555E) significantly inhibit NGF-induced transcription of 
uPAR.  
 Importantly, a valid concern regarding the aforementioned results is 
whether the dominant negative effects observed in SH2B1β(R555E) expressing 
cells are a consequence of SH2B1β(R555E) serving as a dominant negative for 
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SH2B1β or for some other protein.  To alleviate this concern and provide more 
direct evidence foa role of endogenous SH2B1 in NGF-induced neuronal 
differentiation, I created PC12 cells stably expressing shRNA targeted against 
endogenous SH2B1 as well as a control cell line.  In Chapters 3 and 4, we 
demonstrated that the depletion of endogenous SH2B1 inhibits NGF-induced 
transcription of uPAR, Mmp3, and Mmp10 compared to control.  Likewise, 
knocking down endogenous levels of SH2B1 inhibited NGF-dependent 
differentiation.  The knockdown of SH2B1 does not alter the extent or duration of 
the NGF-induced phosphorylation of Akt, or ERKs 1 and 2, suggesting that 
endogenous SH2B1 is required for NGF-dependent neurite outgrowth in a 
manner that is distinct from the activation of P13K/Akt and/or Ras-ERK1/2 
pathways.  Clearly, the results from the SH2B1 knockdown cell line are 
consistent with the effects of SH2B1β(R555E) overexpression, and are 
consistent with the R555E mutation specifically inhibiting the function of 
endogenous SH2B1.  Based upon my current model, I would predict that 
SH2B1β(R555E), unable to access the nucleus, binds to and prevents 
endogenous SH2B1β from entering the nucleus.  In light of the aforementioned 
findings, I wanted to test whether nuclear localization of SH2B1β is required for 
NGF-induced differentiation. 
 To test this hypothesis, I assessed NGF-dependent neurite outgrowth of 
PC12 cells stably expressing a nuclear import mutant of SH2B1β lacking a 
functional NLS (SH2B1β(mNLS)).  The results from Chapter 4 suggest that 
nuclear localization of SH2B1β is required for NGF-dependent neurite outgrowth.  
Moreover, SH2B1β(mNLS) expressing cells were also unable to enhance NGF-
induced transcription of uPAR, Mmp3, or Mmp10 as compared to SH2B1β(WT).  
The mutation of the NLS within SH2B1β successfully blocked nuclear 
translocation, but did not appear to affect the NGF-dependent association with 
activated TrkA.  SH2B1β(mNLS) seemed to be phosphorylated to a similar extent 
as SH2B1β(WT) in response to NGF.  Also, expression of SH2B1β(mNLS) did 
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not alter the NGF-activated phosphorylation of TrkA or ERKs 1 and 2.  Therefore, 
I believe the deficits in neurite outgrowth are specific to the inability of SH2B1β to 
enter the nucleus, and not a result of SH2B1β(mNLS) compromising an 
NGF/TrkA signaling cascade.  Together these results clearly suggest that the 
ability of SH2B1β to translocate to the nucleus is important for both NGF-
dependent morphological and biochemical differentiation.  PC12 cells stably 
expressing SH2B1β(ΔNES) (lacks the nuclear export sequence) were also 
unable to enhance NGF-induced transcription of uPAR, Mmp3, or Mmp10 as 
compared to SH2B1β(WT).  Collectively, these results suggest that SH2B1β 
requires access to both the nucleus and cytoplasm in order to facilitate NGF-
mediated morphological and biochemical changes, raising the possibility that 
SH2B1β directly facilitates transcription of genes required for differentiation.  
  Because SH2B1β’s transport between the nucleus and cytoplasm is an 
energy-dependent mechanism, it is logical to expect that this process would be 
subject to some level of regulatory control.  The finding that SH2B1β requires a 
functional SH2 domain in order to translocate to the nucleus suggests that 
SH2B1β may first have to be phophorylated by one of the tyrosine kinases it 
associates with.  If TrkA-dependent phosphorylation of SH2B1β was required for 
nuclear import, it could account for the inability of SH2B1β(R555E) to translocate 
to the nucleus.  SH2B1β(R555E) is unable to associate with active TrkA, thus 
SH2B1β(R555E) is deficient in both tyrosyl and Ser/Thr phosphorylation after 
NGF stimulation (33, 68).  However, I have been unable to observe an NGF-
dependent compartmental regulation of SH2B1β.  We have mutated several 
phosphorylation sites within SH2B1β, including all tyrosines, several predicted 
Ser/Thr sites, as well as Ser 96 which has previously been shown to be 
phosphorylated by activated ERK in vitro (68).  None of these mutations inhibited 
SH2B1β nuclear accumulation in the presence of leptomycin B.  However, there 
remain multiple Ser/Thr sites we have not yet tested and the possibility remains 
that multiple phosphorylation sites are required for nuclear import.  However, the 
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pattern of continuous nucleocytoplasmic cycling by SH2B1β(WT) and nuclear 
exclusion by SH2B1β(R555E) is maintained whether the cells are serum 
deprived or treated with NGF.  Therefore, if phosphorylation of SH2B1β is 
required for nuclear import, then these results inicated that phosphorylation of 
tyrosyl residue(s) within SH2B1β is nonessential and basal phosphorylation of 
SH2B1β is sufficient for nuclear localization.   
 However, it is possible that NGF-dependent phosphorylation of SH2B1β 
could significantly enhance the nuclear import rate of SH2B1β.  Because the rate 
of nuclear export exceeds that of nuclear import, SH2B1β looks to be 
predominately located at the plasma membrane/cytoplasm.  Therefore it is 
difficult to assess SH2B1β’s rate of nuclear import without first blocking nuclear 
export.  Interpretation of these results is complicated by the fact that the drug 
used to block nuclear export, Leptomycin B, is toxic and may have non-specific 
effects on the cells.  Furthermore, Leptomycin B takes hours to be effective, thus 
making it difficult to assess rapid changes in rates of nuclear import or export.  In 
the near future, I would like to attempt an experiment using fluorescence recovery 
after photo-bleaching (FRAP).  Through conversation with Stephen Lentz, the 
director of the University of Michigan Morphology and Image Analysis Core, we 
decided that using the nuclear accumulated SH2B1β(ΔNES) may be the best 
chance to observe the kinetics of SH2B1β’s nucleocytoplasmic shuttling.  In this 
experiment, I would photo-bleach the nuclear signal and compare the rate of 
fluorescence recovery in the presence or absence of NGF.   
 Of course, it is also conceivable that phosphorylation does not influence 
nuclear import or export of SH2B1β.  The subcellular localization of SH2B1β may 
be regulated by other post-translational modifications.  It is equally possible that 
SH2B1β constitutively cycles between the nucleus and cytoplasm without any 
regulation.  While this may seem inefficient, continuous cycling of SH2B1β may 
offer the cell a means to constantly communicate the events at the plasma 
membrane to the nucleus and vice versa.  
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 That being said, I hypothesize that NGF-dependent phosphorylation of 
SH2B1β is required for its nuclear role.  Phosphorylation of SH2B1β(WT) by TrkA 
at the membrane may alter its interactions with other proteins and 
correspondingly its function within the nucleus.  Because NGF-dependent 
phosphorylation of SH2B1β may be required for the enhanced transcription of 
uPAR, Mmp3, and Mmp10, we must interpret the effects of the SH2B1β(ΔNES) 
mutant with caution.  Based on the findings of Chen et al. (79), SH2B1β(ΔNES) is 
able to associate with active TrkA but at a reduced level compared to 
SH2B1β(WT).  Thus, I believe it is unlikely that the constitutively nuclear SH2B1β 
mutant is phosphorylated to the same extent as SH2B1β(WT) in response to 
NGF.  The latter is based on the finding that in contrast to SH2B1β(WT), 
SH2B1β(ΔNES) does not display an NGF-dependent upward shift in migration, a 
shift which Rui et al. (33, 68)showed was due to increased phosphorylation.  
Therefore, it is possible that SH2B1β(ΔNES) fails to enhance NGF-induced 
transcription and neurtite outgrowth because it is insufficiently phosphorylated.  
Presently, it remains unclear as to why SH2B1β needs access to both the 
cytoplasm and the nucleus.  Is it because SH2B1β requires cytoplasmic 
phosphorylation for an active role in the nucleus, or does it require the cycling 
between the two compartments, possibly functioning as a shuttling protein, or is it 
a combination of the two?  Obviously, the identification of nuclear binding 
partners of SH2B1β or phosphorylation site(s) within SH2B1β would help answer 
these questions. 
 
SH2B1 Associates with Transcription Factor CDCA7 upon NGF Stimulation 
and Rescues Inhibition of Neurite Outgrowth Caused by CDCA7 
Overexpression. 
 One of the difficulties in trying to establish a nuclear role for an adapter 
protein is that there are currently few analogous models to follow.  While there 
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have been several recent reports demonstrating nuclear localization of both 
receptor (and receptor associated) tyrosine kinases as well as their 
corresponding adapter proteins, there has been little conclusive evidence 
concerning their nuclear function.  The lack of functional data have also fueled 
criticisms that nuclear detection of these proteins is purely an artifact of 
immunostaining, cellular fractionation, and/or their overexpression.  However, the 
example of huntingtin-interacting protein 1 (HIP1) serves as strong evidence that 
adapter proteins can serve to regulate transcription directly.  HIP1 has a steady-
state localization at the plasma membrane (308) and was initially characterized 
as a cytoskeletal adapter protein responsible for modulating actin dynamics 
(309).  Interestingly, upon androgen treatment of cells, HIP1 associates with 
androgen receptor, translocates to the nucleus, and functions as a co-activator at 
androgen responsive elements of the endogenous prostate-specific antigen 
(PSA) promoter (308).  If SH2B1β is a novel regulator of NGF-dependent gene 
transcription, a logical target gene is uPAR based on evidence presented in 
Chapters 3 and 4.  There are several potential mechanisms by which SH2B1β 
could enhance the transcription of uPAR.  In order to narrow the field of 
possibilities, I wanted to establish a nuclear binding partner of SH2B1β.  I felt the 
identification of a nuclear interacting protein for SH2B1β could provide needed 
relevance for its nuclear function.   
 In Chapter 5, I discuss the identification of cell division cycle associated 7 
(CDCA7/JPO1) using the tandem affinity purification method.  Currently, there is 
only a small base of knowledge pertaining to the function of CDCA7.  The 
CDCA7 protein was initially described as a c-Myc responsive gene that 
participates in neoplastic transformation (125).  Intriguingly, CDCA7 was found to 
contain a N-terminal leucine zipper motif (286) as well as a C-terminal 
transactivation domain (278) and is localized diffusely throughout the nucleus 
(125). 
 Using a co-immunoprecipitation assay in PC12 cells, I was able to confirm 
the association between endogenous SH2B1 and myc-tagged CDCA7 in cells 
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treated with NGF for 30 min, but not in control cells, revealing that this 
association is dependent on NGF.  As noted in Chapter 5, I was puzzled by the 
size of the endogenous SH2B1 pulled down by CDCA7 because it migrated at 
the high end of where SH2B1β usually migrates after NGF treatment.  These 
results suggested to me that the band was most likely a maximally 
phosphorylated form of endogenous SH2B1β.  However, the antibody I used 
cannot differentiate between SH2B1 isoforms.   
 Although it is unknown if SH2B1δ is endogenously expressed in PC12 
cells, its molecular weight is more consistent with the observed SH2B1 band than 
that of SH2B1β.  In addition, I had previously found that the SH2B1δ isoform was 
predominately nuclear in its subcellular localization.  Based upon sequence 
analysis of SH2B1δ, I believe the increased nuclear presence of the delta isoform 
is due to an additional NLS within the unique C-terminal region.  The presence of 
the C-terminal NLS had been previously speculated by Yousaf et al. (46) but had 
never been tested.  Because all isoforms of SH2B1 contain an NES, I assumed 
that SH2B1δ also undergoes nucleocytoplasmic shuttling.  However, the dramatic 
nuclear localization of SH2B1δ at steady-state would suggest there is more 
nuclear SH2B1δ than SH2B1β at any given time.  Therefore, I thought that 
nuclear SH2B1δ might be more likely than SH2B1β or the other isoforms of 
SH2B1 that lack the second NLS to interact with nuclear CDCA7.  I was able to 
demonstrate an NGF-dependent interaction between overexpressed GFP-
SH2B1δ and CDCA7 by co-immunoprecipitation.  However, I have subsequently 
been unable to detect endogenous expression of SH2B1δ in PC12 lysates based 
on the migration of endogenous SH2B1 in serum-deprived PC12 cells, which 
suggests that the endogenous SH2B1 pulled down with CDCA7 is most likely a 
highly phosphorylated form of SH2B1β, thought to be the primary isoform in 
PC12 cells as assessed by RT-PCR (245).  However, Mr. M. Doche and I are 
working to establish whether SH2B1δ is present in PC12 cells by assessing 
whether its transcript is present. 
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 The overexpression of SH2B1δ revealed a very interesting finding that I 
think is worth pursuing.  In addition to the aforementioned localization to the 
nucleoplasm, SH2B1δ demonstrated a striking subnuclear localization to the 
nucleolus.  It is presently unclear what function SH2B1δ provides the cell, 
although insulin receptor substrate-1 IRS-1 was recently shown to translocate to 
the nucleolus upon IGF-I stimulation (289, 290).  The IGF-I-dependent 
localization of IRS-1 to the nucleolus is thought to enhance the production of 
rRNA which functions to facilitate cell growth through increased protein synthesis 
(290).  It will be interesting to examine whether SH2B1δ similarly facilitates cell 
growth through increased protein synthesis in PC12 cells if they express 
endogenous SH2B1δ or in other cell lines that do express SH2B1δ.   
 It is also interesting to speculate whether FRS2, which is in the same 
family of adapter proteins as IRS-1, also translocates to the nucleus.  The ability 
of IRS-1 to localize to the nucleus is thought to depend upon the nuclear 
translocation of a large complex of signaling molecules (290).  Considering that 
IRS-1 is known to interact with SH2B1 (93) it seems possible that SH2B1 may be 
included along with IRS-1 during its nuclear translocation.  This idea is 
highlighted by the fact that IRS-1 and SH2B1δ both demonstrate a unique ability 
to localize to both the plasma membrane and the nucleolus.  As discussed 
previously, FRS2 competes for the Shc binding site on activated TrkA and has 
been suggested to mediate cellular differentiation versus proliferation in response 
in response to NGF (243).  We are currently investigating the possibility that 
FRS2 undergoes an NGF-dependent nuclear translocation and/or co-localizes 
with SH2B1 in the nucleus.  
 Included in Chapter 5 are my preliminary data concerning the function of 
CDCA7 within PC12 cells.  In my first experiments to test the subcellular 
localization of CDCA7, I discovered that overexpression of CDCA7 dramatically 
inhibits NGF-dependent differentiation of PC12 cells.  I initially questioned the 
significance of this finding.  CDCA7 expression is thought to peak during the G/S 
transition of the cell cycle, thus it has been postulated that CDCA7 is a 
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proliferative transcription factor (125, 278).  Conversely, NGF treatment is known 
to move asynchronous populations of PC12 cells into a G0/G1 arrest (310).  
Therefore, it was not surprising to see CDCA7 oppose the action of NGF.  After 
establishing an NGF-dependent association between SH2B1 and CDCA7, I 
decided to test whether SH2B1β expression could rescue the inhibition of NGF-
dependent differentiation by CDCA7.  While the data in FIG. 5.6B are preliminary, 
the results suggest that overexpression of SH2B1β is able to restore NGF-
mediated neurite outgrowth to cells overexpressing CDCA7.   
 As noted above, after 30 min of NGF stimulation, CDCA7 interacts with a 
highly phosphorylated form of SH2B1, which is most likely SH2B1β.  The fact that 
CDCA7 did not also pull down any lesser phosphorylated species of SH2B1 
indicates that this interaction is dependent upon maximal phosphorylation of 
SH2B1. Therefore, one potential mechanism by which SH2B1 enhances 
transcription of NGF-responsive genes is that NGF stimulation results in the 
transient formation of a highly phosphorylated form of SH2B1, which is able to 
bind and inactivate CDCA7.  This led me to the hypothesis that CDCA7 is a 
repressor of essential NGF immediate-early genes, such as uPAR.  The NGF-
dependent inactivation of CDCA7 by SH2B1 would allow for the induction of 
uPAR in a temporally specific manner.  Intriguingly, EGF stimulation is unable to 
promote tyrosyl phosphorylation of SH2B1β (33), thus I would not expect 
SH2B1β to associate with CDCA7 in response to EGF.  Whether this 
corresponds to the differential ability of NGF but not EGF to induce uPAR, 
remains to be determined (FIG. 6.1). 
 Collectively, the results from Chapter 5 suggest that SH2B1 associates 




FIG. 6.1 Does SH2B1 function to inactivate CDCA7 transcriptional 
repression of specific NGF immediate early genes? 
(A) In the absence of NGF, TrkA is inactive and SH2B1β cycles between the nucleus and 
cytoplasm.  (B) NGF-activated TrkA stimulates the assembly of signaling pathways responsible 
for the prolonged activation of ERKs 1 and 2.  Upon activation, ERKs 1/2 translocate to the 
nucleus where they phosphorylate and activate several transcription factors (TF) that are required 
for the induction of NGF-specific immediate early genes (NGF IEG), such as uPAR.  As 
suggested by the results of Chapter 4, SH2B1β is required to shuttle in and out of the nucleus to 
enhance the transcription of NGF-induced genes required for differentiation.  Our hypothesis 
predicts that CDCA7 functions as a transcriptional repressor of NGF-specific IEGs.  NGF-
dependent phosphorylation of SH2B1β (yellow and green stars) induces an association with 
CDCA7, which may inactivate CDCA7 repression of NGF-specific IEGs, allowing for their 
transcription.  SH2B1β may disrupt CDCA7 binding at the promoter or may shuttle CDCA7 to the 
cytoplasm (?).  Because EGF stimulation does not lead to SH2B1β phosphorylation, EGF would 
not be expected to induce the association of SH2B1β with CDCA7, thus allowing CDCA7 
transcriptional repression of NGF-specific IEGs to persist.   
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Experimental Limitations 
 Unfortunately, for every experimental system there is an experimental 
limitation.  Throughout my work, I have relied upon the overexpression of 
proteins.  The function of a particular endogenous protein may depend upon 
specific stoichiometric interactions with other binding partners, which would 
obviously be altered upon overexpression.  Therefore, overexpression can inhibit 
endogenous proteins and lead to functional artifacts.  In order to reduce the 
potentially adverse effects of overexpression, we have employed the use of 
several stable cell lines, which exhibit a level of expression more closely aligned 
with that of an endogenous protein.  Additionally, the development of better 
antibodies has enabled us to more easily and accurately identify endogenous 
proteins.  However, there are times when analysis of the endogenous protein is 
not possible  (i.e. no antibody or when mutants are required).  In these cases, it is 
necessary to include all controls and leave open the possibility that the results 
are artifactual.  We have made an effort to address these concerns when 
applicable.  For example, in Chapters 3 and 4, we used RNAi to knockdown 
endogenous SH2B1.  We were pleased to see that knocking down endogenous 
SH2B1β led to similar effects as seen in cells overexpressing the dominant 
negative SH2B1β(R555E).   
 The utilization of fluorescent tags such as EGFP and mCherry has 
enabled us to follow and characterize dynamic subcellular movement of SH2B1β 
in living cells.  The obvious downside of creating such fusion proteins is that the 
fluorescence tag may inhibit the protein’s function.  The proteins encoding the 
fluorescent tags are relatively large (~28 kDa) and may sterically hinder proper 
folding of the protein of interest and/or its association with other molecules.  
Unfortunately, the SH2B1 antibody is not optimal for immunocytochemistry, thus 
SH2B1 requires tagging with a known epitope.  In hindsight, I would have 
preferred to use the smaller myc-tag for the SH2B1β constructs to characterize 
their nuclear function.  Indeed, if SH2B1β functions as a co-activator, the bulky 
GFP tag could potentially block recruitment of transcriptional regulators.  In order 
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to combat this, I am remaking the majority of my SH2B1β constructs in myc-
tagged vector.  However, the myc -vector is not as amenable to the formation of 
stable cell lines as the GFP vector.  The GFP-tag enhanced our ability to create 
stable lines in PC12 cells by allowing us to pool together GFP-positive cells at the 
flow cytometry core.  I am currently analyzing the possibility of engineering a 
vector that would contain the GFP tag and a myc-tagged construct, separated by 
an internal ribosome entry site (IRES).  Using this method we could still sort for 
GFP positive cells to make stable lines, but SH2B1β would be conjugated to the 
myc epitope and not GFP.   
 Although the PC12 cell model is a powerful system to establish molecular 
mechanisms of sympathetic differentiation, PC12 cells have a tumorigenic origin.  
One of the most significant criticisms regarding the PC12 model is that PC12 
cells can undergo reversible morphological differentiation upon NGF removal 
(16). The lack of complete terminal differentiation of PC12 cells represents a 
significant difference compared to their true sympathetic neuron counterparts, 
which require NGF for survival (11).  For this reason, we would like to assess the 
physiological relevance of SH2B1β’s nuclear role using an animal model.  This 




Identification of NGF-dependent Serine and Threonine Phosphorylation 
Sites Within SH2B1β . 
 As hypothesized in Chapters 4 and 5, the NGF-dependent 
phosphorylation of SH2B1β may influence its ability to translocate to the nucleus 
and/or facilitate the interaction with CDCA7 and other potential nuclear binding 
proteins.  The Carter-Su lab has identified three sites of phosphorylation in 
SH2B1β, including Tyr 439 and Tyr494 which are phosphorylated by JAK2 (67) 
and Ser96 which is phosphorylated in response to NGF (68).  However, mutation 
of these sites (68) does not reduce SH2B1β’s ability to translocate into the 
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nucleus, nor does it affect SH2B1β enhancement of NGF-dependent neurite 
outgrowth (data not shown).  Importantly, we have evidence to suggest that these 
three sites are not the only/major sites of phosphorylation in response to NGF 
stimulation (68) (Dr. Linyi Chen, unpublished data).  Therefore it is critical that we 
establish the other sites of phosphorylation in SH2B1β.   
 To ascertain these and other unknown post-translational modifications of 
SH2B1β in response to NGF, I would like to purify SH2B1β from PC12 cells after 
15 minutes NGF stimulation and submit it to the Michigan State University 
Proteomics Core or University of Michigan Peptides and Proteomics Core for 
analysis by mass spectrometry.  Through communications with Doug Whitten 
from the Michigan State University Proeomics Core, I have developed a 
preliminary protocol that is fairly similar to the purification and mass spectrometry 
performed in Chapter 5.  This procedure would make use of the preexisting 
stable line expressing TAP-tagged SH2B1β.  Briefly, NGF-treated lysates from 
these cells would be incubated in a column of IgG conjugated beads.  The 
column would then be subjected to several high stringency washes.  Instead of 
digesting SH2B1β from the IgG column using TEV protease, which results in a 
significant loss of protein, the SH2B1β-bound IgG beads themselves would be 
submitted.  Doug Whitten uses a protocol that can digest the protein from the 
beads efficiently and then analyze the resultant protein by MS/MS using a 
Finnegan LTQ FTMS.  The University of Michigan Peptides and Proteomics Core 
also have a similar mass spectrometer, although for identification of post-
translational modification, they often send the samples to the Michigan State 
University Proteomics Core.  The potential problem with this method is obtaining 
the appropriate amount of sample required for accurate detection.  However, the 
TAP procedure in Chapter 5 was performed using 22, 15 cm culture plates of 
subconfluent PC12 cells.  We have the capacity to significantly increase the 
number of cells if the level of protein is insufficient.  More importantly, the most 
time-consuming, technically challenging, and yield-reducing aspects of the TAP 
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assay (TEV cleavage and calmodulin column purification) will be eliminated from 
this procedure. 
 Assuming the successful identification of phosphorylation sites within 
SH2B1β, I will make corresponding single residue mutants (i.e. Tyr to Phe, and 
Ser/Thr to Ala).  Additionally, I will make phospho-mimetic mutations for any 
identified Ser/Thr phosphorylation sites (i.e. Ser/Thr to Asp/Glu).  These mutants 
will be expressed in PC12 cells and evaluated for their ability to undergo 
nucleocytoplasmic shuttling, enhance NGF-induced transcription of uPAR, 
associate with CDCA7, and enhance NGF-dependent differentiation.  In doing 
this, I hope to establish sites of phosphorylation that are required for the nuclear 
translocation of SH2B1β and/or phosphorylation required for the CDCA7/SH2B1β 
interaction.   
 
Does CDCA7 Specifically Inhibit NGF-dependent Differentiation of PC12 
cells? 
 As described in Chapter 5, the overexpression of CDCA7 dramatically 
inhibited NGF-dependent differentiation.  While CDCA7 has been described as a 
putative transcription factor, it presently has no known target genes.  
Interestingly, a closely related protein of CDCA7 (JPO1), JPO2, has been 
described to repress transcription of  monoamine oxidase (287).  Thus, one of 
the more attractive possible mechanisms by which CDCA7 inhibits NGF-
dependent differentiation is that CDCA7 represses the transcription of uPAR or 
other NGF-regulated immediate-early genes.  To test this hypothesis, I will create 
dominant-negative mutants of CDCA7 (dnCDCA7) lacking either the residues 
required for leucine zipper-mediated dimerization or deletions of the 
transactivation domain.  Disrupting the hetero/homodimerization has been 
demonstrated to result in dominant-negative forms of c-Myc (311).   
 I will express a vector control, CDCA7(WT), and dnCDCA7 in PC12 cells 
and assess the ability to:  1) repress/activate a uPAR promoter-driven luciferase 
construct with and without NGF stimulation; 2) repress/activate NGF-induced 
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transcription of uPAR; and 3) inhibit/enhance NGF-dependent differentiation.  If I 
find that expression of CDCA7(WT) inhibits, while dnCDCA7 enhances, NGF-
induced transcription of uPAR, I could use the uPAR promoter-luciferase 
construct to identify the affected promoter region.  There are already several 
transcription factor binding sites mapped out for the uPAR promoter (242).   
 However, it is quite possible that CDCA7 has no direct effect on uPAR 
expression.  For this reason, I would also like to map the region(s) required for 
SH2B1β/CDCA7 binding.  By establishing the region(s) of interaction, I could test 
whether the SH2B1β/CDCA7 association is required for rescuing CDCA7’s 
inhibition of NGF-dependent neurite outgrowth.  Because the interaction between 
CDCA7 and SH2B1 most likely depends upon successful phosphorylation and/or 
translocation of SH2B1, I will map the interaction by making truncation/mutations 
to CDCA7 only.  The interactions will be analyzed using co-immunoprecipitation 
in PC12 cells.   
 
Do SH2B1-/- Mice Demonstrate Defects in Sympathetic Nerve Innervation of 
Target Organs? 
 In our PC12 cell model, we have demonstrated that SH2B1 is required for 
NGF-dependent neurite outgrowth.  In order to complement our molecular work, 
we must address whether SH2B1 is required for sympathetic neuron 
development using a mouse model.  As mentioned in Chapter 1, SH2B1-/- mice 
are viable, although they develop obesity, type 2 diabetes, and demonstrate 
reduced fertility (98).  The SH2B1-/- mice, however, were not analyzed for deficits 
in sympathetic neuron development.  Because the mice are maintained in the 
highly controlled atmosphere of the laboratory, it is conceivable that the SH2B1-/- 
mice could have dramatic developmental defects within their sympathetic 
nervous system without an obvious phenotype.    
 As discussed in Chapter 1, NGF is required for both the survival as well as 
proximal axonal extension of sympathetic neurons (13).  If SH2B1 is truly 
required for the NGF-dependent signaling in sympathetic neurons, I would expect 
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to see a reduced number of sympathetic neurons at distal organs in the SH2B1-/- 
mice.  To test this hypothesis, SH2B1+/+ and SH2B1-/- mice at P0 will be 
anesthetized and sacrificed.  Whole organs, including heart, lungs, trachea, 
stomach, small/large intestine, liver, pancreas kidney, bladder, and gonads will 
be surgically removed and fixed in 4% paraformaldehyde.  Tyrosine hydroxylase 
is the rate-limiting step in catecholamine biosynthesis (312) and is a marker for 
sympathetic neurons.  Therefore, whole-mount diaminobenzidine (DAB)-tyrosine 
hydroxylase immunochemistry would be performed on organs collected from the 
SH2B1+/+ and SH2B1-/- mice.  Sympathetic innervation of the aformentioned 
organs will be compared between SH2B1+/+ and SH2B1-/- mice as described 
previously (13).   
 Despite the requirement for SH2B1 in NGF-dependent neurite outgrowth, 
we may not observe a phenotype.  If we do not see a significant difference 
between sympathetic neuron numbers within the organs of SH2B1+/+ and SH2B1-/- 
mice, we would conclude that SH2B1 is not required for sympathetic neuron 
development.  This result would suggest that the sympathetic neuron is able to 
compensate for the loss of SH2B1. 
 However, if the organs from the SH2B1-/- mice do contain a reduced 
number of sympathetic neurons, we would conclude that SH2B1-/- is required for 
proper sympathetic development.  Since SH2B1 is predicted to play a role in 
neuronal survival and neurite outgrowth, this initial finding would not differentiate 
between neurons lost due to apoptosis at an early stage (before axonal 
projection) or apoptosis resulting from a defect in axonal extension and/or 
subsequent failure to innervate target organs.  As demonstrated by Crowley et al. 
(11), the sympathetic neuron’s dependence upon NGF for survival leads to 
dramatically reduced neuronal numbers within the superior cervical ganglion of 
NGF-/- mice.  Therefore, it would be necessary to evaluate the initial neuronal 
numbers within the sympathetic chain of the SH2B1-/- mice.  A reduced neuron 
count within the sympathetic chain would be suggestive that the neuroblasts are 
unable to properly migrate from the neural tube to form the sympathetic ganglion 
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or that the neuroblasts are unable generate sufficient numbers, possibly due to 
increased apoptosis.  In contrast, if the neuronal counts at the sympathetic chain 
are similar between SH2B1+/+ and SH2B1-/- mice but the SH2B1-/- mice have 
reduced innervation of target organs, then this would suggest that SH2B1 is 
important at a later stage, possibly for axonal extension and/or innervation of the 
sympathetic neuron.  Further studies using a Bax-/- /SH2B1-/- double knockout 
could be used to discern whether SH2B1 is required for neuronal survival, axonal 




 The overall goal of my thesis research was to identify the mechanism by 
which SH2B1β facilitates NGF-dependent differentiation and survival.  I have 
provided evidence that suggests SH2B1β plays a role in the nuclear export of 
pro-apoptotic transcription factor FoxO1 after NGF treatment.  I have identified 
that SH2B1 is required for NGF-dependent neuronal differentiation and NGF-
induced transcription of uPAR, an essential primary response gene required for 
NGF-dependent neurite outgrowth.  In addition, I have provided substantial 
evidence that SH2B1β requires cycling between the nucleus and cytoplasm to 
facilitate NGF-induced transcription of genes responsible for neurite outgrowth.  
Finally, I have provided evidence suggesting that SH2B1β interacts with a 
nuclear protein and putative transcription factor CDCA7 after NGF stimulation.  
Future studies are required to clarify the importance of this interaction.  While 
these molecular mechanisms were elucidated in PC12 cells, an established 
model for sympathetic neurons, we believe the significance of SH2B1’s nuclear 
localization may extend beyond the context of NGF.  SH2B1 is an adapter protein 
for several receptor and non-receptor tyrosine kinases thus we would predict that 
the nuclear function of SH2B1 may also be relevant to the biological actions of 
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